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Abstract 
Katja Borodulin and Katri Sääksjärvi (eds.), FinHealth 2017 Study – Methods. 
Finnish Institute for Health and Welfare. Report 17/2019. 132 pages. Helsinki, 
Finland 2019. ISBN 978-952-343-449-3  
 
This report describes the planning, design and implementation as well as the 
methods and contents of the FinHealth 2017 Study, a comprehensive nationally 
representative health examination survey. The report is targeted to researchers using 
the data for various health and welfare monitoring and scientific research purposes, 
and to those who are planning or conducting large population based health 
examination surveys.  
The main aim of the study is to produce reliable and up-to-date information on 
health, wellbeing, health behaviour and functional capacity as well as their 
determinants in the Finnish adult population in 2017. As the FinHealth 2017 Study 
combines the traditions of previous Health 2000/2011 Surveys and National 
FINRISK 1972-2012 Studies and is largely comparable with them, changes in public 
health can be evaluated over time.  
The sampling design was one- and two-stage stratified, random sample 
comprising individuals aged 18 years or older and living in mainland Finland 
(N=10247, eligible sample). Furthermore, for the Eastern Finland Study with 
condensed study content, an additional sample was drawn (N=1718, eligible sample) 
to increase the sample size in the regions of North Karelia and North Savo. This 
enables analyses on longer time trends utilizing the National FINRISK Studies. 
The fieldwork was carried out in 2017 by the Finnish Institute for Health and 
Welfare. The survey covers different topics extensively, such as self-perceived 
health, quality of life, functional capacity, lifestyles, as well as major public health 
problems and their risk factors. Need for care and use of health services are also 
assessed. The data were gathered using health examination measurements and self-
administered questionnaires. Blood and urine samples were also taken from the 
participants. In addition, register based information was linked to the survey data. 
In the FinHealth main sample, participation rate was 58.1% for the health 
examination, and 68.8% for participating at any phase of data collection. In the 
Eastern Finland Study, the corresponding proportions were 57.4% and 68.1%.  
The FinHealth 2017 Study provides exceptionally good opportunities for health 
and welfare monitoring as well as for multidisciplinary public health and 
epidemiologic research. First results of the survey were published in 2018. Register 
based follow-up further enhances the possibilities for scientific research.  
 
Keywords: FinHealth 2017 Study, health examination survey, health, wellbeing, 
health behaviour, functional capacity, epidemiology, methods, health monitoring 
Tiivistelmä 
Katja Borodulin ja Katri Sääksjärvi (toim.), [FinTerveys 2017 -tutkimus – 
Menetelmät]. Terveyden ja hyvinvoinnin laitos. Raportti 17/2019. 132 sivua. 
Helsinki 2019. ISBN 978-952-343-449-3  
 
Tässä raportissa kuvataan FinTerveys 2017 -tutkimuksen suunnittelua, toteutusta, 
sisältöä ja menetelmiä. FinTerveys 2017 -tutkimus on laaja kansallisesti edustava 
terveystarkastustutkimus. Raportti on suunnattu tutkijoille, jotka käyttävät 
tutkimuksen aineistoa väestön terveyden ja hyvinvoinnin seurantaan ja tieteelliseen 
tutkimukseen, sekä niille, jotka suunnittelevat ja toteuttavat laajoja 
väestötutkimuksia. 
Tutkimuksen tavoitteena on tuottaa luotettava ja ajankohtainen kuva Suomen 
aikuisväestön terveydestä, hyvinvoinnista, terveyskäyttäytymisestä, toimintakyvystä 
ja niihin liittyvistä tekijöistä vuonna 2017. Myös muutoksia väestön terveydessä 
voidaan arvioida, sillä FinTerveys 2017 -tutkimus yhdistää aiempien Terveys 
2000/2011- ja Kansallisten FINRISKI 1972-2012 -tutkimusten pitkät perinteet ja on 
niiden kanssa laajalti vertailukelpoinen. 
Yksi- ja kaksiasteisesti poimittu satunnaisotos koostui 18 vuotta täyttäneistä 
manner-Suomessa asuvista henkilöistä (N=10247, korjattu otos). Itä-Suomen 
tutkimukselle, joka sisälsi rajoitetumman tutkimussisällön, poimittiin lisäotos 
(N=1718, korjattu otos) otoskoon kasvattamiseksi Pohjois-Karjalassa ja Pohjois-
Savossa. Tämä Itä-Suomen lisäotos mahdollistaa pitkien aikatrendien analysoimisen 
Kansallisia FINRISKI -tutkimuksia hyödyntäen. 
Terveyden ja hyvinvoinnin laitos toteutti tutkimuksen kenttävaiheen vuonna 
2017. Tutkimus kattaa laajasti eri teemoja, mm. koettu terveys, elämänlaatu, 
toimintakyky, elintavat, yleisimmät kansanterveysongelmat sekä niiden riskitekijät. 
Lisäksi arvioidaan hoidon ja avun tarvetta sekä terveyspalvelujen käyttöä. Tiedot 
kerättiin terveystarkastusmittauksin ja kyselylomakkein. Tutkittavilta otettiin myös 
veri- ja virtsanäytteitä. Tutkimusaineistoa on täydennetty yhdistämällä siihen 
kansallisista rekistereistä saatavia tietoja.  
FinTerveys-tutkimuksen pääotokseen kuuluvista terveystarkastukseen osallistui 
58,1 %, ja 68,8 % osallistui ainakin yhteen tiedonkeruun vaiheeseen. Itä-Suomen 
tutkimuksen otoksessa vastaavat osuudet olivat 57,4 % ja 68,1 %. 
FinTerveys 2017 -tutkimuksen aineisto tarjoaa ainutlaatuisen mahdollisuuden 
sekä väestön terveyden ja hyvinvoinnin seurantaan että monitieteelliseen 
terveystutkimukseen. Ensimmäiset tulokset tutkimuksesta julkaistiin vuonna 2018. 
Rekisteriseurantatiedot lisäävät aineiston käyttökelpoisuutta tieteelliseen 
tutkimukseen. 
 
Avainsanat: FinTerveys 2017 -tutkimus, terveystarkastustutkimus, terveys, 
hyvinvointi, elintavat, toimintakyky, epidemiologia, menetelmät, terveysseuranta 
Sammandrag 
Katja Borodulin och Katri Sääksjärvi (red.), Undersökningen FinHälsa 2017 – 
Metoder. Institutet för hälsa och välfärd. Rapport 17/2019. 132 sidor. Helsingfors, 
Finland. ISBN 978-952-343-449-3  
 
Denna rapport beskriver planeringen, genomförandet liksom metoderna och 
innehållen i undersökningen FinHälsa 2017, en omfattande nationellt representativ 
hälsoundersökningsstudie. Rapporten riktar sig till forskare som kan använda 
uppgifterna för diverse syften inom övervakningen av hälsa och välfärd samt 
vetenskaplig forskning, och till dem som planerar och genomför stora 
befolkningsstudier om hälsa.  
Syftet med studien är att skapa tillförlitlig och aktuell information om den vuxna 
befolkningens hälsa, välfärd, levnadsvanor och funktionsförmåga liksom 
samhörande faktorer i den finska vuxna befolkningen 2017. Eftersom 
undersökningen FinHälsa 2017 kombinerar traditionerna från Hälsa 2000/2011 -
undersökningarna och nationella FINRISK 1972-2012 -studierna och i stor 
utsträckning är jämförbar med dem, kan förändringar i folkhälsan utvärderas över tid. 
Som urvalsmetod användes ett- och tvåstegs stratifierat slumpmässigt sampel av 
personer som fyllt 18 år och som bor i fasta Finland (N= 10247, korrigerat sampel). 
Dessutom användes ett ytterligare sampel (N=1718, korrigerat sampel) för att öka 
samplet i regionerna norra Karelen och norra Savolax för undersökningen i östra 
Finland med ett begränsat studieinnehåll. Detta möjliggör analyser av trender över 
längre tidsperioder, genom att även använda de nationella FINRISK studierna. 
Fältarbetet genomfördes 2017 av Institutet för hälsa och välfärd. Undersökningen 
berör olika tema på ett omfattande sätt, såsom självskattad hälsa, livskvalitet, 
funktionsförmåga, levnadsvanor, liksom centrala folksjukdomar och hälsoproblem 
och deras riskfaktorer. Behov av vård och användning av hälsotjänster evaluerades 
också. Data insamlades genom hälsoundersökningar och frågeformulär. Av 
deltagarna togs även blod- och urinprov. Dessutom kopplades information från 
register till studien. 
Av personerna i undersökningen FinHälsas huvudsakliga sampel deltog 58,1 % i 
hälsoundersökningen och 68,8 % i åtminstone någon del av datainsamlingen. För 
undersökningen i östra Finland var motsvarnade deltaganden 57,4 % och 68,1 %. 
Undersökningen FinHälsa 2017 erbjuder goda möjligheter för hälso- och välfärds 
övervakning i befolkningen liksom för multidisciplinär forskning inom 
hälsovetenskap. De första resultaten av undersökningen publicerades 2018. 
Uppföljning via register främjar möjligheterna till vetenskaplig forskning. 
 
Nyckelord: Undersökningen FinHälsa 2017, hälsoundersökningsstudie, hälsa, 
välfärd, levnadsvanor, funktionsförmåga, epidemiologi, metoder, övervakning av 
hälsa
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1 Introduction 
Katja Borodulin, Katri Sääksjärvi and Seppo Koskinen 
 
This report descbribes in detail the methods used in the FinHealth 2017 Study. The 
FinHealth 2017 Study is a comprehensive nationally representative health 
examination survey. The aims of the survey are to produce reliable and up-to-date 
information on health, health behaviour, functional capacity, and wellbeing in the 
adult population in Finland, and further to study the determinants and changes in the 
covered topics. Further, the FinHealth 2017 Study adds up to the surveys which 
have a major role in the national health monitoring system, and which have been 
carried out since the late 1960s (Aromaa et al. 2019). The Department of Public 
Health Solutions at the Finnish Institute for Health and Welfare (THL) coordinated 
the survey in cooperation with an extensive network of experts.  
The FinHealth 2017 Study included a health examination, where various 
measurements, blood sample collections, and health interviews were carried out. 
Additionally, self-administered questionnaires were gathered with information on 
different topics, such as self-perceived health, quality of life, health behaviour, 
history of diseases and related conditions, use of medication, use of health services, 
as well as need and use of care and assistance. The study protocol merged the 
protocols of the previously implemented National FINRISK 1972–2012 Studies 
(Borodulin et al. 2018) and the Health 2000/2011 Surveys (Heistaro 2008, 
Lundqvist & Mäki-Opas 2016), which enables high comparability over time.  
The methods in the FinHealth 2017 Study and the preceding health examination 
studies at THL constitute a solid platform for expertise in monitoring, evaluating 
and projecting population health. This expertise requires continued national and 
international collaboration. We seek for high comparability over time and across 
countries. Our work receives mutual support and benefits from the European Health 
Examination Survey guidelines (Tolonen et al. 2018), which emphasise the need to 
monitor population health and the use of survey based information for evidence 
informed planning and evaluation of health policies and preventive activities. The 
continued development and evaluation of health examination methodology will 
assist us, for example, in recognizing new public health problems, developing novel 
research methods, and reaching higher participation rates. 
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2 Planning and preparation 
2.1 Project organisation and funding 
 
Katja Borodulin and Seppo Koskinen 
 
The project organisation involved a wide range of organisations and experts. THL 
had the overall responsibility for the project planning and implementation. A large 
number of specialists from different organisations participated in the project 
organisation. An Executive Board was set up to plan, direct and evaluate the 
FinHealth 2017 Study. The Executive Board comprised experts from THL. Much of 
the implementation, planning and execution was done by the Fieldwork coordination 
team at THL. Expert groups on different main topics of the survey participated in all 
phases of the preparation and execution of the survey. The topics covered by these 
teams were e.g. cardiovascular diseases and diabetes, mental health, musculoskeletal 
disorders, oral health, reproductive health, diet, health behaviour, functioning, and 
need and use of services. 
The project organisation involved more than 200 researchers and other experts 
covering different topics and taking part in planning, training and supervision of the 
field examinations, as well as reporting. In addition, many other researchers from a 
number of research institutes, universities, hospitals and clinical health care facilities 
use the data in their research. The main results covering persons aged 30 and over 
were published in spring 2018 under the title “Health, functional capacity and 
welfare in Finland – FinHealth 2017 Study” (Koponen et al. 2018). Results on some 
key indicators can be also found from the interactive health indicator portal 
Terveytemme.fi (Our health). Furthermore, the results from the National FinDiet 
Sub-study on dietary habits and nutrient intake of the adult population were 
published in 2018 (Valsta et al. 2018). The main results concerning young adults 
(18–29-year-olds) were published in spring 2019 (Jääskeläinen et al. 2019).  
The overall costs of preparing and implementing the fieldwork, management and 
quality control for the data, and preparing the baseline report totalled approximately 
2.6 million Euros. This included a large amount of work carried out by permanent 
staff members and experts at THL and other participating organisations as part of 
their daily work. The funding was collected from several sources. The largest 
contribution was received from THL budget, The Social Insurance Institution of 
Finland, and the FinGen Research Project. The other main sponsors were European 
Food Safety Agency, the Juho Vainio Foundation, the Regional Council of North 
Karelia, the Gyllenberg Foundation, the Finnish Diabetes Association and the 
University of Tampere/Elsemay Björn Fund. 
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2.2 Ethical approval  
 
Katja Borodulin 
 
The FinHealth 2017 Study received approval from the Coordinating Ethics 
Committee at the Hospital District of Helsinki and Uusimaa (Reference 
37/13/03/00/2016). The study followed the principles of good scientific practice at 
THL and the ethical principles of the Declaration of Helsinki for medical research 
involving human subjects. Participants at the health examination received and read 
an information leaflet on the study protocol, were informed at the reception of the 
health examination and gave their signed informed consent (see Chapter 3 for more 
details). 
 
2.3 Sampling design 
 
Tommi Härkänen, Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
The sampling design of the FinHealth 2017 Study was based on the Health 2000 
Survey sampling design in order to form representative data on the Finnish 
population. We first give an overview of the Health 2000 and 2011 Survey sampling 
designs and after that we describe the FinHealth sampling design. 
 
Sampling design of the Health 2000 and 2011 Surveys 
 
The target population of the Health 2000 Survey comprised individuals aged 18 
years or older and living in mainland Finland on 1 July 2000 (Laiho 2004). In 
addition to the household population, people living in institutions were included. 
The Autonomous Territory of Åland and other municipalities on islands not 
accessible by road were excluded.  
A stratified one- and two-stage sampling design was used. Mainland Finland was 
divided into 20 strata defined by the 15 largest cities and towns (their health centres) 
and the remaining rural areas based on the five university hospital regions. The 15 
towns were selected with probability 1 (one-stage sampling), and the remaining 65 
health centres were selected from the rural strata using a systematic probabilities 
proportional to size (PPS-SYS) design (two-stage sampling). The second stage 
involved sampling individual persons from those districts. The sample size for each 
health centre within a stratum was equal so that the total sample size in a stratum 
was proportional to the target population. Oversampling of the people aged 80 and 
older was carried out using double inclusion probabilities. The total sample size was 
9,922. Those who were at least 30 years of age (N=8,028) were invited to participate 
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in the health examination; young adults (N=1,894) were invited to participate in the 
health interview and to fill in the questionnaires. In 2011 all members of the Health 
2000 Survey sample who were alive, living in Finland in 2011, had contact details 
available and had not refused to participate in further surveys were invited to take 
part in the Health 2011 Survey (N=8 135). A new random sample of persons aged 
18–29 years was also included (N=1994) (Härkänen et al. 2016).  
 
Sampling design of the FinHealth 2017 Study 
 
To reduce the costs of the field work, only 50 health centre districts (HCDs) out of 
the 80 HCDs of the Health 2000 Survey were selected for the FinHealth 2017 Study. 
These 50 HCDs were the 15 largest cities and seven randomly selected HCDs from 
each of the five rural strata.  
Due to the fact that there were changes in the municipal borders between 2000 
and 2017, the geographical coordinates of addresses in 2016 and the municipal 
boundaries in 2000 were applied to link the HCD codes with the Population Register 
Centre data covering the whole population of Finland in 2016. There can be overlap 
or underlap between the true municipal borders and the polygon-based, approximate 
municipal borders, but we consider these differences small, because these underlap 
or overlap areas are usually sparsely populated. The population sizes in 2016 based 
on the municipal boundaries in 2000 were based on the Population Register Centre 
data to determine the sample sizes for each HCD. The exact population sizes along 
with the actual samples were obtained from the Population Register Centre at the 
time of the sampling to calibrate the weights for analyses.  
The sample size of individuals in each stratum was proportional to the 
corresponding population size (Table 2.3.1). Study subjects were at least 25 years of 
age, and a small sample (n=298) from the age group 18–24 years (all study areas) 
was also selected. These samples are called here as the main sample, in which the 
total sample size was 10,305. Two additional, geographically defined samples were 
selected from the study areas in North Karelia (n=1400, including an additional 
HCD of Kitee, Kesälahti and Rääkkylä) and North Savo (n=332) for comparison 
with the former FINRISK Study areas. The sample was drawn on November 17, 
2016. The sample information was updated altogether 5 times (in 2017: Jan 16, 
March 20, June 12, Nov 1; and in 2018: April 25) from the population register, to 
receive information on deaths and changes in the place of residence. 
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Table 2.3.1. Sample sizes in the FinHealth 2017 Study.  
Sample Age group (yrs) Men Women All 
FinHealth young 
adult sample 
18–24 164 134 298 
FinHealth adult 
sample 
25–34 883 837 1720 
 35–44 890 837 1727 
 45–54 903 845 1748 
 55–64 1005 895 1900 
 65–74 794 837 1631 
 75–84 373 547 920 
 85+ 96 265 361 
 All 4944 5063 10 007 
FinHealth main 
sample (adult + 
young adult) 
All 5108 5197 10 305 
North Karelia 
additional sample 
25–74 736 664 1400 
North Savo 
additional sample 
25–74 152 180 332 
 All 888 844 1732 
All samples  5996 6041 12 037 
 
 
Representativeness of the samples 
 
In the main sample, the HCDs of the rural strata were selected in 2000 using the 
PPS-SYS sampling based on the population sizes in 2000, thus the sample sizes per 
HCD were adjusted by the population growth between 2000 and 2016 to retain equal 
sampling probabilities per individual. As the sample sizes in the 15 largest cities as 
well as the total sample sizes in each rural stratum were proportional to the 
population sizes, the sampling probabilities were equal in the age group 25 years and 
older, but considerably lower in the age group 18-24 years, in which the sample size 
was small. 
The additional samples from North Karelia and North Savo are not to be 
analysed as part of the main sample, because the study protocol was very much 
condensed, and the results would be less representative at the national level due to 
an excessive number of participants from these areas. In North Karelia, the HCD of 
Kitee, Kesälahti and Rääkkylä, was selected in the sample, thus it must be analysed 
as a separate stratum in the sampling design.  
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Samples for sub-studies and selected additional samples  
 
Part of data collection was targeted to smaller sub-samples, called as sub-studies in 
this report (Table 2.3.2).  
 
Table 2.3.2. Description of the sub-studies and additional samples of the FinHealth 
2017 Study. 
Name of sub-
sample 
Sample 
size 
Age at 
sample 
draw 
Area Selection criteria 
Young adults 298 18–24 All Age 
FinDiet 3112 18–74 All 18–24-year-olds: all included 
(n=298); 25-64-year-olds: a randomly 
chosen 30% sub-sample (n=2129); 
65–74-year-old: a randomly chosen 
42% sub-sample (n=685). 
70-year-olds 1992 70+ All Age 
Joint function 4812 55+ All Age 
Physical activity 
and sleep 
2000 25+ All Randomly chosen 2000 individuals of 
the sample; not included in the diet 
sub-sample 
Spot urine 2814 25–74 All Those included in the FinDiet sub-
sample 
24-h urine 1555 25–74 Selected 
locations 
Those included in the FinDiet sub-
sample 
Urine validation 692 25–74 
 
Those included in the FinDiet sub-
sample and the 24-h urine sub-
sample 
Bioimpedance 
validation 
150 25–74 Helsinki Area, randomly chosen 150 
individuals from the sample in 
Helsinki 
North Karelia 
additional sample  
1400 25–74 North 
Karelia 
Geographical location, including also 
the Kitee health centre district 
North Savo 
additional sample 
332 25–74 North 
Savo 
Geographical location 
 
The selections were based on, for example, age or geographical area. Age criteria 
were based on the age at the time of the sample draw (November 2016). Sub-studies 
were implemented on a smaller number of participants mainly to ease the burden of 
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the participant during the health examination. At the same time, the sample size was 
calculated to study reliably the phenomenon in focus of each sub-study. The 
contents of the measurements for sub-samples are described elsewhere in this report 
(see Chapter 20, and Chapters 15, 18 and 19 regarding the Questionnaire for persons 
aged 70 years or older). 
 
2.4 Preparation of fieldwork  
 
Katja Borodulin, Katri Sääksjärvi, Niina Kaartinen, Päivikki Koponen, Seppo 
Koskinen, Laura Råman, Päivi Sainio, Hanna Tolonen, Liisa Valsta and Hanna 
Valtonen 
 
Planning of the FinHealth 2017 Study started in 2015. The fieldwork protocol 
including all questionnaires and the health examination was designed by the 
FinHealth field coordination team at THL (see Appendix 2) together with many 
experts from THL and from other academic institutions. Validated and commonly 
used methods were chosen whenever possible to ensure the quality of data and 
international comparability of the results. Moreover, the methods and contents of the 
survey were aimed to be as similar as possible with the previous health examination 
surveys at THL, i.e. the Health 2000/2011 Surveys and the National FINRISK 
Studies to ensure comparability of the results across the surveys. If the questions and 
protocols in these two previous surveys were different, the coordination team 
decided which of them was chosen.  
A simplified schedule of planning and implementation of the FinHealth 2017 
Study is described in Figure 2.4.1. The preparations took on average a full year of 
working time for a few experts and part time for several other experts. There were 
several important elements in the planning, including e.g. planning detailed 
protocols for the measurements, selection of the study locations, and preparation of 
the logistics system.  
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Figure 2.4.1. Schedule for planning and implementation of the FinHealth 2017 
Study. 
 
 
Recruitment of the fieldwork personnel 
 
A total of 43 persons (including public health nurses, nurses, bioanalysts/laboratory 
technicians, physiotherapists and nutritionists) from six cities in Finland (Helsinki, 
Kuopio, Lahti, Oulu, Tampere and Turku) were recruited. Positions for the study 
nurses were advertised in all major local newspapers and other relevant locations. 
Job interviews were carried out in October through November 2016. The interviews 
were carried out by the field coordinator and the laboratory coordinator, who were 
most capable of identifying the needed practical skills and building functional, co-
operative teams. For the FinDiet sub-study, the recruitment process and interviews 
2016 2017 2018
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PREPARATIONS
Research plan finalised
Questionnaires finalised
Funding secured
Ethics Committee application
Preparations for sample draw
Inform Ministry of Health and Social Affairs
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Schedule for study locations finalised
Contacts with towns/study locations
Logistics system up and running
Pilot Study implementation
Recruitment of nurses: contact previous 
staff
Recruitment of nurses: local newspapers
Recruitment of nurses: interviews
Contact persons for research location set
Sample draw
Study sites : facilities set, agreements
Questionnaires & materials: layout, printing
Logistics system updated with the sample 
and schedule
Toll-free telephone service set up
Study manuals ready
Order laboratory equipment and devices
FIELD PHASE
Invitations to participants sent
Training of telephone service staff
Training of nurses
Health examinations
DATA MANAGEMENT
Preparations on variables: xml, metaform
Web-based questionnaires ready
Logistics system set up
Quality control of the field phase
Main results/report published
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were carried out by the FinDiet coordinator. Six teams with six members were 
chosen to cover the six study areas. Furthermore, a separate team in the Helsinki 
headquarters with substitute workers and telephone service was recruited.  
 
Pilot Study 
 
A pilot Study was implemented to test the feasibility of the study protocol. It was 
designed to include all measurements and all elements in the data collection of the 
FinHealth 2017 Study.  
A random sample of 200 men and women aged 18 years and above, in the cities 
of Espoo, Helsinki and Vantaa, were drawn from the population register. A 
personalized invitation letter together with the first questionnaire was sent to the 
sample by mail on August 2, 2016. The invitees were asked to confirm their pre-set 
health examination time by themselves using the online appointment application or 
by calling the toll-free service number. The recruitment process of the invitees is 
described in detail later in this report.  
The pilot health examinations took place from August 22nd to September 6th in 
2016 at four examination rooms at THL premises in Helsinki. Dietary interviews 
continued by phone until September 15th, 2016. The study personnel were 
permanent staff members from THL who also had a two-day training before the 
pilot. After the data collection period, all materials were coded to numerical formats 
and checked for accuracy and feasibility. All experiences, including those of study 
nurses and the participants were taken into account to make sure that the FinHealth 
2017 Study would be as successful as possible. The participants were asked to fill in 
a feedback questionnaire (65 questionnaires were returned), and discussions with the 
study nurses were organized.  
 
Several points of the feasibility were considered for conducting the full FinHealth 
2017 Study: 
• The participation rate of the pilot study was 50%, which was considered 
close to what was expected in the Helsinki region. The recruitment process 
was decided to be enhanced by sending teaser postcards to all participants 
prior to the formal invitation letter, by creating a detailed contact protocol 
that assisted in creating phone call lists and other tasks for reminding the 
invitees, and by paying attention to easy access to all examination locations. 
• The participants used an online appointment application to confirm or 
change their pre-set examination time. A new logistics system was 
developed for this purpose. The application worked satisfactorily and the 
user feedback was encouraging enough to include the application in the 
FinHealth 2017 Study.  
• The online system for filling in questionnaires was designed earlier at THL 
and developed for use in the pilot study. The system was accessed with 
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personalized user names and passwords that were given in the invitation 
letter. Based on the user feedback from the participants, the application 
worked satisfactorily and it was decided to be used in the study.  
• The health examination protocol was tested for timing and order of the 
measurements. The timing of the measurements was not balanced between 
the examination rooms and this was taken into account in later decisions on 
the final protocol. 
• The participants were generally satisfied with the study protocol, the 
contents of the study and the friendly personnel. However, they gave 
negative feedback mainly on the length of the questionnaires and the length 
of the health examination visit with some waiting time for the 
measurements. However, it was decided that no major parts of the 
questionnaires or examinations would be cut off, as the return rate of the 
questionnaires was acceptable and the length of the examination visit could 
be reduced with minor changes in the protocol.  
 
Training of the study personnel 
 
Training of the field work personnel was organized in two parts at THL in Helsinki, 
where the first part (Jan 12-13th, 2017) included training of the six fieldwork team 
leaders and their two substitute study nurses. This training focused at team leading 
tasks and administration. The second part (Jan 16-27th, 2017) was targeted to all 
study personnel and nutritionists and lasted two weeks. The training was planned by 
the FinHealth field coordination team.  
The general training of all fieldwork personnel covered an introduction to the 
aims and protocols of the study, ethical issues, data protection and informed consent, 
quality assurance, safety instructions, the roles and responsibilities of the central 
office and the fieldwork personnel as well as rules and principles for communication. 
The study personnel received the full field manual in the training period so that they 
could check and recap the standards during the fieldwork and find instructions for 
challenging situations. In addition, general IT training and an introduction to the 
terms and conditions of employment (working hours, vacations, sick leaves, travel 
arrangements and allowances) was given.  
The training was tailored to the content of the respective measurement stations 
and it covered lectures and practical training for interviewing techniques and 
measurements. The content and guidelines for each measurement station are 
explained in more detail under the specific chapters describing the contents of the 
health examination. Before the actual fieldwork, the personnel had one day of 
practice of the full study protocol with volunteer participants at THL and another 
day at the real study sites at the first six study locations across the country. The 
personnel also had short check-up lists to make sure all tasks were carried out as 
instructed.   
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At the end of the training period, the fieldwork personnel were asked to fill in a 
feedback questionnaire, which nearly all of them returned. Based on the feedback, 
all fieldwork personnel had received enough information about the survey aims, 
research ethics and obtaing informed consents, and the specific measurements. A 
few considered that the introduction to the terms and conditions of employment, and 
the training on IT programmes and equipment was somewhat insufficient. The 
personnel gave several comments indicating that they found the training inspiring. 
They also told that there was enough time for practicing each of the measurements. 
However, some of them felt that there should have been more time to practise the 
full protocol, and critique was also received on some unfinished materials and 
incomplete IT programmes. 
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3 Implementation  
3.1 Central office, fieldwork locations, facilities and personnel 
 
Katja Borodulin, Katri Sääksjärvi, Niina Kaartinen, Päivikki Koponen, Seppo 
Koskinen, Laura Råman, Päivi Sainio, Hanna Tolonen, Liisa Valsta and Hanna 
Valtonen 
 
The fieldwork was conducted between 31st of January and 17th of May, 2017. The 
additional field work in the Eastern Finland sub-study in North Karelia and North 
Savo continued until 18th of June, 2017.  
The central headquarters were located at the Finnish Institute for Health and 
Welfare (previously called the National Institute for Health and Welfare) in Helsinki, 
where also the management of the entire survey was situated. The central office 
offered the toll-free telephone service for the subjects, and managed the returned 
questionnaires, blood samples, and other materials. The blood samples were 
analysed and further stored at the central laboratory at THL (see Chapter 6). 
The fieldwork was carried out in 50 locations across the country (Figure 3.1.1) 
by the six field teams. Each team had a detailed schedule (see Appendix 3). The 
schedule for each team was designed based on the distance from the central town of 
the corresponding team to optimise travel time and make the fieldwork as feasible as 
possible. The length of stay in each location depended on the number of subjects to 
be examined based on the sample design. The teams travelled between locations 
with rented cars bringing along all required examination equipment. 
Accommodation was arranged at hotels. Outside the central towns, each week 
started on Monday morning with a travel to the study site and ended by Friday 
evening upon returning to the central town.  
The facilities required for the health examinations included five to six furnished 
examination rooms located in close proximity to one another. Other relevant 
requirements included a common waiting area and a toilet. The facilities for the 
health examination were requested from local health centres. Majority of the 
facilities were provided in co-operation by the local health centres, while just a few 
were rented from the private market. A few facilities were also provided by the local 
municipality, hospital district or university.  
The six fieldwork teams comprised each six members. Each team had one study 
nurse who served as a team leader (hereafter called as leading study nurse). Each 
team member had a specified role in one examination room and the tasks were 
maintained throughtout the field phase (Table 3.1.1). Only one study nurse in each 
team travelled to stay some days with other teams to assure blood pressure 
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validation between the teams. The detailed description of the tasks for each 
examination room is given in the health examination section in this report (see 
Chapter 3.4). Furthermore, at the central office in Helsinki there were several 
substitution workers who covered sickness absences and travelled to the study 
locations when needed.   
 
 
 
Figure 3.1.1. Study locations in the FinHealth 2017 Study. 
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Table 3.1.1. The roles and tasks of the personnel in each team. 
Title Examination room and task 
Leading study nurse 
(team leader)  
Examination room 1A; registration, information and consent, blood pressure, 
visual acuity, waist and hip circumference, questionnaires. Interaction with 
central office and study location, management of the team.  
Study nurse  Examination room 1B; registration, information and consent, blood pressure, 
visual acuity, waist and hip circumference, questionnaires, travel between 
teams for blood pressure validation. 
Bioanalysts 1 and 2 Examination room 2; height, weight, bioimpedance, blood draw. 
Physiotherapist or  
study nurse 
Examination room 3; functional capacity, cognitive tests, accelerometry, 
questionnaires. 
Nutritionist Examination room 4; 24-hour dietary interview. 
 
3.2 Recruitment of the participants  
 
Katri Sääksjärvi and Katja Borodulin 
 
A pre-notice postcard was sent to all sampled persons two weeks before sending the 
invitation letter. The subjects were invited to participate in the health examination 
with a personalized invitation letter including a pre-set appointment time. The 
information leaflet and Questionnaire 1 were sent together with the invitation. The 
materials were sent in Finnish or Swedish. The language was selected based on the 
native language recorded in the Population Register. English versions of the 
invitation letter and information leaflet were also mailed in addition to the Finnish 
one, if the person had a mother tongue other than Finnish, Swedish or Sami. Also 
English versions of questionnaires could be mailed later or given at the examination 
site, if requested. Mail batches were sent every second Monday starting from 
2.1.2017, 4–6 weeks before the pre-set appointment time for the health examination 
(Figure 3.2.1). Postal addresses were obtained from the population register. In the 
invitation letter, the subjects were asked to confirm their pre-set health examination 
time by themselves using the online appointment application or by calling the toll-
free service number. In either case, the invitees had the option to change the 
appointment time and place for a more convenient one. 
Private phone numbers for the sampled persons were obtained from a company 
offering telephone directory service, or collected when the invitees called to the 
service number of the survey. For those who had a mobile telephone number 
available, an automatic SMS reminder was sent two days before the appointment 
time whether or not the time was confirmed, as the appointment time was held 
assigned to the invitee even if the time was not confirmed. If the appointment was 
not confirmed at least two weeks before the health examination time, the central   
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Figure 3.2.1. Recruitment protocol of the participants. 
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office personnel started re-contacting the invitees by phone calls and SMS messages 
or by postcards if a telephone number was not available. 
The central office personnel were trained for re-contacting the invitees to 
motivate participation in the health examination. Along with reminding about the 
appointment time and the possibility to reschedule it, they offered detailed 
information about the survey and why it is important to participate, explained the 
confidentiality of information given by invitees during the survey, and informed 
about the laboratory test results and the personal Health Profile each participant 
would receive later. All persons unable or not willing to attend the health 
examination were asked to return the Questionnaire 1 or, if this was not possible, to 
attend a short phone interview. Information on re-contacts and attempts to re-contact 
was recorded into the database through the online service portal. In case of refusals, 
information on what part of the survey the subject was refusing from and the reason 
for it was also recorded in the database. 
After the field teams had finished their journey according to the schedule, they 
returned to the corresponding central town of the team for a few days of additional 
health examination appointments. A new invitation letter for this ”last chance” 
health examination was sent to those who had not participated in the health 
examination but not refused from it. Invitees were asked to confirm their pre-set 
appointment time, re-contacted if necessary, and reminded with SMS messages 
according to the original recruitment procedure (Figure 3.2.1). For the Helsinki area 
the protocol was different, as a pre-set appointment time was not given due to the 
large number of potential participants. Instead they received a post card with an 
invitation to the health examination and a request to book the appointment time 
either online or by phone, using the toll free service number. Postcard was folded 
and sealed, because it included the individualised password information.  
Later after the field phase, SMS reminders were sent to request those 
questionnaires not yet returned. After that, a second batch of questionnaires was 
mailed to those persons who were invited but had not participated in the health 
examination (Questionnaire 1), or had not returned the questionnaires given at the 
health examination. In addition, as a last wave of re-contacting in August 2017, the 
central office personnel performed short phone interviews by calling those subjects 
who had refused to participate in the health examination but not in the whole survey 
and had not returned Questionnaire 1. However, due to limited resources, only a 
small part of such subjects were re-contacted. 
Special attention was paid to the recruitment of participants in order to achieve as 
high participation as possible, covering many methods described in the European 
Health Examination Survey protocol (Tolonen 2016a). No gifts or other 
compensation were used to increase participation, but the participants were 
promised that a feedback letter would be sent to them in a couple of weeks with their 
personal blood test results, and another one after the survey including a 
comprehensive personal Health Profile. The Health Profile included their own 
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results compared with the results of the general population in the respective age/sex 
group, as well as advice on health promotion and information on reference values (a 
more detailed description is given in Chapter 21). A free taxi ride to and from the 
health examination site was offered for people with physical disabilities or other 
problems in mobility.  
Phone numbers were an essential part of the recontacting the participants and 
they were available for about two-thirds of the sample. Some of the numbers were, 
however, found to be incorrect or not in use anymore. Moreover, subjects with 
prepaid phones or secret numbers were not listed in telephone directories. Some 
efforts were made to search phone numbers from the internet, and occasionally 
phone numbers for business phones of the subjects were found. In those cases, extra 
attention during the phone call was paid to assuring the identity of the subject in 
order to make sure that the right person was invited to participate. However, this was 
time consuming, and most of the central office’s resources were targeted to re-
contacting those with a phone number available from the telephone directory service 
provider. 
 
3.3 Informed consent 
 
Katja Borodulin and Katri Sääksjärvi 
 
An information leaflet describing the study and its objectives was sent to the 
subjects along with the invitation letter. At the study site, participants were asked if 
they had read the information leaflet and if they had additional questions. In the 
examination rooms study nurses explained the purpose of the study and informed the 
participant about the questionnaires, measurements and blood samples taken during 
the examination, and the linkage of register-based data and survey data, as well as 
how all these will be used for medical research purposes in the future. The voluntary 
nature of participation and the right to withdraw and cancel the participation at any 
stage was emphasized.  
The participants gave their written informed consent in two identical copies. If 
the participant was unable to fill in the consent form due to physical or cognitive 
disability, the consent was signed by a third party, in most cases by an 
accompanying family member or personal assistant. Use of a third party was marked 
in the questionnaire (n=81, i.e. 1.4 % of the participants were unable to give the 
consent themselves). The study nurses checked that the signature and other 
information was correct and then, by signing the consent form, confirmed that the 
subject had been informed and gave the consent voluntarily. 
The FinHealth 2017 Study had two separate consent forms. The first one, signed 
upon arrival at the registration, was the main consent of the FinHealth 2017 Study. If 
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the participant refused to sign this first consent, the examination was not started and 
the refusal to participate in the health examination was recorded in the logistics 
system (the participant could still fill in Questionnaire 1 if willing). The second 
consent concerned the use of samples and information collected in the survey by the 
THL Biobank. A separate Biobank information leaflet was given to the participant, 
and the participant was given time to read the information leaflet. The signatures for 
the Biobank consent were obtained at the second examination room from both the 
participant and the study personnel, before taking the blood samples. For the 
Biobank consent, only participant’s own signature was accepted, and if this was not 
possible due to the participant’s physical or cognitive disability, the samples for the 
Biobank were not taken.   
 
3.4 Health examination 
 
Katja Borodulin, Katri Sääksjärvi, Niina Kaartinen, Päivikki Koponen, Seppo 
Koskinen, Laura Råman, Päivi Sainio, Hanna Tolonen, Liisa Valsta and Hanna 
Valtonen 
 
The health examination protocol is presented in Figure 3.4.1. The used measurement 
devices and techniques as well as their detailed contents are described in separate 
chapters in this report. The identification of individuals, including sticker 
identification numbers is described in Chapter 5.1. Each examination day was 
scheduled in advance with pre-arranged time slots for the participants. Daily visits 
were managed using a daily visit list.  
The participant arrived at the first examination room, where the leading study 
nurse (examination room 1A) and study nurse 2 (examination room 1B) had the 
following tasks: welcome the participant, check identity, give information on the 
study and receive signed consent, place sticker (see Chapter 5.1) on the daily visit 
list and on the questionnaires, check and help (if needed) with Questionnaire 1, give 
information and guidance on THL Biobank and the biobank consent, give 
information and guidance for Questionnaire 2, Food frequency questionnaire (FFQ), 
Food propensity questionnaire (FPQ) (sub-study), Questionnaire for persons aged 70 
years or older (sub-study), measure upper arm circumference, measure pulse rate 
and blood pressure, measure waist and hip circumference, test visual acuity (near 
and distance) and give feedback on the measurement results. Participants were given 
a folder including these material as well as sticker labels with bar codes for 
collection of biological samples (see Chapter 6.2). The study nurses in the 
examination rooms 1A and B also tried to contact by phone those who didn’t arrive 
for the appointment (no-show subjects).  
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Figure 3.4.1. The health examination protocol in the FinHealth 2017 Study.  
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The participants were asked to fill in the Questionnaire 1 before arriving at the 
examination. If the form had not been completed, study nurse encouraged and 
helped the subject to fill in the questionnaire. The other questionnaires were given to 
take-home or filled in while waiting for admission to the following examination 
rooms (if feasible). Participants were asked to mail these questionnaires to the 
central office using a free-of-charge envelope, or return them in the third 
examination room or the dietary interview room.  
The tasks of the two bioanalysts or laboratory technicians in the second 
examination room were the following: check identity and sticker (see Chapter 5.1), 
measure height, weight and body composition (bioimpedence), give feedback on 
these measurement results, receive the signed biobank consent and check if the 
subject had any questions concerning the THL Biobank, draw blood samples, collect 
spot urine (sub-study), give information and guidance on 24-hour urine sampling 
and hand out the collection material and diary (sub-study). While the other 
bioanalyst/study nurse was carrying out these tasks the other’s tasks were: to 
manage (e.g. sentrifuge, divide, freeze) blood samples, read the matrix tubes into the 
database and store them in the freezer, and read the sample packages into the 
database before sending them to the central office. 
In the the third examination room a physiotherapist or study nurse carried out the 
functional capacity tests. The tasks in this room were as follows: check identity, 
carry out tests on cognitive functioning, hand grip strength and chair stand,  joint 
functioning among 55+-year-olds, give information and guidance on how to wear 
the accelerometer and fill in the diary on physical activity and sleep (sub-study), 
receive questionnaires that had already been filled in during the examination or 
remind the subject to fill them in at home, and finally thank for participation and ask 
if the participant had any further questions about the survey or his/her personal 
results and give feedback on the measurement results. If the participant belonged to 
the dietary interview sub-sample, the final task was to guide the participant to the 
room where the dietary interview was carried out. 
The final, fourth examination room was reserved for the dietary interview by a 
nutritionist, with the following tasks: check identity, check the FPQ, guide the use of 
picture book on meal portions, carry out a 24-hour dietary interview, make an 
appointment for the phone interview, and thank for participation and ask if the 
participant had any further questions about the dietary survey.  
At the end of each day, the teams saved the information that was collected during 
the day in electronic format. Questionnaires were packed into postal packages and 
further shipped to THL. Further, the teams tried to contact the no-show subjects by 
phone, and printed out the daily visit lists for the subsequent day. 
The protocol was mostly identical for all teams, except for some sub-studies; as 
the 24-h urine collection was implemented only in selected locations to ensure 
logistics for the samples (described in detail in Chapter 20.3) and the body 
composition validation sub-study was implemented only in Helsinki. The sub-study 
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of the additional eastern Finland sample was carried out after the FinHealth protocol 
had ended with a condensed protocol (see Chapter 20.4). The sample sizes for the 
sub-studies are presented in detail in Chapters 2.3, 4 and 20. The detailed description 
of the sub-studies and additional samples are presented in detail in Chapter 20. 
A tailored daily schedule of the appointments was created for different study 
locations. In the morning shifts examination times took place from 7.30 am until 
14.30 pm, and in the evening shifts from 11.00 am until 18.00 pm. In most weeks, 
Mondays and Fridays were morning shifts and Tuesdays and Thursdays evening 
shifts. Every second Wednesday was either a morning or an evening shift. The time 
slots were given in 10-minute intervals, making up to 38 appointment times per day 
(see Appendix 4). Every fourth appointment time was reserved for a dietary sub-
study participant to ensure smooth flow between the participants. Furthermore, 
lunch and coffee breaks for the study personnel were included in the daily schedules. 
Other types of daily schedules were also applied, such as short morning shifts and 
late evening shifts. When moving from one location to the next one, the teams spent 
on average one hour in packing and one hour in unpacking the equipment.  
The appointment times were divided beforehand for each participant. On average 
some 30 subjects per day in each team were invited. The schedule was planned in 
such a way that with about 60% participation rate, there would be a feasible and 
smooth day of some 18 participants per day. The number of participants per day 
varied from just a couple of persons up to a maximum of 27 participants. If the 
schedule seemed too tight, based on the confirmed appointment times, the personnel 
of the central office helped in balancing the daily visit lists by calling the 
participants to rebook another appointment time. 
The duration of the health examination for each participant was approximately 
one hour, or 1h 45 minutes if the dietary interview was included. The actual time 
spent in the examination varied based on the age and functional capacity of the 
participant, with longer durations among older people. There were certain rush hours 
in the examinations, such as early mornings and lunch breaks that sometimes caused 
queuing. The participants could also change their scheduled times independently in 
the electronic portal, making it difficult to foresee and prevent the potential rush 
hours. 
The first day of the field phase was January 30th, 2017, when the study personnel 
invited friends or relatives to take part and to train their routines in a less stressful 
situation. The field phase started officially on January 31st 2017. On the first actual 
field day the daily schedule was made less tight with a 30 minute interval between 
the appointment times, so that the nurses could train their routines in a slower pace.  
The participants received feedback on their measurements on several occasions: 
immediately during the examination, after the laboratory analysis results were 
available and after the questionnaire data was available for analyses. The feedback 
procedure is described in detail in Chapter 21.1. 
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3.5 Questionnaires 
 
Katja Borodulin 
 
The FinHealth 2017 Study included several questionnaires (Table 3.5.1).  
 
Table 3.5.1. Questionnaires in the FinHealth 2017 Study.  
Name of the questionnaire and main 
contents 
Selection criteria Phase of Survey 
when given 
Language 
Questionnaire 1 
Health status, functional capacity and 
wellbeing, exercise, smoking, nutrition, 
alcohol consumption, weight and height, 
sleep, background information, women’s 
health 
Entire sample Mailed with  the 
invitation letter 
Finnish, 
Swedish, 
English 
Questionnaire 2 
Health status, illnesses of family members, 
weight management, physical activity, work 
ability and working conditions, use of health 
care, provision of assistance, quality of life, 
social relationships, smoking, nutrition, 
lifestyle counselling, sleep, mood, sexual 
and reproductive health 
If participated in 
health 
examination 
At health 
examination to be 
filled in at home or 
during the 
examination visit 
Finnish, 
Swedish, 
English 
Food frequency questionnaire 
Meal frequency, special diet, consumption 
of foods, beverages and supplements 
If participated in 
health 
examination 
At health 
examination to be 
filled in at home or 
during the 
examination visit 
Finnish, 
Swedish, 
English 
Food propensity questionnaire 
Consumption of specific foods 
FinDiet sub-
study 
To be filled during 
health 
examination (or 
later at home) 
Finnish, 
Swedish, 
English 
Questionnaire for persons aged 70 years 
or older Housing, living environment, use 
of assistive devices, daily activities, oral 
health, receiving help  
Age 70 years or 
over at the time 
of sample draw 
(Nov 2016) 
At health 
examination to be 
filled in at home or 
during the 
examination visit 
Finnish, 
Swedish, 
English 
Physical activity and sleep diary 
(Accelerometer diary) 
Physical activity 
and sleep sub-
study 
At health 
examination to be 
filled in at home  
Finnish, 
Swedish 
Urine collection diary FinDiet sub-
study and 
selected 
locations 
At health 
examination to be 
filled in at home 
Finnish, 
Swedish 
Urine collection validation diary FinDiet sub-
study and capital 
region 
At health 
examination to be 
filled in at home 
Finnish 
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Questionnaire 1 was mailed with the invitation letter to the entire sample. It was also 
re-sent after the health examination phase for those who had not participated in the 
examination. All other questionnaires were given only to those who had participated 
in the health examination or who were selected for certain sub-studies. All 
questionniares are shown at the website of the FinHealth 2017 Study 
(www.thl.fi/finhealth). 
 
3.6 Short phone interview 
 
Katja Borodulin 
 
A short phone interview was offered to those participants, who could not take part in 
the health examination or did not want or were not able to fill in Questionnaire 1. 
These were mostly older participants who refused from the health examination due 
to their poor functional capacity or severe health problems and found the 
questionnaire too demanding to be filled in and returned. Questions in the short 
phone interview were chosen from the key questions and were identical to those in 
Questionnaire 1 (except for the minor differences adapting the self-administered 
questions to an interview form). The short interview covered questions on self 
perceived health, chronic diseases and disabilities, functioning, health behaviour and 
background. The interview was made by trained staff at the central office. The 
phone interview was carried out when the invited persons actively contacted the 
central office or when the staff at the central office called the invited persons to 
confirm appointments or to contact those who had not participated. 
 
3.7 ICT environment and toll-free telephone service 
 
Katja Borodulin and Katri Sääksjärvi 
 
In the training phase, the team members took in use individual laptops. Each laptop 
had internet access via internal sim-cards and also via a spare system with two 
portable 4G USB modems in each team.  
The toll-free telephone system was run with the Elisa Ring Service. Each staff 
member at the central office logged on to the system and handled the calls with their 
own THL mobile phones. The Elisa Ring System was also used to type in 
personalized SMS messages. These were used for example when trying to reach the 
participants who had not confirmed their health examination appointment two weeks 
before the suggested appointment time. The attempted contacts, both phone calls 
and SMS messages, were registered in the logistics service (see Chapter 5.6). In 
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addition, an automatic SMS reminder was sent two days before the appointment 
time for those who had a mobile telephone number available in the logistics service, 
whether or not the appointment time was confirmed. These messages were sent by 
an automated Java program every day according to the schedule and included 
information on participant’s name, reserved appointment time and location with 
detailed address.   
 
3.8 Communications  
 
Katja Borodulin, Johanna Leinonen, Heli Tapanainen, Hanna Tolonen and Katri 
Sääksjärvi 
 
The communications team was assigned to help in planning and implementation of 
communications in the project. The communication plan included activities for both 
internal and external communication. All efforts were made to motivate the invitees 
and thus increase participation rate. The aim of the team was to help in finalizing the 
materials (both those informing the invitees as well as the questionnaires and other 
study materials), and in preparing material for the media. The team for example 
reviewed and edited the material to make sure they were user-friendly and clear to 
all types of readers. Particularly much emphasis was paid to the invitation letter and 
the information leaflet. A graphic designer was used in designing the layouts for the 
post cards and information leaflets. Furthermore, FinHealth webpages were created 
for communication under the THL website.  
One of the main aims in the communication strategy was to ensure a high 
participation rate. The activities to reach this target were, for example: 
• design material that was easy to read and understand 
• create tailored post cards for different age and language groups 
• use social media for information dissemination, such as paid advertisements 
in Facebook. 
• contact local media to increase public awareness about the research project 
and interest to check personal invitations 
• use FinHealth website actively to guide all invited persons 
• upload pictures and videos from voluntary participants at the website to 
encourage others to participate 
 
When the field phase started, a press release was prepared and six kick-off media 
events were organized all over the country. National and local media attention was 
abundant and positive. One press release was also prepared later when the Eastern 
Finland sub-study was started in North Karelia and North Savo. During the field 
phase in spring 2017, continued efforts to receive publicity were carried out by 
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contacting local media in the study locations. Contacts were made from THL 
communications unit, the central office and also by the leading study nurses in the 
teams. 
The communications units in municipalities and health care districts were 
contacted so they would spread information about the study in the area. The aim was 
that also local health professionals would engourage their clients and patients to 
participate. 
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4 Participation  
Katja Borodulin, Anne Juolevi, Harri Rissanen and Katri Sääksjärvi 
 
Participation rates were calculated for several different phases in the study flow; the 
health examination, questionnaires and sub-studies (Table 4.1). The proportion of 
those who participated in any of the study phases (Health examination, 
Questionnaire 1 or Short telephone interview) was 68.8% (n=7050). Women 
(72.8%, n=3759) participated more often than men (64.8%, n=3291). The original 
sample size was 10305, but after updating vital status, moves abroad or unknown 
address information, the corrected sample (hereafter called as eligible sample) size 
was 10247. Further, there were some individuals who participated in the health 
examination but cancelled their consent afterwards. These people are considered as 
non-participants in our analyses. Participation rates are calculated using the eligible 
sample.   
In the recruitment process, people were first invited to the health examination. 
The examination was undergone by 2733 (53.8%) men and 3219 (62.4%) women 
(Table 4.1). Of these 5952 men and women, almost all (n=5939) gave blood samples. 
Those who did not participate in the examination were asked to fill in Questionnaire 
1 (n=841, 8.2%) or were interviewed by phone (Short telephone interview, n=257, 
2.5%).  
 
Table 4.1. Sample size and participation by gender (FinHealth main sample, adult + young). 
 Men Women All 
 N % N % N % 
Sample       
Original sample size 5108 49.6 5197 50.4 10305 100 
Eligible sample size1 5079 49.6 5168 50.4 10247 99.4 
       
Participated in       
Health examination 2733 53.8 3219 62.4 5952 58.1 
Questionnaire 1 only 415 8.2 426 8.2 841 8.2 
Short telephone interview 143 2.8 114 2.2 257 2.5 
At least one of the above-
mentioned phases 
3291 64.8 3759 72.8 7050 68.8 
Non-participation 1788 35.2 1409 27.2 3197 31.2 
1 Excluding deaths (n=34), moved abroad (n=14) or unknown address (n=10), based on updated 
information from the population register   
4 Participation 
 
THL – Report 17/2019 27 The FinHealth 2017 Study – Methods 
 
Participation rates differed by age group from 53.8% to 81.9% (Table 4.2). The 
highest participation rate was reached in the age groups of 60–69 and 70–79 years. 
These age groups had the highest proportions in all the phases of the study, except 
for the Short telephone interview. The lowest participation rates appeared in the 
youngest age group of 18–29 years. In the oldest age group of 80 years and above, 
participation was particularly low in the health examination, but higher regarding 
Questionnaire 1 and the Short telephone interview. 
 
Table 4.2. Participation by gender and age group in the main data collection phases. 
 Eligible 
sample 
Health 
examination 
Questionnaire 
1 
Short telephone 
interview 
At any phase of 
data collection 
 N N % N % N % N % 
18–29 1162 524 45.1 598 51.5 26 2.2 625 53.8 
30–39 1752 903 51.5 1014 57.9 29 1.7 1044 59.6 
40–49 1673 953 57.0 1057 63.2 21 1.3 1078 64.4 
50–59 1825 1134 62.1 1276 69.9 37 2.0 1313 72.0 
60–69 1873 1302 69.5 1459 77.9 55 2.9 1514 80.8 
70–79 1246 836 67.1 979 78.6 40 3.2 1020 81.9 
80+ 716 300 41.9 407 56.8 49 6.8 456 63.7 
Total 10247 5952 58.1 6790 66.3 257 2.5 7050 68.8 
 
Participation rates were different depending on the native language of the invitees. 
Native language was based on the information from the population register. Highest 
participation was reached for people whose native language was Sami (Native 
language of population in Northern part of Finland) with 78%, followed by Swedish 
with 72% and by Finnish with 70%. In all other language groups together the 
participation rate was considerably lower, 54%.  
Table 4.3. shows participation rates by educational group and employment status 
across age groups. When looking at the participation rates by educational groups, the 
FinHealth participants comprised more highly educated persons (39.9%) than what 
the general population (31.6%). Lower participation, hence, was seen among the low 
educated in the FinHealth participants (20.2%) when comparing to the general 
population (25.8%). Similar systematic difference across educational groups and 
participation was seen in all age groups except in the 18–24-year-olds. The 
participation rate differences across employment status where smaller than those 
found for educational groups. The FinHealth participants were slightly more often 
employed or retired and less often student or unemployed as compared to the 
general population. Much of the differences found for employment status appeared 
at the working aged and particularly in 18–24-year-olds. 
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Table 4.3. Participation (%) by educational group and employment status compared to the general Finnish population. 
 18−24 y 25−44 45−64 y 65+ y 18+ y 
 Participated 
in the 
health 
examination 
(n=524) 
Population 
 
Participated 
in the 
health 
examination 
(n=524) 
Population 
 
Participated 
in the 
health 
examination 
(n=3626) 
Population 
 
Participated 
in the 
health 
examination 
(n=1802) 
Population 
 
Participated 
in the 
health 
examination 
(n=5952) 
Population 
 
 % % % % % % % % % % 
Level of 
education1 
          
 Low 27.0 30.0 8.3 15.1 13.3 17.4 40.2 47.5 20.2 25.8 
 Middle 68.7 65.2 41.4 44.8 44.4 44.0 30.9 29.0 39.9 42.5 
 High 4.4 4.8 50.4 40.0 42.3 38.6 28.9 23.5 39.9 31.6 
Employment 
status2 
          
 Employee3 40.9 37.2 79.1 73.3 73.1 70.4 3.3 3.2 53.1 50.4 
 Student 46.1 42.8 6.6 6.4 0.8 0.9 0.06 0.1 3.2 6.7 
 Retired 2.6 1.3 1.5 2.6 12.1 13.0 95.8 95.8 34.1 30.0 
 Unemployed4/ 
Other 
10.4 18.7 12.8 17.7 14.0 15.7 0.8 0.9 9.6 12.8 
1 Low: primary school; Middle: Vocational or high school; High: College or university. Information from Statistics Finland, for participants from the years 2014, 2015 and 2016 (the most 
resent information available selected), and for the population from the year 2016. 
2 Information from Statistics Finland, for participants from the years 2014 and 2015 (the most recent information available selected), and for the population from the year 2015. 
3 Including entrepreneurs and those unemployed for less than six months 
4 Unemployed for six months or more. Most of the FinHealth 2017 participants belonging to the group “Unemployed/Other” were unemployed (84.2%). 
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Table 4.4. Participation (%) by health status compared to non-participants (sample in the FinHealth 2017, n=10 247).  
 18−29 y 30−64 y 65+ y 18+ y 
 Participated in 
the health 
examination 
(n=524) 
Participated 
at any 
phase of 
data 
collection 
(n=625) 
Non-
participants 
(n=537) 
Participated 
in the health 
examination 
(n=3626) 
Participated 
at any 
phase of 
data 
collection 
(n=4183) 
Non-
participants 
(n=2024) 
Participated 
in the health 
examination 
(n=1802) 
Participated 
at any 
phase of 
data 
collection 
(n=2242) 
Non-
participants 
(n=636) 
Participated 
in the health 
examination 
(n=5952) 
Participated 
at any 
phase of 
data 
collection 
(n=7050) 
Non-
participants 
(n=3197) 
 % % % % % % % % % % % % 
Psychiatric 
diagnosis for 
hospital or 
primary care1 
9.9 10.1 11.4 8.2 8.8 11.1 17.2 18.6 26.3 11.0 12.0 14.1 
Has been in 
inpatient 
care2 
2.3 2.9 3.4 3.5 3.9 5.6 9.7 11.9 19.2 5.3 6.4 7.9 
1 Percentage of those who have had a psychiatric diagnosis for hospital or primary care during the past six months from the date when invited to participate in the FinHealth 2017 
Study, based on information from the Care Register for Health Care (inpatient care and outpatient visits, diagnoses and operations and other care procedures, relevant ICD codes), 
and the Register of Primary Health Care Visits (relevant ICPC and ATC codes).  
2 Percentage of those who have been in inpatient care during the past six months from the date when invited to participate in the FinHealth 2017 Study, based on information from the 
Care Register for Health Care (relevant ICD codes). 
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Participation rates were compared in the FinHealth sample against information on 
health status (Table 4.4). Comparisons included those who participated in the health 
examination, participated in any phase of the study and did not participate in the 
study. Proportions of those who had had a recent psychiatric diagnosis or who had 
been in inpatient care were higher among the non-participants (14.1% for diagnoses 
and 7.9% for inpatient care) than among those participated in the health examination 
(11.0%, 5.3%) or in any phase of the study (12.0%, 6.4%).     
Response rates regarding the different questionnaires given at the health 
examination are provided in Table 4.5. Here, participation rates are presented both 
as 1) the proportion of the eligible sample that participated and 2) as the proportion 
of participants in the health examination who filled in the respective questionnaire. 
The first figure shows the response rate in the whole sample and the latter how well 
the participants adhered to the different phases of the study. 
 
Table 4.5. Response rates for the questionnaires that were given at the health 
examination. 
 Eligible 
sample 
Participated 
in the health 
examination 
Filled in the 
questionnaire 
Participation 
rate / eligible 
sample1 
Participation 
rate / health 
examination2 
 N N N % % 
Questionnaire 2 10247 5952 5337 52.1 89.7 
Food frequency 
questionnaire FFQ 
10247 5952 5125 50.0 86.1 
Food propensity 
questionnaire FPQ 
3099 1814 1787 57.7 98.5 
Questionnaire for 
person aged 70 years 
or older 
1962 1136 1076 54.8 94.7 
1 Calculated for the entire (sub-)sample, regardless of participation status in the health examination. 
2 Calculated for those who participated in the health examination. 
 
Questionnaires were given at the health examination based on either age or pre-
selection to the sub-samples by defined criteria. Questionnaire 2 was filled in by 
89.7% of those who attended the health examination and by 52.1% of the entire 
sample. The corresponding percentages for other questionnaires were: Food 
frequency questionnaire 86.1% and 50.0%; Food propensity questionnaire 98.5% 
and 57.7%, and Questionnaire for participants aged 70 years or older 94.7% and 
54.8%. The participants had a chance to fill-in either electronic or paper forms. For 
Questionnaire 1, 80% returned their answers in paper forms and 20% through 
internet. The corresponding distribution in other questionnaires was 86% and 14% 
for Questionnaire 2, and 88% and 12% for Food frequency questionnaire, and 98% 
and 2% for Questionnaire for persons aged 70 years or older.   
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Participation in the sub-studies is described in Table 4.6. The FinDiet Study 
obtained acceptable face-to-face and telephone interviews from 91.2% of those who 
participated in the health examination and 53.4% of the entire sub-sample. The 
corresponding percentages for the other sub-samples were the following: spot urine 
participation rate 90.9% and 55.2%, 24-hour urine collection 85.6% and 24.6%, 24-
hour urine validation collection 78.4% and 24.3%, Physical activity and sleep 81.8% 
and 46.9%, Joint function 97.4% and 61.9%, and bioimpedance validation 91.4% 
and 53.1%. 
 
Table 4.6. Participation in the sub-studies. 
 Eligible 
sample 
Participated 
in the health 
examination 
Participated 
in the sub-
study 
Participation 
rate / eligible 
sample1 
Participation 
rate / health 
examination2 
 N N N % % 
FinDiet (face-to-face 
and telephone 
interview) 
3099 1814 1655 53.4 91.2 
Spot urine collection 2802 1699 1546 55.2 90.9 
24-hour urine 
collection 
1546 935 (444)3 380 24.6 85.6 
24-hour urine 
validation collection 
686 400 (213)3 167 24.3 78.4 
Physical activity and 
sleep 
1991 1140 933 46.9 81.8 
Joint function 4771 3034 2954 61.9 97.4 
Bioimpedance 
validation 
148 84 65 43.9 77.4 
1 Calculated for the entire sample, regardless of participation status in the health examination. 
2 Calculated for those who participated in the health examination and fulfilled the eligibility criteria. 
3 Number of persons who took the urine collection canister back home for collection. 
 
Participation in the Eastern Finland Study was similar to that of the FinHealth 2017 
Study (Table 4.7). Two thirds (68.1%) of the sample participated in at least one 
phase of the study. Women (73.1%) participated more often than men (63.4%). 
Proportion of those who participated in the health examination was 53.5% in men 
and 62.7% in women. Of these 996 men and women who participated in the health 
examination, almost all (n=982) gave blood samples. 
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Table 4.7. The Eastern Finland Study: Sample size and participation by gender. 
 Men Women All 
 N % N % N % 
Sample       
Original sample size 888 51.3 844 48.7 1732 100 
Eligible sample size1 878 51.1 840 48.9 1718 99.2 
       
Participated in       
Health examination 470 53.5 527 62.7 996 57.4 
Questionnaire 1 only 65 7.4 84 10.0 149 8.7 
Short telephone interview 22 2.5 3 0.4 25 1.5 
At least one of the above-
mentioned phases 
557 63.4 614 73.1 1170 68.1 
Non-participation 321 36.6 226 26.9 548 31.9 
1 Excluding deaths (n=8), moved abroad (n=2) and unknown address (n=4), based on updated 
information from the population register  
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5 Data management 
5.1 Identification of the participants 
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
Data managers created identification numbers for each participant that enabled the 
linkage of all research materials during the data collection and also for later analyses, 
without using names or birth dates. Each person in the sample received an 
identification code, personalized bar code numbers for questionnaires, and a 
password to access the electronic portal for questionnaires. The information on all 
personalized numbers and password was sent to the invitees in the invitation letter 
and accompanying questionnaire 1.  
For those who participated in the health examination, a bar code sticker series 
was created. Serial numbers in the bar code series linked the participant with other 
material that was collected during the health examination. All number series in the 
data collection were unique and appeared only once. This way the risk of errors in 
linking the collected information with the right person was minimised. 
In the above described ways the data were pseudonymized in line with the 
General Data Protection Regulation (GDPR 2019), so that the personal data could 
no longer be attributed to a specific participant without the use of additional 
information, which is kept separately at THL and available only to a few data 
managers.  
 
5.2 Descriptions in xml language 
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
Questionnaires were described using xml-language. These descriptions were then 
used to create:  
• an analysis database and the so called LOPA-database which was used to 
create electronic questionnaires 
• a parser that enabled saving the data into electronic form with predefined 
correct contents and structures  
• html-based files of the questionnaires that comprised variable names and 
response options 
• html-based LOPA-files that visualized the electronic questionnaires 
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5.3 Data collection and saving 
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
The participants filled in the questionnaires (Table 5.3.1) either in paper or 
electronic format. Filling in electronic questionnaires required the use of the 
identification code and password that were included in the invitation letter. The 
participants had access to Questionnaire 1 in three languages upon receiving the 
invitation letter. The remaining questionnaires, also in three languages, were 
scheduled to be accessed electronically the day following their health examination 
visit, after the leading study nurse had saved the daily visits into the database at the 
end of the day. The participants had a tailored selection of questionnaires to be filled 
in, depending on the sub-samples and age group they belonged to. 
The paper questionnaires were returned to the main office, where the reception of 
each paper form was recorded in the database and then further delivered to an 
outsourced company responsible for saving data into electronic format, Tikkurilan 
Kopiopalvelu (TKP). During the data collection period, questionnaires were 
regularly sent to TKP in small batches. TKP scanned and saved the questionnaires 
optically. The scans produced a picture of each page in a png-format. The FinHealth 
team advised TKP in the saving process, also allowing some corrections to the data. 
The corrections were marked with a per cent sign (%) or a hashtag sign (#), where 
the per cent noted a correction by the personnel of TKP and the hashtag an item that 
did not fall into the predesigned categories of allowed responses and was left to the 
FinHealth Team to correct. Data were sent from TKP to THL in csv-format and 
further downloaded into the analysis data base.  
Responses collected through electronic questionnaires with the LOPA-service 
were saved into the LOPA-database and further downloaded in the main analysis 
database on a daily basis.  
In the saving process, the xml-descriptions enabled the creation of a template. A 
Metaform-tool was created to make sure the saved data followed the right structure. 
For example, each variable had a predefined variable name and right number of 
response categories that also followed the right coding options. The xml-
descriptions and the Metaform tool were used for saving the questionnaire 
information both in paper and electronic format. 
There were a number of questionnaires and forms that were used by the study 
personnel to collect and save information during the health examination (Table 
5.3.1). The questionnaires included for example the information collected in each 
examination room (mainly measurement results and notes on deviations from the 
protocol and explanation for missing results). These were collected using paper 
forms and generally saved at the end of each day in the LOPA-database.   
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Table 5.3.1. Questionnaires and forms in the data management process. 
Name of the questionnaire or form Filled in by… Saved in electronic format by… 
Daily visit list Leading study nurse Leading study nurse 
Daily visit list, double saving 
process 
Leading study nurse Study personnel in Central office 
Consent form Leading study  nurse and 
participant 
Nurse in Examination Room 1A 
and 1B 
Biobank consent form Leading study nurse and 
participant 
Tikkurilan Kopiopalvelu 
Examination Room 1 form Study nurse in 
examination room 1A and 
1B 
Study nurse in examination room 
1A and 1B 
Examination Room 2 form Study nurse in 
examination room 2 
Study nurse in examination room 2 
Examination Room 3 form Study nurse in 
examination room 3 
Study nurse in examination room 3 
Bioimpedance measurement form Receipt from the 
bioimpedance device 
Study personnel in Central office 
Questionnaire 1, paper format Participant Tikkurilan Kopiopalvelu 
Questionnaire 1, electronic format Participant Participant 
Questionnaire 2, paper format Participant Tikkurilan Kopiopalvelu 
Questionnaire 2, electronic format Participant Participant 
Food frequency questionnaire, 
paper format 
Participant Tikkurilan Kopiopalvelu 
Food frequency questionnaire, 
electronic format 
Participant Participant 
Food propensity questionnaire, 
paper format 
Participant Tikkurilan Kopiopalvelu 
Food propensity questionnaire, 
electronic format 
Participant Participant 
Questionnaire for persons aged 70 
years or older, paper format 
Participant Tikkurilan Kopiopalvelu 
Questionnaire for persons aged 70 
years or older, electronic format 
Participant Participant 
Physical activity and sleep diary Participant Study personnel at Central office 
Urine collection diary Participant Study personnel at Central office 
Urine collection validation study 
diary 
Participant Study personnel at Central office 
Short telephone interview Study personnel at 
Central office 
Study personnel at Central office 
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The central laboratory at THL analysed blood and urine samples regularly during the 
data collection period. These results were received in csv-format from the laboratory, 
and were transformed into a SAS-file by the data manager and further saved in the 
analytic database. 
  
5.4 Data cleaning 
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
Data cleaning was done at several phases: 
1. Hashtag-marks (#) were listed by each question using csv-files and the 
scanned pictures of the page where the answers were checked and corrected 
by the FinHealth team. 
2. Frequency tables were created to check that all response categories were as 
expected and no outliers could be seen. 
3. Potential double questionnaires were listed. In case duplicates were found, 
the field coordinator screened the responses with data managers and judged 
for a higher quality (more complete) version to be included in the final data. 
4. Missing information was screened in all response items for potential 
correction. The corrections were made in some selected instruments where 
the respondent had systematically checked “yes”-items but left “no” 
missing. In these cases, the missing information was replaced as “no” 
option. 
5. Zero-values were searched and added for instruments that should logically 
include a value ”0”, based e.g. on the other responses in the same 
instrument. 
6. Orders to jump over to a new question were checked. If the respondent had 
not followed the jump advice, the answers were visually checked and a 
logical decision was made to correct the answers or leave the information 
missing.  
7. Logically meaningful values were checked and corrected when needed. 
This included an inspection of minimum, maximum, mean or median values.  
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5.5 Quality assurance 
 
Katja Borodulin, Katri Sääksjärvi and Päivikki Koponen  
 
Quality assurance in the FinHealth 2017 Study followed the principles presented in 
the European Health Examination Survey manual on planning and preparation of a 
health examination survey (Tolonen 2016a), including components such as good 
overall management of the survey, agreement on survey procedures that ensure 
standardized measurements, training of the survey personnel on using the standard 
procedures, piloting the fieldwork phase, quality control measures taken to monitor 
the survey process, and evaluation of the achieved quality. 
 
Fieldwork quality assurance 
 
The study personnel received the full field manual in the training period so that they 
could check and recap the standards during the fieldwork and find instructions for 
challenging situations. They also had short check-up lists to make sure all tasks were 
carried out as instructed.  
Quality control of health examinations during the field phase was implemented 
by an external audit visit to each team. The external auditor concluded in her report 
that the measurements were satisfactorily carried out as instructed in the field 
manual. Furthermore, the external auditor visited the central office, and evaluated 
whether the central office activities were acceptably performed.  
In addition to the external audits, the FinHealth field coordination team made 
more than 40 visits to all teams to ensure high quality and identical measurements 
across the teams and across the whole field phase. Measurement results on blood 
pressure, height, weight, and waist and hip circumference were checked several 
times during the field phase for outliers, means, distributions, and last digits. The 
information recorded in the health examinations were systematically evaluated 
during the field to intervene on potential systematic error, such as missing values. If 
any potential problems were identified in the data, these were discussed with the 
staff to ensure the standards and accurate recording. In addition to helping to resolve 
any problems, the field visits by the coordination team were an important source of 
encouragement and an evaluation tool. During these visits the actual measurements 
were observed with the consent of the participant, and feedback was immediately 
given to the study personnel to encourage them to follow the standards or to pay 
more attention to some details, if needed. 
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Quality control 
 
Quality control in the FinHealth 2017 Study aimed to obtain high quality data from 
all teams and all measurers, as well as from all questionnaires. Another aim for data 
quality was to ensure comparability with data from previous data collection rounds. 
Quality control measures were taken to monitor the survey process, so that any 
problems could be detected at an early stage, and actions were taken to correct the 
detected problems as soon as possible. A large number of quality control measures 
were built into the study at different stages of the survey process. Activities by the 
field coordination team to ensure good quality of the collected data included for 
example:  
• check that a written signed consent was received from all participants 
• check the linkage between participant id and the bar code serial number by 
double saving the daily visit lists 
• compare blood pressure, waist and hip circumference, and height and 
weight measurements (maximum, minimum, mean, last numbers for 
preference and odd numbers) between the study personnel 
• screen the data recorded by the field teams, checking the number of entered 
forms and if there were missing values 
• check that all questionnaires and forms were received and that the data 
entry was complete for all participants 
• screen the quality of data from paper forms entered in the data set at TKP 
(TKP entered data from a small proportion of questionnaires manually, 
compared the manual data with the optically entered data and reported these 
comparisons to the data management team) 
• compare the quality of the examination room forms by double entry for 
some forms at the central office 
Further details about the quality control are described in the chapters for each 
measurement. Quality control was carried out by the field coordination team at the 
central office, i.e. as internal quality control, except for the field laboratory activities 
(see Chapter 6.4).  
 
Quality assessment 
 
The quality of the FinHealth 2017 Study data has been assessed on the basis of pre-
defined criteria. The survey data was evaluated and documented at the central office. 
For different data items different issues were checked. More details about data 
cleaning and check-ups are described in Chapter 5.4. 
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5.6 Logistics service  
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
The FinHealth 2017 Study used a logistics service, referred as Research and 
Scheduling Service (tutkimus- ja ajanvarauspalvelu) TAP, to handle the massive 
field phase. The TAP Service was developed by THL mainly for the use of 
questionnaire surveys but it included also features needed for the logistics of the 
field phase of a health examination survey. The TAP Service was an essential part of 
the survey and included detailed information for each individual in the sample on: 
• the sample (name, address, phone numbers, date of birth, sub-sample) 
• location of the health examinations (name of health centre / other facility 
and detailed address) 
• health examination time (previous reservations and updates) 
• appointment time for dietary telephone survey (previous reservations and 
updates)  
• refusal, death or move 
• contact attempts by the study personnel 
• scheduled access to questionnaires and information on saved questionnaires 
 
The TAP Service also provided practical tools for daily work during the data 
collection period. These included: 
• printable daily visit list for each field team, with detailed information on 
participants of the day 
• possibility to link daily visits and the series number of the bar code sticker 
of each participant 
• list of non-confirmers for re-contacts 
• management of the daily appointment times for the health examinations and 
telephone interviews 
• management of logistics for the blood samples and questionnaires 
• SMS messages with information on participant’s name, reserved 
appointment time and location that were sent every day according to the 
schedule using an automated Java program. The subjects received the SMS 
message two days prior to the reserved appointment time, if they had a 
mobile phone number available in the TAP Service.  
The TAP Service produced daily automated CSV-files for quality control use. They 
included the following information: sample, received electronic questionnaires, daily 
health examination visits and the saved bar code stickers, refusals, confirmed and 
non-confirmed health examination appointments. 
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5.7 Data from registers 
 
Päivikki Koponen, Anne Juolevi, Harri Rissanen and Seppo Koskinen 
 
Data obtained for the sample from the National Population Register comprised 
information on some key characteristics of each person (Table 5.7.1). In addition, 
administrative register data have been obtained with specific permissions sought 
from the institutes/organisations responsible for each register, and these can be 
updated later to enable register-based follow-up of survey participants, and in some 
cases also follow-up of non-participants. Register linkages were made using the 
personal registration number assigned to all residents in Finland.  
Register data can be used for several purposes e.g. to analyse non-response, and 
to obtain additional information on sociodemographic characteristics, health status 
and on the use of health services and benefits before and after the survey. Register 
data can also be used to study whether the use of health services is adequately based 
on the needs identified in the survey data. A comparison of the participants’ and 
non-participants’ health in the light of register based information also helps to 
evaluate the accuracy of the results obtained by questionnaires and health 
examination. Register data were used to assess the characteristics of the non-
participants and to construct the survey weights to be used in the analysis (see 
Chapter 5.9).   
Due to changes in data protection rules, all register data obtained for the previous 
surveys (Health 2000/2011 Surveys and/or the FINRISK Studies) are not available 
for the FinHealth 2017 Study sample. From Statistics Finland, personal data have 
been obtained only for participants (those who gave consent for register-linkage). 
The Social Insurance Institution (KELA) has so far not given the FinHealth 2017 
researchers any permission to obtain their data, neither for participants nor the non-
participants. In KELA the informed consent was considered to be too general as the 
participants didn’t give detailed consent for specific KELA register data linkage.  
Register based follow-up provides incidence data enabling future epidemiologic 
studies to find out how the survey data predict the development of the participants’ 
health, by linking the cross-sectional survey data with follow-up data on the 
participants’ causes of death and illnesses, as well as use of services and work-force 
participation (employment).  
The record-linkage was designed and carried out in close co-operation between 
the THL project organisation and the bodies maintaining the registers concerned. 
The most important register data cover causes of death, hospital treatments and 
primary care visits (with specific ICD-10 and ICPC codes), births and induced 
abortions (for women), cancer screening and cancers, as well as employment and 
pensions. 
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Table 5.7.1. Register data available for the FinHealth 2017 sample.  
Register authority Topics  
Population Register Centre* Age, sex, date and place of birth, marital status, native language, 
country of birth  
Finnish Institute for  
Health and Welfare (THL)* 
Care Register for Health Care (inpatient care and outpatient visits, 
diagnoses and operations and other care procedures) 
Register of Primary Health Care Visits  
Cancer Registry (diagnosed cancers) 
Mass Screening Registry (mammography and pap smear) 
Medical Birth Register (year(s) of giving birth, prenatal care and care 
during births) 
Register of Induced Abortions (year(s) and types of procedures) 
National Infectious Diseases Register (selected diagnosed diseases) 
Ministry of Employment  
and the Economy* 
Employment service register data: periods of unemployment and 
participation in labour market training and work/training trials 
Statistics Finland ** Education,  occupation and socioeconomic status  
Causes of death 
The Social Insurance  
Institution (KELA)*** 
Coverage by the social insurance in Finland 
Disability, rehabilitation and sickness allowances 
Reimbursement for medicine expenses 
Purchases of selected medicines 
Allowances for pensioners 
Finnish Centre for 
Pensions* 
Earnings related pensions  
* Register data available for the total sample 
** Register data available for those participating in the health examination 
*** Permission to use register data in the FinHealth 2017 Study applied, not (yet) received 
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5.8 Using the data for research purposes 
 
Anne Juolevi, Harri Rissanen and Katja Borodulin 
 
The data of the FinHealth 2017 Study are available for research purposes in 
collaboration with the project organization and through THL Biobank. In order to 
obtain access to the data, researchers must first submit a study proposal to the 
FinHealth 2017 or the THL Biobank Scientific Board. The forms to apply access to 
the data are available on the website of the FinHealth 2017 Study and the THL 
Biobank. The FinHealth 2017 website includes all the forms used during the 
fieldwork and the corresponding variables. Once access to the data is granted by the 
Scientific Board, a signed agreement is required and all researchers must confirm to 
follow the THL data security rules.   
 
5.9 Statistical analyses  
 
Tommi Härkänen and Tarja Palosaari 
 
The sampling design and the guidelines for statistical analyses follow closely those 
of the Health 2000 and 2011 Surveys, which have been successfully conducted by a 
large number of researchers over the past decades. Thus, analyses on the FinHealth 
2017 data can be conducted in a similar way. 
Below an overview is presented of the most important aspects to take into 
account in practical statistical analyses. Furthermore, background on the weights 
needed to account for the sampling probabilities and non-response is given.  
 
Practical guidelines for researchers on data analysis 
 
Relevant guidance to statistical analyses of the FinHealth 2017 data can be found at 
the website of the Health 2011 Survey containing documentation and some 
examples to analyse the Health 2011 Survey data. These examples can be easily 
applied for the FinHealth 2017 Study as well by changing the variables 
corresponding to the sampling design and weights according to Table 5.9.1. These 
examples cover analytical procedures to produce descriptive statistics and to 
perform common regression analyses. The analyses are not restricted to cross-
sectional analyses, as the survey data have been linked to various population 
registers with regular updates in the future (see Chapter 5.7), thus prospective (and 
retrospective) analyses can also be conducted. Access to the data may be granted for 
research purposes (see Chapter 5.8). An empirical comparison of different statistical 
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methods to handle missing data in the Health 2011 Survey have been described 
elsewhere (Härkänen et al. 2016). 
Various statistical software packages can be applied to account for the sampling 
design and the weights for missing data, for example,  
• SAS/STAT software, with the Survey procedures (SAS Institute Inc 2019),  
• Sudaan (Research Triangle Institute 2008),  
• Stata, with the “svy” prefix, see Stata survey data reference manual 
(StataCorp. 2019)  
• R (R Core Team 2019), with package “survey” (Lumley 2004, Lumley 
2019) and also  
• SPSS, only with the “Complex Samples” module (IBM Corporation 2019). 
 
Background information for statistical analyses 
 
The non-response to population surveys has increased considerably in the 2000’s, 
and researchers should assess the possible mechanisms which cause non-response, 
and in each analysis perform corrective measures among which commonly applied 
methods are:  
• Weighting of observations corrects the distribution of known background 
factors (age, sex etc.) in the group of participants to match the distribution 
in the population. Weighting methods are useful in correcting unit non-
response. The weight variable should match the analysis variables, e.g. if 
the analysis involves variables collected in the health examination then the 
health examination weight should be selected. There are several weights, 
which are based on participation in different parts of the survey: 
o participation in the health examination 
o participation in any part of the survey (good for questionnaire 
variables) 
o participation in sub-studies 
• Multiple imputation is a more advanced and efficient method which can 
handle item non-response better than weighting, but it requires more 
experience in conducting analyses. In order to minimize bias, the 
imputation models must be constructed separately for each research 
problem. It is advisable to incorporate appropriate register variables, which 
have been linked also with the non-respondents, in the imputation model, if 
possible.  
Non-participation can depend (directly) on the variables of interest, e.g. healthy 
individuals participate and individuals with a disease do not. This kind of missing 
not at random (MNAR) non-participation can be very difficult or impossible to 
correct for by using any statistical methods without additional information such as 
register data on health status of both non-participants and participants. 
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The original Health 2000 Survey was based on a complex sampling design, 
which should be taken into account using proper statistical methods such as the 
design-based methods. 
• The sample is not a simple random sample from the population, thus 
standard statistical methods assuming independence of observations 
generally underestimate standard errors.  
• Geographical representativeness of the Health 2000 Survey was limited 
to continental Finland and the five university hospital districts as well as the 
biggest cities. In the FinHealth 2017 Study the number of health centre 
districts (HCD’s) in the rural strata was decreased, thus the 
representativeness is now weaker than in the Health 2000 and 2011 
Surveys. Therefore, the sample does not cover small regions, and 
representative results can be reported only for the university hospital 
districts and the city of Helsinki. In other cities both the sample size and the 
number of participants is likely to be too small for meaningful analyses. 
 
The analyses on the FinHealth 2017 data can be conducted using most general-
purpose statistical software packages. Multiple imputation can be conducted using, 
for example, SAS (SAS Institute Inc 2010), Stata (StataCorp 2009) or R (R Core 
Team 2019) software packages. Design-based analyses can be performed using 
Sudaan (Research Triangle Institute 2008) as well as using SAS, Stata or R (survey 
package, Lumley 2004; lme4 package, Bates et al. 2012) software packages. The 
latter software packages can be utilized also for model-based mixed-effects analyses. 
Model adjusted estimates based on the predictive margins (Graubard & Korn 1999) 
can be calculated using Stata and Sudaan software packages. In the examples given 
for the Health 2011 Survey the variables describing the sampling design and the 
weights need to be replaced according to Table 5.9.1 for analysing the FinHealth 
2017 Study data. 
 
Table 5.9.1. Corresponding variables in the Health 2011 and FinHealth 2017 data 
sets. 
Description Health 2011 Survey FinHealth 2017 Study 
Strata OSITE  ft17_otos_osite  
Primary Sampling Unit 
(PSU) 
RYVAS  ft17_otos_ryvas  
Analysis weight ALL_ANALYSIS_W  w_perus_kys1_ana  
Expansion weight ALL_EXPANSION_W  w_perus_kys1_exp  
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Sampling probabilities 
 
The equal probability of selection method (EPSEM) of the Health 2000 Survey 
yielded equal sampling probabilities in the age group of 18 to 79 years, and in the 
age group of 80 years or older this probability was chosen to be twice as high in 
order to obtain oversampling among the oldest age group (Laiho et al. 2008). The 
EPSEM does not hold after year 2000, because the population sizes have changed. 
The true population sizes in year 2017 as well as in 2000 based on the boundaries 
between municipalities in 2000 were obtained from Statistics Finland. The notation 
needed to calculate the sampling weights is presented in Table 5.9.2.  
 
Table 5.9.2. Notation corresponding to the population and sample sizes, and to the 
sampling weights. For the 15 largest towns, define 𝐦𝐬: =  𝐍𝐬𝟏
𝟎𝟎: =  𝐍𝐬𝟏
𝟏𝟕 ∶=  𝟏. 
 Year 2000 
 
Year 2017 
  Age group  18+ Age group  18+ 
Sample size in stratum 𝑠 and health centre district 𝑘 𝑛𝑠𝑘
00 𝑛𝑠𝑘
17 
Number of strata 𝑆 𝑆 
Population size in stratum 𝑠 𝑁𝑠
00 𝑁𝑠
17 
Number of health centre districts sampled in stratum 𝑠 𝑚𝑠
00 𝑚𝑠
17 
Population size in stratum 𝑠 and health centre district 𝑘 𝑁𝑠𝑘
00 𝑁𝑠𝑘
17 
Participation status 𝑅𝑖
00 𝑅𝑖
17 
Sampling probability 𝑝𝑖
00 𝑝𝑖
17 
Expansion weight 𝑤𝑖
00 𝑤𝑖
17 
 
The inclusion probability of individual sampling unit 𝑖, who belonged to stratum 
𝑠: =  𝑠(𝑖) and health centre district 𝑘: = 𝑘(𝑖), in year 2000 was written as  
 
𝑝𝑖
00: =
𝑛𝑠𝑘
00
𝑁𝑠𝑘
00
𝑚𝑠𝑁𝑠𝑘
00
𝑁𝑠
00 =
𝑚𝑠𝑛𝑠𝑘
00
𝑁00
  (Equation 5.9.1) 
 
The “size” of cluster 𝑘 was the corresponding population size 𝑁𝑠𝑘
00 of age 18 or older. 
The sampling weight was defined as 𝑣𝑖
00 ≔ 1/𝑝𝑖
00. Equation 5.9.1 reduced nicely, 
but in 2017, however, the PPS (probability proportional to size) probabilities were 
the same as in 2000, thus the inclusion probabilities in 2017 did not reduce similarly. 
In other words, the sampling design was not self-weighting in 2017, but the sample 
sizes per HCD were defined proportional to the corresponding population sizes, thus 
the design in 2017 was close to self-weighted. 
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𝑝𝑖
17 ≔
𝑛𝑠𝑘
17
𝑁𝑠𝑘
17
𝑚𝑠𝑁𝑠𝑘
00
𝑁𝑠
00    (Equation 5.9.2) 
 
The sampling weight was defined as above: 𝑣𝑖
17,∗: = 1/𝑝𝑖
17 using Equation 5.9.2. 
Note that the sampling probabilities and the sampling weights 𝑣𝑖
17,∗
 were equal 
(within a HCD) in the age group 25 years and older, but in the age group 18–24 
years a considerably smaller number of individuals were selected into the sample, 
thus the sampling weights 𝑣𝑖
17,∗
 were larger.  
We rescaled the sampling weights in 2017 so that their sum equals the population 
size in each stratum by  
𝑤𝑖
17,∗: =
𝑣𝑖
17,∗𝑁𝑠𝑖
17
∑ 𝑣𝑖
17,∗
𝑖∈𝑠
.   (Equation 5.9.3) 
 
In the rural strata the number of HCDs was only seven, and these HCDs were 
randomly selected from the HCDs selected into the Health 2000 Survey, thus the 
sampling probability 𝑝𝑘
17 of HCD 𝑘 was smaller in the FinHealth 2017 Study than 
the original sampling probability 𝑝𝑘
00  in 2000. The ratio of the HCD sampling 
probabilities 𝑚𝑠
17/𝑚𝑠
00 is the same for all HCDs within each stratum, thus it cancels 
out, when the weights are calibrated with respect to the population size (Equation 
5.9.3). 
 
Adjusting the weights for non-response 
 
Weighted statistics, such as a weighted mean and prevalence, provide representative 
results on the target population (the adult population aged 18 and over of the 
continental Finland, or some subgroups).  
First, define some notation. Let 𝑅𝑖
17: = 1 for the participants of the FinHealth 
2017 Study and 𝑅𝑖
17: = 0 for all others.  Let 𝑋𝑖  denote register-based data, which 
were associated with the participation 𝑅𝑖
17 in year 2017.  
The sampling weights were updated to account for differences in the 
participation probabilities based on the inverse probability weighting method 
(Robins et al. 1994) as follows.  
The participation ( 𝑅𝑖
17 = 1 ) probability ℙ𝛽{𝑅𝑖
17 = 1|𝑋𝑖}  was modelled here 
using the random forest method (Liaw & Wiener 2002), and the probability 
estimates were produced using the corresponding ‘predict’ function of the 
randomForest package in R (R Core Team 2019). The inverse of the probability is 
the non-response weight.  
 
𝑣𝑖
17: =
1
ℙ𝛽{𝑅𝑖
17=1|𝑋𝑖}
.    (Equation 5.9.4) 
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For non-participants 𝑅𝑖
17 = 0  we defined 𝑣𝑖
17: = 0 . We assumed that the non-
participation can be explained by the observed register-based variables 𝑋𝑖  in 
Equation 5.9.4, that is, the missing data mechanism was assumed to be missing-at-
random (MAR, Rubin 1987, Molenberghs and Kenward 2007). In reality, the 
missing data mechanism is likely to be often not-missing-at-random (NMAR), in 
which case the non-participation is likely to depend on unobserved factors possibly 
including outcome variables of analyses such as the health status at the time of the 
FinHealth 2017 Study.  
The covariate vector 𝑋𝑖 contained register variables listed in Table 5.9.3. For the 
internal use of THL, some additional register variables of Statistics Finland were 
also used: 3-category urban-rural classification of municipalities, 3-category 
education (low, middle, high), 7-category socioeconomic status, taxable income, net 
income and main occupation. 
 
Table 5.9.3. Register variables in the weighting model. 
Register Variable Details 
Population Register Centre Age  
 Gender  
 Language Finnish, Swedish or other 
 Marital status Unmarried, Married, Divorced, 
Widowed 
 Area University hospital region 
borders in 2000 
The Care Register for Health 
Care 1996-2016 
 Time since the most recent 
treatment with the ICD-10 
codes… 
 Cardiovascular disease 
diagnoses 
I00-I99 
 Mental health  F00-F99 
 Infections  A00-B99 and J00-J22 
 Births and Pregnancy O00-O00 
 Accidents, poisonings and 
external causes 
S00-Y98 
Ministry of Economic Affairs 
and Employment 
Last employment Time since expiry of the last 
period at work in years 
 Last unemployment Time since the last 
unemployment period in years 
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The expansion weights were obtained by calibrating the product of the sampling 
weights 𝑣𝑖
17,∗
 and non-response weights 𝑣𝑖
17 by stratum and age group 𝐴𝐺𝑖 ∈ {(18-
24), (25-54), (55-69), (70-74), (75+)}. The corresponding population sizes were 
𝑁𝐴𝐺𝑖𝑠𝑖
17 . The final, calibrated weight was then 
𝑤𝑖
17: = 𝑣𝑖
17,∗𝑣𝑖
17
𝑁𝐴𝐺𝑖𝑠𝑖
17
∑ 𝑣ℓ
17,∗𝑣ℓ
17
ℓ:(𝐴𝐺ℓ𝑠ℓ)∈(𝐴𝐺𝑖𝑠𝑖)
.    
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Other methods to handle effects of missing data 
 
Various methods have been proposed to handle effects of missing data 
(Molenberghs & Kenward 2007). In addition to the IPW and post-stratification 
(Lehtonen and Pahkinen 2004) methods described above, there are improved 
methods based on weighting (e.g. the doubly robust methods, Wirth et al. 2010), and 
other methods based on augmenting the missing data values.  
Generally weighting is most appropriate in cases where the proportion of item-
non-response is low. In other cases the missing data values in the few variables can 
be imputed, and all information contained in the partially observed sampling units 
can be utilized.  
In multiple imputation (MI) the missing data values are imputed using a 
predictive distribution, which is based on the observed data and possible prior 
information (Rubin 1987, Schafer 1999). This imputation model can differ from the 
analysis model, which is applied on the imputed data containing no missing values. 
The imputation model should be at least as complex (variables and interactions) as 
the analysis model. Generally there is considerable uncertainty in the imputed values, 
thus a single imputation would underestimate the uncertainty (variance) of the 
results. Therefore in MI several copies of the original dataset are created, both the 
imputation procedure and the statistical analyses are performed separately on each of 
them, and finally the results based on the imputed datasets are combined.  
In a typical item-non-response case the analysis variables cannot be ordered to 
form a monotonic missing data pattern. This restricts the range of adequate MI 
methods. In standard statistical software packages the variables, which contain 
missing values, are assumed to follow a multi-normal distribution, which does not 
suit well to categorical or other non-Gaussian variables. Binary variables are, 
however, often approximated by normal distribution in MI. These problems can be 
avoided by multiple imputation based on chained equations (van Buuren et al. 1999), 
which is available in many statistical software packages, for example in R (van 
Buuren & Groothuis-Oudshoorn 2011). 
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6 Laboratory measurements 
Laura Råman, Liisa Valsta, Katja Borodulin and Jouko Sundvall 
 
Two kind of biological samples were collected in the FinHealth 2017 Study. Blood 
samples were collected from all participants at the health examination, and 
information on them is presented in this chapter. Urine samples were collected from 
a sub-sample of participants, thus information on them is presented in Chapter 20.3. 
 
6.1 Blood collection 
 
Samples of whole blood, serum, fluoride-citrate plasma and EDTA plasma were 
collected from all participants at the health examination (Figure 6.1.1). The samples 
were divided into aliquot tubes as illustrated in Figure 6.1.2.  
 
 
 
Figure 6.1.1. Blood tube chart. 
 
 
All the necessary supplies were delivered in advance to each field Team. Teams had 
their local storage room at their central home town. If there was lack of some 
equipment, it was ordered from THL and delivered to the sites. The field laboratory 
personnel estimated the amount of the supplies needed and delivered them to 
different study sites. All the required equipment, including a field centrifuge and a 
chest freezer, were moved with the laboratory. Electrical and manual pipettes were 
used to aliquot the samples. 
 
 
1 
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2 
2 ml 
   FLS  
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Figure 6.1.2. Aliquot tube chart. 
 
 
Eight tubes of blood were drawn from each participant (5 to 10 ml plastic-walled, 
evacuated Becton Dickinson tubes for all other except Vacuette fluoride-citrate 
tubes, gel tubes for serum). The sampling order was determined by the purpose of 
the samples, where high priority was set to the first serum tube to enable the basic 
analyses. If difficulties were met with drawing the samples, three attempts were 
made with the participant’s approval, to get at least one serum tube. 
Venous blood samples were collected from a vein in the arm, with the participant 
in a sitting position. Blood sampling was taken, preferably, from the left arm. To 
prevent hemolysis the tourniquet was released as soon as the blood began to flow. If 
a sample could not be obtained from the arm, it was drawn from the back of the 
hand using a wing or open needle. Serum and EDTA tubes were carefully inverted 
at least six times against the plugs. Fluoride-citrate plasma tubes were inverted at 
least 10 times. Usually a tube rocker was used to mix the samples. 
After sampling, the study personnel affixed labels (also called bar code stickers) 
on the tubes. Labels contained only a random number that was linked to the subject 
in the first study room. After the sample collection, the serum samples were allowed 
to clot for at least 30 minutes in a vertical position after the final tube had been 
collected. The maximum storage time allowed at room temperature before 
centrifugation was 60 minutes. The plasma samples were kept at room temperature 
for the same time as serum samples so that they could be centrifuged together. 
 
SEER  
Serum 
S 11 S 12 S 13 
S 14 S 15 
EDTA 
  P31   P32 
SEER  SEER  
2D coded 
cryo vials 
   FLS 
  GLUK 
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Participants were asked to fast for at least four hours before their scheduled 
health examination time. The last time the participant had eaten or had drunk 
anything but water was asked and recorded. Furthermore, the participants were 
asked if they had used any antibiotics during the past 14 days. 
 
6.2 Blood sample processing and management 
 
The samples were processed according to Figure 6.1.2. Two DNA samples and the 
HbA1c sample of EDTA whole blood were frozen as such. The sample was frozen 
without opening the cap. The serum, EDTA and fluoride-citrate plasma tubes were 
centrifuged at 2200 G for 11 minutes. The sera from three centrifuged gel serum 
tubes were collected into one large pooling tube. The pooled serum was mixed by 
carefully inverting the tube five times and aliquoted into 1 ml cryo-tubes and 0.5 ml 
2D-coded cryo-tubes. If one of the serum tubes was haemolysed, it was not added to 
the pool but pipetted into separate aliquot tubes. EDTA plasma tube was centrifuged 
and pipetted into 1 ml aliquots on cryo-vials and 0.5 ml 2D-coded cryo-tubes. 
Fluoride-citrate plasma was separated and pipetted to a polypropylene tube. All the 
samples were frozen at –20°C immediately after handling. 
The date and time of sample handling, the ID code of the study personnel, the 
number and type of samples obtained, and the volume of all serum and plasma 
aliquots were entered into the laboratory form. Any deviations in sampling or in 
sample processing were also recorded on the laboratory form.  
The participants handed their folder to the study personnel. The folder included 
labels for sample tubes, arranged in the order the samples were to be drawn. Each 
label in the sheet carried the same recurring secondary key for that particular set of 
labels. Storage tube labels also included an unequivocal primary key in both barcode 
and alphabetical format and a code describing the type of sample. The laboratory 
form was also labelled with a special label designed for this purpose. 2D-coded 
cryo-vials were linked to the blood sample collecting tube in THL’s sample logistics 
system, SamWise. The 2D codes of the vial were linked either to the barcoded 
sample collecting tube or the sera pooling tube which was also labelled with barcode 
label. 
 
6.3 Storage and shipment of blood samples 
 
Serum, plasma and whole blood samples were immediately frozen at –20°C on the 
site, normally within 45–60 minutes, but not later than 120 minutes after sampling. 
If the samples were left at room temperature for longer than the maximum time (60 
minutes) after the centrifugation, it was recorded in the laboratory form. The 
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samples were stored in fibreboard boxes that had been labelled before or to the 2D-
sample racks that contained pre-printed barcode by the manufacturer. The storage 
boxes were filled with tubes according to a pre-planned box chart. All the samples 
were kept frozen at -20°C throughout the storage at the field (collecting) sites. The 
temperature of the freezer was followed with a calibrated temperature gauge and the 
daily minimum and maximum temperatures were recorded. 
The samples in the boxes were packed in dry ice and transferred from the field 
storage points to their final storage location at THL no later than 1–2 weeks after 
sampling. The sample boxes were shipped via a door to door carrier. The sample 
boxes were read to the logistics programme at the field laboratory before shipment 
to keep track of the boxes sent. A mechanical thermometer was also included in the 
transport container to monitor the temperature during transport. 
When the sample shipment arrived at THL, the temperature and the overall 
condition of the shipment were checked. The content of the shipment was read into 
the logistics programme to make sure that all sample boxes that were sent from the 
field had also been received at THL. The serum, plasma and whole blood sample 
aliquots were sorted on the basis of the aliquot type and transferred to storage at –
70C. DNA samples were stored at –20C. HbA1c and fluoride-citrate plasma 
samples were also stored in –20 C after the analysis.  
 
6.4 Field laboratory quality assurance 
 
Laboratory work followed strictly the field manual that was specifically prepared for 
the FinHealth 2017 Study. Procedures for sampling and sample processing were 
tested during two pilot phases. The field laboratory personnel were trained in 
advance during a 2-week training period. The sampling and sample handling sites 
were audited once by an external auditor. Also the person responsible for the 
laboratory work audited the sites one or two times during the field examinations.  
One of the major concerns during planning was how to minimize the risk of 
errors during sampling and sample handling. Therefore all the samples from each 
participant were processed at the same time. In the event of problems, the field 
laboratory personnel contacted the person in charge at THL by e-mail or phone. A 
job rotation scheme was operated with personnel responsible for sample collection 
and sample processing, exchanging jobs at about one-week intervals. 
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6.5 Basic laboratory measurements 
 
The basic laboratory measurements were performed at the biochemistry laboratory 
of the Genomics and Biomarker Unit at THL, Helsinki. The laboratory 
measurements were carried out for  alanine aminotransferase, albumin, 
apolipoproteins A-I and B, aspartate aminotransferase, calcium, cholesterol, 
creatinine, glutamyltransferase, HDL-cholesterol, high sensitive CRP, triglycerides 
and uric acid measurements from serum samples, glucose measurements from 
fluoride citrate plasma samples and glycated haemoglobin A1c measurements from 
EDTA blood samples. LDL cholesterol was calculated using the Friedewald formula 
(Friedewald et al. 1972). All measurements were performed on a clinical chemistry 
analyser Architect ci8200 (Abbott Laboratories, Abbott Park, IL, USA). The 
biochemistry laboratory (T077) is accredited by the Finnish Accreditation Service, 
FINAS and it fulfils the requirements of the standard SFS-EN ISO/IEC 17025:2005. 
The scope of accreditation covers all analyses except albumin, aspartate 
aminotransferase and uric acid. The determinations were carried out on frozen 
samples within one month after sampling. Table 6.5.1 provides more detailed 
information concerning the methods used.  
For standardizing the measurements, the laboratory has taken part in the Lipid 
Standardization Program organized by CDC, Atlanta, USA and External Quality 
Assessment Schemes organized by Labquality, Helsinki, Finland. The quality of the 
results of the series of analysis was ascertained by using controls, which were used 
to determine interassay coefficients of variation (CVs). During the course of the 
study comprising four months in 2017, the precision between series expressed as 
coefficients of variation (CV%), the accuracy of the methods (mean bias% ± SD) 
and the traceability of the methods are demonstrated in the Table 6.5.1. The bias 
indicates the difference between the laboratory’s own result and the target value of 
the quality assessment sample and describes the laboratory’s systematic error. 
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Table 6.5.1. The precision between series, the accuracy of the methods and the 
traceability of the methods. 
Assay Method CV% ± SD, (N)1 Bias% ±  SD, (N)2 Traceability 
Alanine 
Aminotransferase 
NADH (with P-5’-P), IFCC, 
Abbott 
5.3 % ± 3.9 (5) - 3.4 %  ± 4.1 (6) IFCC 
Albumin Photometric, Bromcresol 
Purple, Abbott 
2.0 % ± 0.3 (5) - 1.1 %  ± 2.0 (6) ERM-DA470/IFCC 
Aspartate 
Aminotransferase 
NADH (with P-5’-P), IFCC, 
Abbott 
2.3 % ± 1.0 (5) + 2.7 % ± 2.7 (6) IFCC 
Calcium Photometric, arsenazo III, 
Abbott 
1.3 % ± 0.2 (5) - 0.5 %  ± 1.2 (6) NIST SRM 956 
Cholesterol, total Enzymatic, Abbott 0.8 % ± 0.4 (6) - 0.3%  ± 0.9 (18) Abell-Kendall 
verification, CDC 
Cholesterol, HDL Enzymatic, homogenous 
direct, Abbott 
1.9 %  ± 0.6 (6) + 2.7 %  ± 1.9 (18) Abell-Kendall 
verification, CDC 
Creatinine Enzymatic, Abbott 1.7 %  ± 0.2 (5) + 1.0 %  ± 2.5 (6) NIST SRM 967 
C-Reactive Protein, 
High Sensitivity 
Immunoturbidimetric, Abbott 2.0 %  ± 0.3 (5) + 5.9 %  ± 4.9 (3) ERM-DA472/IFCC 
Glucose Enzymatic, hexokinase, 
Abbott 
2.2 %  ± 0.2 (5) + 4.7 %  ± 3.5 (6) NIST SRM 956 
Gamma-Glutamyl 
Transferase 
Photometric, kinetic (IFCC), 
Abbott 
2.2 %  ± 0.5 (5) - 3.7  %  ± 3.8 (6) IFCC 
Haemoglobin A1c, 
glycated 
Enzymatic, Abbott 1.2 %  ± 0.2  (3) - 1.7 %  ± 2.1 (4) IFCC Monitoring 
Program Reference 
Samples 
Lipoprotein, apo A1 Immunoturbidimetric, Abbott 1.6 % ± 0.3 (6) + 2.1 % ± 2.5 (18) WHO/IFCC/CDC 
Standard SP1-01 
Lipoprotein, apo B Immunoturbidimetric, Abbott 1.2 % ± 0.3 (6) - 4.2 % ± 1.2 (18) WHO/IFCC/CDC 
Standard SP3-08 
Triglycerides Enzymatic, Abbott 2.6 % ± 1.1 (6) - 5.2 % ± 3.5 (18) ACS Grade Glycerol 
Uric Acid Enzymatic, Abbott 0.9 % ± 0.3 (5) + 1.3 % ± 1.1 (6) NIST SRM 913 
CV = interassay coefficient of variation; SD = standard deviation; (N)1 = number of different control; (N)2 = number 
of quality assessment sample  
 
 
 
 
 
 
 
 
7 Anthropometric measurements 
 
THL – Report 17/2019 56 The FinHealth 2017 Study – Methods 
 
7 Anthropometric measurements  
Katja Borodulin and Laura Råman 
 
7.1 Height 
 
Height was measured using a portable, stand-alone (Seca 213) stadiometer. On 
assembly and every day a carpenter’s level was used to verify the correct vertical 
and horizontal placement of the stadiometer. After measuring the correct placement 
of the stadiometer was marked with tape. A thin non-slip mat/carpet was placed 
under the stadiometer to stabilize its place on the floor. 
Height was measured with light socks or barefoot (Tolonen 2016b). Hair 
ornaments interfering with the measurement were removed. Participants were 
instructed to stand upright with feet together on the stadiometer´s platform with the 
back of the head, back, buttocks and heels against the measuring rod. The head was 
positioned so that the top of the external auditory meatus (ear canal) and the bony 
orbit (cheek bone) were in a straight line. The reading was read at eye level of the 
measurer, when a small ladder was used when needed. Height was recorded to an 
accuracy of 0.1 cm.  
Height was not measured if the participant was unable to stand upright or if the 
participant exceeded the maximum height of the stadiometer (205 cm). In these 
cases self-reported height was asked and recorded. For quality control central office 
staff followed the last digits and means of the height measurements by each study 
personnel. 
 
7.2 Weight and body composition 
 
Bioelectrical impedance analysis was carried out to measure body composition. This 
included weight, basal metabolic rate and amounts and proportions of fat, muscle, 
bone and water masses. Tanita DC-430-MA with four electrodes at the platform and 
a remote display was used. Horizontal placement of the platform of the scale was 
checked daily with a carpenter’s level and the device was cleaned with antiseptic 
fluid after every subject.  
For the bioimpedance measurement, the electrodes of the platform were cleaned 
and moistened. The study personnel typed in the participant’s data (age, gender, 
height) on the display. The participants were asked to take off heavy outer garments 
and to empty their pockets. An automatic reduction of 0.5 kg for clothing was made. 
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The participant stepped on the platform with bare feet and in light clothing. The 
study personnel checked the position of the feet and posture. The measurement took 
no more than 30 seconds and the results were printed out. The study personnel 
checked the readings and recorded them. All results were recorded to an accuracy of 
one decimal point (e.g. 0.1 kg for weight). 
The bioimpedance analysis was not carried out if the participant had a cardiac 
pacemaker or another electronic device in the body, was pregnant or had metal parts 
in their body. Weight was measured as a part of the bioimpedance measurement, but 
if not possible due to the exclusion criteria, or if the participant refused the 
bioimpedance measurement, weight was measured using a digital floor scale (Seca 
877). Neither weight nor bioimpedance were measured if the participant had 
difficulty in standing steady or if the participant’s weight exceeded the maximum of 
the scale (Tanita 270 kg, Seca 200 kg). In these cases the participant’s self-reported 
weight was asked and recorded. 
For a small validation sub-study, an older model, Tanita TBF-300MA, was used 
in the Helsinki region. In the validation, each participant had their body composition 
analysis carried out twice using both Tanita devices. This information was collected 
to compare the results between the two devices. For the additional Eastern Finland 
sub-sample, only the older model, Tanita TBF-300MA, was used in all body 
composition measurements.  
Weight and body composition devices were calibrated before the field work 
started. 
 
7.3 Waist and hip circumference 
 
Waist and hip circumferences were measured (Tolonen 2016b) using a plastic 
measuring tape. The tape had a push button to lock the tape at the target level, 
allowing the study nurse to adjust the right place and tightness for a precise 
measurement. A longer 3-meter tape was also available if the standard tape (max 
150 cm) was too short. For the measurement, the participants were asked to undress 
jackets, pullovers and other clothing that hid the waist-hip area. The circumferences 
were measured preferably on bare skin or wearing light underwear. The participants 
were asked to stand with their weight evenly balanced on both feet, a small gap 
between the feet and hands hanging loosely beside the body. The study nurse was 
seated in front of the participant and checked that the measuring tape was in a 
horizontal position also in the back side and that the tape was not twisted.  
Waist circumference was measured at the midway between the lower rib margin 
and the iliac crest with the tape all around the body in horizontal position. Hip 
circumference was measured 2.5 cm above the pubic bone. The measuring tape was 
fastened firmly but so that the measurer was able to fit a finger between the subject’s 
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body and the tape. The participant was instructed to breathe normally and the 
reading was taken during light expiration. The readings were recorded to the nearest 
millimetre.  
For quality control, the length of the measuring tape was checked against a stiff 
metallic tape measure. The study nurses checked the length of the tape on every 
Monday and recorded this. In case the measuring tape had stretched, it was 
immediately replaced with a new one. All measuring tapes were replaced once a 
month with new ones. Further, for quality control the central office staff followed 
the last digits and means of the measurements by each study nurse. 
Waist and hip measurements were not done if the participant was pregnant 
(pregnancy week above 20) or could not stand in upright position during the 
measurement. 
 
  
8 Blood pressure measurements 
 
THL – Report 17/2019 59 The FinHealth 2017 Study – Methods 
 
8 Blood pressure measurements  
Tiina Laatikainen, Pekka Jousilahti and Katja Borodulin 
 
Blood pressure was measured before any other measurements. In the invitation the 
participants were requested to refrain from heavy exercise prior to the examination 
and to avoid eating and drinking for at least four hours before the examination. 
Blood pressure was measured by a trained study nurse in a room carefully selected 
to meet the requirements of privacy, silence and adequate temperature. The room 
temperature was recorded.  
The measurements were done in a sitting position from the right arm of the 
participant using a mercury sphygmomanometer. There were four different sizes of 
cuffs available: small, medium, large, and extra large. The cuff was selected based 
on measured arm circumference so that a small cuff was used when the arm 
circumference was less than 24 cm, a medium cuff when the circumference was 24–
32 cm, a large cuff when the circumference was 32–48 cm and an extra large cuff 
when the arm circumference was more than 48 cm. Before the measurement the 
participants sat at least five minutes with the cuff set ready around their arm. 
Measurements were repeated three times with at least one minute between 
measurements. After the first blood pressure measurement, pulse was measured by 
palpating the wrist artery and counting the number of pulses from the artery for 60 
seconds. 
The measurement technique followed the recommendations of the European 
Health Examination Surveys (Tolonen 2016b). For each participant the following 
possible exceptions were recorded, if relevant: irregular rhythm, measurement 
performed from the left arm, measurement performed on supine position, or 
Korotkoff IV phase recorded as diastolic pressure. If the blood pressure 
measurement was not performed at all the reason for that was also recorded. 
The study protocol included several quality management procedures regarding 
blood pressure measurements as this measurement, especially when using 
sphygmomanometers, is prone to measurement error by the measurers. First of all 
the study nurses measuring blood pressure were provided a 9-day training on the 
measurement techniques including practicing and final assessment. All the 
measurers also passed a hearing test. During the field work, all study nurses who 
carried out these measurements circulated between the teams in one week intervals 
from February 20th until March 31st. Inter-individual variability of recorded blood 
pressure levels and possible zero (or other last digit) preference was followed at the 
central office during the data collection. The field protocols were also audited by 
internal and external visits 
.  
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9 Sociodemographic factors 
Seppo Koskinen and Katri Sääksjärvi 
 
Demographic factors 
 
Information on age, sex, date and place of birth, marital status, place of residence 
and mother tongue was obtained for the whole sample (participants and non-
participants) from the Population Register Centre. Furthermore, information on 
marital status and education were inquired with Questionnaire 1.  
 
Socioeconomic status 
 
Register data were acquired from Statistics Finland concerning level of education, 
occupation and socioeconomic position for those individuals who participated in the 
health examination. Furthermore, the Ministry of Employment and Economy 
provided information on unemployment for all individuals included in the sample. 
In Questionnaire 1, the participants were asked about their main activity, with the 
following six response alternatives: employed or self-employed (includes unpaid 
employment in a family-owned business, apprenticeship, and paid internship); 
unemployed; student, further education, or unpaid internship; retired; on family 
leave, or a stay-at-home mother/father; other.  
Questionnaire 1 included a question “How large was your household’s income 
last year (before tax deduction)?”, with ten response alternatives ranging from less 
than 15 000 euros to more than 90 000 euros. Furthermore, the questionnaires 
collected information on the financial situation of the respondents by posing the 
questions “How satisfied are you with your economic situation?” with five response 
alternatives (very satisfied; satisfied; somewhat satisfied; unsatisfied; very 
unsatisfied) (Questionnaire 1), and “Do you have enough money to meet your 
needs?” with five response alternatives (not at all; a little; moderately; mostly; 
completely) (Questionnaire 2). 
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10 Quality of life 
Seppo Koskinen and Katri Sääksjärvi 
 
Quality of life (QOL) refers to a broad, multidimensional concept that usually 
includes subjective evaluations of both positive and negative aspects of life while 
health related quality of life (HRQOL) aims to capture the aspects of QOL that can 
be influenced by health and health care. These include domains related to physical, 
mental, emotional, and social functioning. Several methods to assess QOL and 
HRQOL exist.  
In the FinHealth 2017 Study, the EUROHIS-QOL 8-item index (Power 2003, 
Schmidt et al. 2006) was included in Questionnaire 2.  The EUROHIS-QOL 8-item 
index is composed of eight items (overall QOL, general health,  daily activities, self-
esteem, relationships, home, energy, and financial situation) taken from the 
WHOQOL-BREF. Each item has a five-point response scale and is scored positively. 
The overall QOL score is formed by a simple summation of scores on the eight 
items, with higher scores indicating better QOL.  
In addition, Questionnaire 1 included one question on each of the three 
dimensions of wellbeing outlined by Allardt (Allardt 1976), i.e. having, loving and 
being. The questions were “How satisfied are you with your economic situation?”, 
“How satisfied are you with your family life?”, and “How satisfied are you with 
your accomplishments in life?”, with five response alternatives (very satisfied; 
satisfied; somewhat satisfied; unsatisfied; very unsatisfied). 
Finally, self-rated quality of life was assessed in Questionnaire 2 with a global 
question “How would you rate your quality of life?”, with five response alternatives 
ranging from very poor to very good. This question is one of the eight items 
included in the EUROHIS-QOL index, but it is also often used as a separate 
indicator of quality of life. 
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11 Health behaviours 
11.1 Smoking  
 
Otto Ruokolainen  
 
In Questionnaire 1, smoking, snuff use, electronic cigarette use, nicotine 
replacement therapy and exposure to environmental tobacco smoke were assessed. 
For all participants, a question: “Have you ever smoked?” (no; yes) was 
presented in the Questionnaire 1. For those, who answered ‘yes’, a follow-up 
question was asked: “Have you during your life smoked at least 100 times 
(cigarettes, cigars or pipefuls)” (no; yes). The rest of the questions on smoking were 
put to those who had smoked at least 100 times. A five-category variable for 
smoking status was generated using, in addition to these two questions, the 
following questions (and the corresponding answer options): “Have you ever 
smoked regularly (almost every day for at least a year)? How many years altogether?” 
(I have never smoked regularly; I have smoked regularly for __ years [an open 
ended question]), “When was the last time you smoked?” (yesterday or today; 2 
days–1 month ago; between 1 and 6 months ago; 6 months–1 year ago; 1–5 years 
ago; 6–10 years ago; over 10 years ago).  
The classes for smoking status were: Daily smoker; Occasional smoker; Quitter 
1–12 months ago; Quitter over 1 year ago; Non-smoker. The respondents’ current 
smoking was enquired with the question: “Do you smoke nowadays (cigarettes, 
cigars, pipefuls)?” (yes, daily; yes, occasionally; not at all). The initiation age of 
smoking was assessed with the question “How old were you when you started 
smoking”, with years as the open-ended answer option. Nicotine addiction was 
measured using a two-question version of the Fagerström Test for Nicotine 
Dependence (Heatherton 1991), also known as Heaviness of Smoking Index, HSI. 
The first question was “How soon after waking up do you smoke your first 
cigarette?” (in 5 minutes; in 6–30 minutes; in 31–60 minutes; more than 60 minutes 
after waking up). Second, an open-ended question was asked: “On average, how 
much do you smoke or did smoke before you quit?” (manufactured cigarettes; self-
rolled cigarettes; pipefuls; cigars).  
Snuff use was assessed with a question “Do you use snuff?” with answer options 
being: yes, __ portions a day (an open-ended question); sometimes; not at all. 
Nicotine replacement therapy use was asked as follows: “Have you during the last 
12 months used nicotine replacement therapy (gum, patches, pills, lozenge, 
sublingual tablet, inhaler) or prescription drugs that can help you quit smoking?” (no, 
I have not; yes, to help me stop smoking; yes, for other reason). Current electronic 
11 Health behaviours 
 
THL – Report 17/2019 63 The FinHealth 2017 Study – Methods 
 
cigarette use was assessed with the question: “Are you currently using electronic 
cigarettes with nicotine?” (daily; sometimes; never). Exposure to environmental 
tobacco smoke was asked with a question: “How many hours do you daily spend in 
indoor spaces where you have to inhale other people’s smoke?”. The open-ended 
answer options were: at home; at work; other places. 
In questionnaire 2, the remaining four questions comprising the full Fagerström 
Test for Nicotine Dependence (Heatherton 1991) were addressed to ever smokers 
(current smoker or former smoker): “Is it difficult for you to refrain from smoking in 
places where smoking is banned?” (yes; no), “Which cigarette is the most difficult 
for you to give up?” (the first of the morning; some other cigarette), “Do you usually 
have a habit of smoking more frequently in the first hours after waking than at other 
times of day?” (yes; no), and “Do you smoke even when you are so ill that you have 
to stay in bed for most of the day?” (yes; no; I can’t say). Also, two questions for 
only current smokers were posed: “Would you be willing to quit smoking?” and “If 
you were to try to quit smoking, do you believe that you could completely give up 
smoking?”. The answer options for these questions ranged from 1 (not at all willing 
/ not at all confident) to 10 (very willing / very confident). 
 
11.2 Alcohol consumption  
 
Janne Härkönen and Pia Mäkelä 
 
The information concerning alcohol consumption was collected by Questionnaire 1 
The respondents were first asked to define, whether they were a) lifetime abstainers 
(or have only tasted an alcohol beverage maximum of 10 times during their lifetime), 
b) former drinkers (from which year, until which year) or, c) current drinkers (from 
which year). 
Next the respondents completed the first three questions of the Alcohol Use 
Disorders Identification Test (AUDIT-C): the frequency of drinking, quantity of 
alcohol typically consumed, and the frequency of drinking six or more drinks on one 
occasion. The definition of a standard drink was given (one 330 ml standard bottle 
of medium strength beer, a small 12 cl glass of wine, or one 4 cl shot of spirits; and 
a 50 cl pint of beer/cider equaling 1.5 standard drinks). Each AUDIT-C question had 
five answer choices, which were rated from zero to four, thus resulting in a total 
score of 0 – 12 points (scores of zero reflect no alcohol use in the past year). 
Following the Current Care Guidelines, a score of six or more was considered 
positive in men for hazardous or problem drinking; in women, a score of five or 
more was considered positive (Working group set up by the Finnish Medical Society 
Duodecim and the Finnish Society of Addiction Medicine, 2015). 
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Lastly, using the standard drink measurement, the respondents were asked how 
many drinks of the following beverages they had consumed during the last week: 1. 
medium beer or similar strength cider/alcopops, 2. strong beer or similar strength 
cider/alcopops, 3. wine, 4. spirits. 
 
11.3 Dietary habits  
 
Satu Männistö, Niina Kaartinen, Mirkka Maukonen, Heli Tapanainen, Heikki 
Pakkala, Anne Juolevi, Harri Rissanen, Katja Borodulin and Liisa Valsta 
 
Questionnaire 1 contained questions on dietary habits including frequency of meals 
and snacks consumed during weekdays, most commonly used fat spread, cooking fat, 
milk type, and consumption frequency of vegetables, fruits and berries during the 
past week. In addition, Questionnaire 2 contained questions on importance of 
different claims related to food choices as well as perception of saltiness of food, 
and salt consumption.  
 
Food Frequency Questionnaire (FFQ) 
 
Information on habitual diet was collected by a food frequency questionnaire (FFQ) 
developed and validated at THL. The FFQ is the primary method in epidemiological 
studies concerned with the association of diet and the risk of diseases (Willett 2013), 
as it provides information on diet over a long period. The main aim of FFQ is to 
rank participants according to their food or nutrient intakes, not to measure the 
absolute intakes. The FFQ is easy for participants to complete and the answers are 
straightforward digitized, which makes it quite inexpensive to use in large 
population-based studies. The development of the questionnaire itself, however, is a 
time-consuming exercise and it is always necessary to ascertain the validity of the 
FFQ compared to food records or recalls. 
The THL's semi-quantitative FFQ was initially developed for the Kuopio Breast 
Cancer Study (Männistö et al. 1996). The questionnaire has been updated every five 
years since 2000, and it is widely used in many studies. While the food 
rows/physical appearance of the FFQ have remained largely unchanged 
(approximately 130 -items), the updates have concerned the sex-specific portion 
sizes associated with each food row, and the food composition database codes 
composing each of the food rows (information needed for dietary calculations, and 
not visible for the subjects). The updates made for the FFQ used in the FinHealth 
2017 Study were based on data from the FinDiet 2017 Study (two non-consecutive 
24-hour dietary recalls). 
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In general, the participants were asked to describe their habitual diet over the past 
12 months. The questionnaire listed 134 foods, mixed dishes and alcoholic 
beverages commonly used in Finland, grouped in the following categories: dairy 
products; grain products;  fat  spreads;  vegetables;  potatoes, rice and pasta; meat; 
fish; chicken, turkey and eggs; fruit and berries; desserts; sweet and snacks; and 
beverages. The average use of 134 foods was recorded by ten frequency categories 
ranging from never to at least six times a day. Participants can adjust the reported 
frequency for a food item if their own portion size differs from the predefined size 
on the questionnaire. The questionnaire also included additional questions on special 
diets and dietary supplements.  
The FFQ was given to all participants in the health examination and they were 
asked to complete it later at home. The questionnaire was introduced to each 
participant and the filling instructions were reviewed together with them. Of these 
participants 89% returned the FFQ. Exclusions were made due to blank or 
incompletely filled FFQs (n=110), duplicate answers (n=9), withdrawal of the 
written consent to participate (n=7) and daily energy intake cut-off points 
corresponding to 0.5 per cent at both ends of the daily energy intake distributions for 
men and women separately (n=51). Eventually, intake of food and nutrients was 
calculated for 5125 (86%) participants. 
The average daily intakes of ingredient groups (e.g. wheat, fish and berries), food 
groups (e.g. fish soups) and nutrients (e.g. energy-yielding nutrients, fibre and 
vitamin C) were calculated using the National Food Composition Database 
(FINELI®) and the FINESSI software of THL (Reinivuo et al. 2010). The final 
dietary dataset comprises around 80 ingredient groups, 80 food groups and 100 
nutrients that can be used for research purposes. 
The reproducibility of the FFQ versions has been measured twice (Männistö et al. 
1996, Paalanen et al. 2006) and the validity compared with dietary records three 
times (Männistö et al. 1996, Paalanen et al. 2006, Kaartinen et al. 2012). In those 
validation studies, the first evaluation of FFQ included diet as a whole, the second 
one concentrated more on the differences between sex, age and BMI groups, and the 
third one focused on carbohydrate fractions, dietary glycaemic index (GI) and the 
glycaemic load (GL). The reproducibility and validity results were similar compared 
to large internationally well-known studies (e.g., Pietinen et al. 1988, Willett 2013). 
As a consequence, the FFQ is reasonably accurate when the cautions concerning 
some foods and nutrients are taken into account. 
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11.4 Physical activity and sedentary behaviour  
 
Katja Borodulin  
 
Physical activity refers to movement that results in energy expenditure and 
comprises elements such as type, frequency, duration, and intensity. Information on 
physical activity was collected in Questionnaire 1 and in Questionnaire 2. Objective 
measurements of physical activity and sedentary behaviour by accelerometers are 
described under Chapter 20.2. 
Questionnaire 1 included questions on occupational, commuting, and leisure time 
physical activity as well as on time spent sitting in different contexts. The question 
on occupational physical activity was formulated as “How demanding is your work 
physically? Please choose the option that best applies to your situation”, with 
response options 1) I do not work or my work is mainly done sitting down and I do 
not walk much during my working hours, 2) I walk quite much in my work, but I do 
not have to lift or carry heavy objects, 3) I have to walk and lift much or to take the 
stairs or go uphill, and 4) My work is heavy manual labor in which I have to lift or 
carry heavy objects, to dig, shovel or chop, etc. 
Commuting physical activity was assessed with the question: “On your way to 
work or school, how many minutes do you travel on foot, by bicycle or similar? Add 
up the journeys to and from work/school”. The six response options were the 
following: 1) I do not work or I work at home, 2) I use a motor vehicle for the entire 
trip, 3) less than 15 minutes daily, 4) 15–29 minutes daily, 5) 30–60 minutes daily, 
and 6) over an hour daily.  
For leisure time physical activity, the question was stated as: “How much do you 
exercise and stress yourself physically in your leisure time?” The response 
categories were: 1) In my leisure time I read, watch TV and do other activities in 
which I do not move much and which do not strain me physically, 2) In my leisure 
time I walk, cycle and move in other ways several hours a week. This includes 
walking, fishing and hunting, and light home gardening, 3) In my leisure time I 
exercise several hours a week. This includes running, jogging, cross country skiing, 
fitness training, swimming, ball games, and strenuous garden work, and 4) In my 
leisure time I practice regularly strenuous sport several times per week. This 
includes competitive sports such as running, orienteering, cross country skiing, 
swimming and ball games.  
For time spent sitting, the question was: “How many hours on average do you sit 
in a weekday? Mark 0 if not at all.” The participant was asked to estimate the hours 
and minutes for each location or context: During the workday in office or 
equivalent; At home, in front of the TV, computer, or mobile device; In a vehicle; 
and other sitting.  
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Questionnaire 2 included two additional sets of questions on physical activity. 
The other was an instrument for volume of total physical activity per week that also 
allowed an estimation of reaching the current recommendation of physical activity. 
This instrument included four activity levels by their intensity, frequency and 
duration, as well as the frequency of muscle strengthening activities. The second 
instrument in questionnaire 2 was the physical activity frequency questionnaire that 
assessed weekly frequency of more than ten types of activities across winter and 
summer time.  
 
11.5 Sleep and sleeping  
 
Timo Partonen 
 
In the self-administered Questionnaire 1, the habitual duration of sleep was assessed 
with a single question asking “How many hours do you sleep in 24 hours?” The 
answer was requested to be given as on average in hours and minutes. Sleep 
satisfaction (insufficient sleep) was assessed with the question asking “Do you think 
you sleep enough?” The participants were also asked, how often over the past month 
they “have felt excessively tired or sleepy during the daytime”, “have had 
nightmares”, and “have had trouble sleeping”. These items concerned the frequency 
of common symptoms of insomnia. 
In the self-administered Questionnaire 2, there were the following questions on 
sleeping and disturbances of sleep. The habitual schedule for sleep was assessed by 
the two items asking “What time do you usually go to bed (to prepare to sleep)?” 
and “What time do you usually get up from bed (without going back again)?” The 
responses were asked separately for “On workdays or weekdays” as well as “On 
days off or weekends”. The habitual duration of sleep was calculated on the basis of 
these answers separately for working days as well as free days. Further, the social 
jetlag was calculated on the basis of these two durations of sleep. The behavioural 
trait of morningness-eveningness (chronotype) was assessed with a single question 
asking “There are so-called ‘morning people’ (early to rise, early to bed) and 
‘evening people’ (late to rise, late to bed). Which are you?” Participants were also 
asked “Do you snore when sleeping? (Ask others if you are not sure)”, “Have you 
noticed (or have others noticed) respiratory arrests when you sleep?”, and “How 
many times a night do you need to get up to urinate?” These items concerned the 
frequency of common symptoms of sleep apnea. 
Some questions which are related to sleep were also presented in other parts of 
the survey protocol. These include the questions asking “Has a doctor diagnosed or 
treated you for sleep apnea during the past 12 months?” (as one of the 10 medical 
conditions listed), “When was the last time you used sleeping pills?” (as one of the 
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11 medications listed), “How much does the duration of sleep change for you 
according to different seasons?” (as part of the Global Seasonality Score, GSS), and 
“Have you recently lost much sleep over worry?” (as part of the General Health 
Questionnaire, GHQ). 
In addition, to a random sample attending the health examination, an 
accelerometer (Actigraph GT9X Link) was given to be worn on the non-dominant 
wrist continuously as well as a sleep diary to be kept for seven days, measuring the 
rest-activity cycles. See Chapter 20.2 for more information. 
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12 Self-rated health and long-
term illnesses 
Katja Borodulin, Seppo Koskinen and Päivikki Koponen 
 
The global measure of self-rated health has consistently been identified as a 
predictor of several health problems and mortality (Baćak & Ólafsdóttir 2017). It 
has been assumed that people take into account a more comprehensive set of 
physical and psychological conditions when rating their health than what would be 
possible to measure in any one survey. While the question on self-rated health is 
widely used, the exact wordings and response options of questions on self-rated 
health vary. Thus the levels and distributions are not directly comparable between 
different surveys (Jylhä 2009). The question is also sensitive to cultural factors and 
differences in data collection modes.  
Self-rated  health was measured  in Questionnaire 1 by a standard question used 
in previous national health surveys in Finland: “Is your present state of health…”, 
with  response options  ‘good’, ‘rather good’, ‘moderate’, ‘rather poor’, and ‘poor’. 
This wording differs from the European (Eurostat 2019) and most international 
standards (Jylhä 2009), but was chosen for the FinHealth 2017 Study to follow 
national trends.  
Longstanding illnesses or health problems were assessed with the Minimum 
European Health Module question:  “Do you have any longstanding illness or health 
problem?” and the response options were ‘no’ or ‘yes’ (Eurostat 2019). This 
question differs from the wording used in previous national health surveys in 
Finland. It was chosen because of the simplicity of the question and problems 
identified with the previously used national questions on longstanding illnesses and 
health problems. 
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13 Diseases and risk factors 
13.1 Cardiovascular diseases and diabetes  
 
Tiina Laatikainen and Pekka Jousilahti 
 
In the FinHealth 2017 Study, questions on cardiovascular diseases and diabetes were 
included in the self-administered questionnaires as in the previous FINRISK Studies. 
Thus, the comparability with the corresponding Health 2000/2011 interview 
questions is low. Questionnaire 1 included previous FINRISK questions concerning 
these diseases.  
First, the list of diseases diagnosed or treated by a doctor during the past 12 
months included cardiac insuffiency and coronary heart disease. The questions on 
hypertension covered last time when the respondent’s blood pressure had been 
measured (with five response options ranging from ‘during the last six months’ to 
‘never’), and having ever been diagnosed for high or elevated blood pressure, and 
having ever used medicine for blood pressure. For medication, the last time when 
the respondent had taken the medicine was asked (with six response options ranging 
from ‘today or yesterday’ to ‘over 5 years ago’). The frequency of using a blood 
pressure monitor at home (with six response options ranging from ‘daily’ to ‘never’) 
was also asked. 
Further, questions were asked about having ever been diagnosed by a doctor, 
first with myocardial infarction, and second with stroke, cerebral haemorrhage or 
cerebral thrombosis. There were also questions for having ever had coronary bypass 
surgery, or angioplasty (balloon distension). If the answer was yes to any of these, 
the subject was asked to specify what year was the last one. The question on 
medication included use of ‘Acetylsalicylic acid to prevent myocardial infarction or 
cerebral infarction (e.g. Aspirin, Disperin, Primaspan)’ and ‘Blood thinner 
medications, anticoagulants (Marevan, Pradaxa, Xarelto or Eliquis)’ with five 
answer options from ‘during the past week’ to ‘never’.  
Information on diabetes covered the last time the respondent had his/her blood 
sugar level measured (with response options from ‘during the last six months’ to 
‘never’, and ‘do not know’). They were asked about having ever been diagnosed 
with diabetes with the answer options covering the type (elevated blood glucose 
levels or prediabetes); type 1diabetes (childhood-onset diabetes), type 2 diabetes 
(adult-onset diabetes), gestational diabetes, or not knowing which type. The year of 
diagnosis was also asked. When diagnosed with diabetes the respondents were asked 
about the treatments: lifestyle counselling only, tablet or insulin treatment or none of 
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these. Current use of medicines for diabetes was also asked (nothing, insulin, tablets 
or both).    
Blood pressure was measured (Chapter 8) and blood lipids, glycated hemoglobin 
and fasting glucose were analysed among those who participated in the health 
examination (Chapter 6). 
 
13.2 Respiratory diseases and allergies  
 
Tiina Laatikainen and Pekka Jousilahti 
 
In the FinHealth 2017 Study, questions on respiratory diseases and allergies were 
included in the self-administered questionnaires as in the previous FINRISK Studies. 
Thus, the comparability with the corresponding Health 2000/2011 interview 
questions is low. In Questionnaire 1, the subjects were asked whether a doctor had 
ever diagnosed them with asthma, chronic obstructive pulmonary disease (COPD) 
or chronic bronchitis. The following symptoms were also asked (with reference to 
usually and answer options yes or no): coughing phlegm when waking up on winter 
mornings, during the day or at night during winter, or on most days or nights for at 
least 3 months yearly.  
The FinHealth Questionnaire 2 included additional questions on respiratory 
symptoms, i.e. having noticed over the past 12 months: ‘a wheezing or hissing sound 
when breathing’, experiencing ‘while wheezing shortness of breath (dyspnea) at the 
same time’ and noticing ‘a wheezing sound when you breathe even though you are 
not suffering from a common cold or a respiratory infection’. In addition, the 
respondents were asked if, over the past 12 months, they had ever been awakened 
‘because your breathing became laboured’, ‘because of shortness of breath‘ or 
‘because of a coughing fit’. After these questions the respondents were asked if they 
currently take any asthma medications (nebulizer, inhaler or pills). 
Questions on allergies in Questionnaire 1 inquired if the respondent had ever had 
hay fever or other allergic nasal symptoms, allergic eye symptoms or an itching rash 
which was called milk crust (infantile eczema), or atopic rash (atopic eczema). The 
answer options were ‘no’, ‘yes, during the last 12 months’ and ‘yes, the last time 
was over a year ago’.   
The question on medication included use of ‘Asthma medication’ and ‘Hay fever 
medication’ with five answer options from ‘during the past week’ to ‘never’.  
No measurements concerning respiratory function were included in the health 
examination, but serum samples were taken and stored for possible future analyses 
of specific IgE and other biological markers.  
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13.3 Infectious diseases  
 
Kirsi Liitsola and Jussi Sane 
 
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, 
viruses, parasites or fungi. The diseases can be spread, directly or indirectly, from 
one person to another. Infectious diseases can cause conditions ranging from mild to 
fatal. Antibiotics are used to prevent and treat bacterial infections. Because of the 
overuse of antibiotics, antibiotic resistance has become a public health threat. Many 
infections can be prevented by vaccines. Despite the existing control methods, the 
burden of infectious diseases remains high.  
In the FinHealth 2017 Study, Questionnaire 1 included three questions 
concerning the use of antibiotics. The question “When was the last time you used 
the following medication?” included antibiotics as well as several other drugs. In 
addition, there were two antibiotic-specific questions. The reason for the last 
antibiotic treatment was asked, with answer options: respiratory tract infection, 
stomach problems including diarrhea and vomiting, urinary tract infection, skin or 
wound infection, some other reason. Also a question on where the recent antibiotic 
treatment had been started was presented, with the answer options: inpatient ward, 
at home.  
Questionnaire 2 included two questions concerning the burden of common 
infections in sickness absences:  absences from work/study during the last 30 days 
because of respiratory infections (a common cold, influenza, tonsillitis, maxillary 
sinusitis, pneumonia, etc.), or because of stomach problems including diarrhoea and 
vomiting.  
Since the national vaccination register currently only includes vaccinations given 
in public primary health care, a question of self-paid vaccinations was included in 
Questionnaire 2. The question was “Have you ever taken any of the following 
vaccinations, and paid for them yourself?”, with the answer options: tick-borne 
encephalitis, combined hepatitis A and B, hepatitis A, pneumonia, varicella, shingles, 
influenza, other. 
 
13.4 Symptoms on indoor air quality  
 
Juha Pekkanen, Pekka Jousilahti and Tiina Laatikainen 
 
Symptoms related to indoor air quality were asked in the FinHealth 2017 Study in 
Questionnaire 2. Three questions were presented: 1) “Have you ever experienced 
symptoms related to poor indoor air quality at your home?”, 2) “Have you ever 
experienced symptoms related to poor indoor air quality at your workplace?” and 3) 
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“Have you ever attended a medical doctor or received medical care due to symptoms 
or illness, which were suspected to be mainly caused by poor indoor air quality?“ 
The response options for all these questions were: “no”, “yes, during the past 12 
months” or “yes, over a year ago”. 
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14 Mental health  
Jaana Suvisaari, Timo Partonen and Pia Solin 
 
Mental health and substance use-related problems were assessed with questionnaires 
(Questionnaire 1, Questionnaire 2), which assessed mood and anxiety symptoms, 
psychological distress, and mental well-being (positive mental health). In addition, 
there were a few questions on treatment. 
The instruments used for the assessment of mental health in the study 
questionnaires and interviews are presented in Table 14.1. 
 
Table 14.1.The instruments used for the assessment of mental health. 
 Questionnaire 1 Questionnaire 2 
Treatment x x 
BDI-6  x 
GHQ-12  x 
MHI-5 x  
Depression 
symptoms 
x  
SPAQ  x 
WEMWBS  x 
 
Current psychological distress was assessed with two sets of questions. The first was 
the 12-item version of the General Health Questionnaire (GHQ-12, Goldberg 1972). 
GHQ-12 includes 12 questions assessing symptoms commonly related to depression 
as well as general functioning, e.g. ability to face problems and make decisions. All 
items have a 4-point scoring system ranging from a “better/healthier than normal” 
option, through a “same as usual” and a “worse/more than usual' to a “much 
worse/more than usual” option. These are scored using a 0-0-1-1- scoring, so that 
“better” and “usual” responses are scored as 0, and “worse” and “much worse” 
responses are scored as 1. The responses to individual items are added to give a total 
score which varies from 0 to 12. The cut-off for current psychological distress was a 
total score above 3. 
The second set of questions for assessing current psychological distress was the 
Mental Health Inventory (MHI-5) derived from the SF-36 scale (McHorney & Ware 
1995). MHI-5 includes five questions covering the past four weeks: (1) Have you 
been a very nervous person? (2) Have you felt so down in the dumps that nothing 
could cheer you up? (3) Have you felt calm and peaceful? (4) Have you felt 
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downhearted and blue? (5) Have you been a happy person? All items have a 6-point 
scoring system ranging from “All of the time” to “None of the time”. When the total 
score is calculated, the answers to two items (the third and fifth) are reversed. The 
raw scores are then transformed to a scale ranging from zero to 100 (Aalto et al. 
1995). The cut-off for current psychological distress was a total score of 52 or below. 
Current depressive symptoms were screened using the 6-item version of the Beck 
Depression Inventory (BDI-6) (Aalto et al. 2012). The scoring of each of the BDI-6 
questions in the version that was used in the study is described in Table 14.2. The 
scores of individual items are added to give the total score which varies from 0 to 18.  
 
Table 14.2. Scoring of the Beck Depression Inventory-6 (BDI-6). 
Question 1 1=0 2=1 3=2 4=2 5=3 
Question 2: 1=0 2=1 3=2 4=2 5=3 
Question 3: 1=0 2=1 3=2 4=2 5=3 
Question 4: 1=0 2=1 3=2 4=2 5=3 
Question 5: 1=0 2=1 3=2 4=2 5=3 
Question 6: 1=0 2=1 3=2 4=3  
 
Seasonal variations in mood and behaviour were assessed with seven items derived 
and adapted from the Seasonal Pattern Assessment Questionnaire (SPAQ, Rosenthal 
et al. 1984), including the six seasonal variations in sleep duration, social activity, 
mood, weight, appetite, and energy level. Two modifications were made to the 
original scoring as follows. Each item was scored from zero to three (none, slight, 
moderate or marked), not from zero to four, with the sum or global seasonality score 
(GSS) ranging from 0 to 18. The psychometric properties of this modified 
questionnaire have been tested and been shown to be good (Rintamäki et al. 2008). 
The 7/8 cut-off score was applied for the two GSS categories (0–7 vs. 8–18). In 
addition, there was a question: “If you experience changes by seasons, do you feel 
that these are a problem for you?” The first part of this item was scored from zero to 
one (no variations, variations but no problem), and if there was a problem, the 
second part of this item was scored from two to five (variations of mild, moderate, 
marked or severe problem). 
Positive mental health was measured with Warwick Edinburgh Mental Well-
being Scale (WEMWBS) (Tennant et al. 2007). The scale consists of 14 positively 
worded items covering positive affect (feelings of optimism, cheerfulness, 
relaxation), satisfying interpersonal relationships and positive functioning (energy, 
clear thinking, self-acceptance, personal development, competence and autonomy). 
The questions are: I’ve been feeling optimistic about the future 2) I’ve been feeling 
useful, 3) I’ve been feeling relaxed, 4) I’ve been feeling interested in other people, 5) 
I’ve had energy to spare, 6) I’ve been dealing with problems well, 7) I’ve been 
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thinking clearly, 8) I’ve been feeling good about myself, 9) I’ve been feeling close 
to other people, 10) I’ve been feeling confident, 11) I’ve been able to make up my 
own mind about things, 12) I’ve been feeling loved, 13) I’ve been interested in new 
things and 14) I’ve been feeling cheerful. The respondents are asked to rate their 
experience over the past two weeks; 1 (none of the time), 2 (rarely), 3 (some of the 
time), 4 (often) and 5 (all of the time). The total score ranges from 14 to 70 points. 
In addition to the aforementioned questionnaires, there were single items on 
mental health and its treatment as follows. In Questionnaire 1, as part of the 10-item 
list (Question 5) asking “Has a doctor diagnosed or treated you for any of the 
following diseases during the past last 12 months?”, the participant was asked about 
“depression” as well as “other psychological or mental illness”, and to answer either 
“no” or “yes”. Later (Question 36), the participant was asked “Have you during the 
last 12 months had a period of at least two weeks when, for most of the time you 
have been low-spirited or depressed?” and “Have you during the last 12 months had 
a period of at least two weeks when, for most of the time you have lost interest in 
most things, such as hobbies, work or other things that usually give you pleasure?”, 
to both of which the participant was asked to answer either “no” or “yes”. Later, as 
part of the 11-item list (Question 38) asking “When was the last time you used the 
following medication?”, the participant was asked to choose the correct alternative 
of “during the past week”, “1–4 weeks ago”, “1–12 months ago”, “over a year ago” 
or “never” for “sleeping pills”, “tranquillizers” and “antidepressants”. In 
Questionnaire 2, there was one question on health service use during the past 12 
months due to mental health problems. In addition, Questionnaire 2 had a list of 
questions on family history of different health problems (mother, father), including 
mental health problems. 
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15 Oral health  
Liisa Suominen and Eero Raittio    
 
Information on oral health was collected in Questionnaire 1 and Questionnaire 2 and 
in the Questionnaire for persons aged 70 years or older. The questions covered the 
aspects of self-reported oral health and symptoms, oral self-care, and use of services. 
The questions were largely the same that were used in the Health 2011 Survey 
(Lundqvist & Mäki-Opas 2016), in the Health 2000 Survey (Suominen-Taipale et al. 
2008) and in the Mini-Finland Study (Vehkalahti et al. 1991) but included also some 
new or slightly modified questions.  
In Questionnaire 1, information on self-reported oral health was collected by 
asking the participants ‘Is the condition of your teeth and the health of your mouth at 
present’ good, rather good, moderate, rather poor or poor. Oral self-care was 
inquired by two questions: ‘How often you usually brush your teeth’ with answer 
options ‘more often than twice a day’, ‘two times per day’, ‘once a day’, ‘less 
frequently than daily’ or ‘never’, and ‘How often do you use for cleaning and caring 
for your mouth and teeth dental floss or interdental brush?’ with answer options 
‘daily’, ‘weekly’, ‘less frequently’ or ‘not at all’.  
Questions on toothache or other oral health-related trouble and symptoms were 
included in Questionnaire 2. Participants were asked ‘Have you during the past 12 
months had toothache or other trouble related to your teeth or dentures’ with answer 
options ‘yes’ or ‘no’.  Questions on bad breath (halitosis or malodor) and dry mouth 
were new and were inquired with a question ‘Have you during the last month (past 
30 days) had the symptoms or problems?’ with answer options ’daily’, ‘less 
frequently’ or ‘not at all’. 
Questions on use of oral health care services were also included in Questionnaire 
2. Participants were first asked about their habitual use of dentist’s services by a 
question ‘Do you usually go to a dentist’ with answer options ‘regularly for a check-
up’, ‘only when having toothache or some other trouble’ or ‘never’. They were also 
asked ‘When was the last time you visited a dentist’ with answer options ‘less than 1 
year ago’, ‘1 to 2 years ago’, ‘3 to 5 years ago’, ‘over 5 years ago’ or ‘have never 
visited a dentist’. Number of visits to any oral health care was asked by the question 
‘Over the past 12 months, how many times have you visited...’ and the answers were 
requested separately for a dentist working at public dental services (a health centre), 
a private practice, or other place (the Finnish Student Health Services, military, 
university, hospital etc.), a dental technician, a dental hygienist working at a health 
centre or at a private clinic, or other oral health care. Barriers for not having received 
care were inquired by the question ‘Have the following factors prevented you from 
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getting the dentist’s treatment you wanted?’ with answer options ‘queuing to access 
to care’, ‘poor commuting to treatment place’ or ‘too high service charges or prices’.    
Questionnaire for persons aged 70 years or older included questions concerning 
presence of natural teeth and/or dentures and denture cleaning. Participants were 
asked whether they had ‘full dentures and no natural teeth or tooth remnants’, 
‘dentures and natural teeth’, ‘no dentures but natural teeth’ or ‘neither dentures nor 
natural teeth’. Those having dentures were asked how often they cleaned their 
dentures with answer options  ‘more often than twice a day’, ‘twice a day’, ‘once a 
day’, ‘less frequently than daily’ or ‘never’. 
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16 Accidents  
Anne Lounamaa and Persephone Doupi 
 
An accident is an unexpected event in which a person is injured or killed. The 
common hallmark of an accident is bodily injury of varying degrees. The prevention 
of accidental injuries begins with the identification of hazards: the better the 
different hazards are recognized, the more effectively prevention addresses them, 
reducing the risk of accidents and reducing accidents. 
In the FinHealth 2017 Study, there were two questions related to accidental 
injuries (Questions 12 and 13), incorporated in the section of Questionnaire 2 where 
survey respondents provide a self-assessment of their health status.  
The first question aimed at collecting information regarding the type and partly 
the circumstances of accidental injuries the respondent had sustained during the year 
prior to participation in the survey. Only injuries which had required medical care 
were included.  
 
Respondents could tick ‘yes’ or ‘no’ boxes for a selection of options:  
• traffic accidents (distinguishing between those involving motor vehicles and 
others, incl. bicycles), 
• work injuries,  
• injuries during on the to or from work (if not a road traffic accident),  
• home and leisure time injuries (separately indoors and outdoors) and 
• sport injuries (separately indoors and outdoors).  
 
The second question aimed to gauge the impact of injuries on the functional ability 
of the respondents. They were requested to give the number of days – in the course 
of 12 months prior to the survey – normal activities of daily living were impossible 
or very difficult to them as a result of their injuries. 
The data collected on injuries during the FinHealth 2017 Study are not directly 
comparable to those from the Health 2000 (Heistaro 2008) and 2011 Surveys 
(Lundqvist & Mäki-Opas 2016), due to changes in the focus and structuring of the 
pertinent questions, as well as the method of data collection.  
Data collection approaches over the different studies have strengths and 
weaknesses, since they focus on different aspects of injury and its impact on 
functional ability and daily living. In earlier studies, the role of injury as a 
permanent disability factor was emphasized. Thus the survey identified more severe 
injuries, but did not provide information on the circumstances in which they 
occurred. The current FinHealth 2017 question setting combines information on the 
impact of the injury on functional ability of respondents, with basic data on the 
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circumstance (type) of injury, which in turn is essential background for targeting of 
injury prevention activities. 
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17 Sexual and reproductive 
health 
Päivikki Koponen, Reija Klemetti and Kirsi Liitsola 
 
Most questions on reproductive and sexual health were based on questions included 
in previous Finnish surveys, in the Health 2000/2011 and/or the FINRISK surveys. 
A few questions were adapted and specified, e.g. due to changes in hormone therapy 
for women and most frequently used contraceptive methods. The Health 2000/2011 
interview questions were also adapted to the self-administered questionnaires. Due 
to these adaptations comparability with the previous survey questions on 
reproductive health is limited. In addition, three new questions on sexual behaviour 
were included.  
Questions on reproductive health were at the end of Questionnaire 1 and these 
were targeted to women. First, there were questions on hormonal contraception: 
using contraceptive pills, intrauterine devices (IUD) or other hormonal 
contraceptives currently, not now but before, and never. The total number of years 
the contraceptives had been used was also specified. Second, use of hormone 
therapy (other than contraceptives) in the form of tablets, gel, vaginal suppository, 
vaginal cream, or patch was asked with  the options of using these by prescription or 
over the counter (without prescription) or not having used any. Women were also 
asked to specify for how many years they had been using the hormone therapy. 
There was also a question on having periods nowadays, and if yes, whether the 
periods were regular and if not, why (due to hormone medication or IUD, periods 
ended naturally with menopause, because of pregnancy, or due to other reasons such 
as e.g. no uterus or other disease).  
The questions also specified breastfeeding currently, never, in total less than one 
month or the total years and months having breastfed. Questions on births, abortions, 
miscarriages, and extrauterine pregnancies had answer options of “no” or “yes, how 
many”. The women were also asked if they had ever had high blood pressure during 
pregnancy and how often they examine their own breasts by themselves (more often 
than once a month, about once a month, occasionally or never).  
Further questions on sexual and reproductive health were included at the end of 
Questionnaire 2. It was specified that these questions apply to both men and women. 
First these questions addressed experiences of infertility, seeking examinations and 
treatments due to infertility, and the success of these treatments (having a child). 
The respondents were also asked if they wish to have (more) children in the future.  
The questions on sexual behaviour in the past 12 months were related to sexual 
activity including the gender of the sex partners, the types of sex (vaginal 
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intercourse, anal intercourse, oral sex, or none of these) and the number of partners. 
Additionally, contraceptive methods used in the past 12 months were asked. 
Questions on screening and health examinations also comprised items related to 
reproductive and sexual health (e.g. mammography and cervical cancer screening, 
and HIV testing, see Chapter 19).   
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18 Functioning 
Päivi Sainio, Sari Stenholm, Heli Valkeinen, Mariitta Vaara, Markku Heliövaara 
and Seppo Koskinen 
 
WHO’s International Classification of Functioning, Disability and Health (ICF, 
WHO 2001) is a biopsychosocial approach to describe and structure functioning and 
disability. It portrays functioning and disability as a dynamic interaction between the 
health conditions and personal factors of the individual and the contextual factors of 
the environment. The ICF framework classifies human functioning on three levels: 
functioning at the level of body or body part (body functions), the whole person 
(activities), and the whole person in a social context (participation, WHO 2002). The 
ICF has also been accepted as a framework for the definition and operationalization 
of functioning and disability in population surveys by e.g. Eurostat, WHO and 
Washington Group on Disability statistics. The FinHealth 2017 Study included 
measurements on physical, psychological, cognitive and social functioning, work 
ability and usual and basic activities of daily living. Information was also gathered 
on various environmental and personal factors as well as on the health conditions. 
The topics of functioning in the FinHealth 2017 Study quite comprehensively cover 
the various components of ICF. The majority of the methods applied to measure 
functioning in the FinHealth 2017 Study are described in this chapter (Table 18.1).  
 
Table 18.1. Measures of functioning in the FinHealth 2017 Study and the chapters 
in this report where the methods are described. 
Physical functioning Chapter 18.1 
Vision, hearing Chapter 18.2 
Cognitive functioning Chapter 18.3 
Psychological functioning Chapters 14 and 12 
Social functioning  Chapter 18.4 
Basic and usual activities of daily living Chapter 18.7 
Quality of life  Chapter 10 
Work ability and working conditions Chapter 18.6 
Living environment and housing Chapter 18.8 
Use of assistive devices, use and need of help Chapter 18.9 
Activity limitations (based on the global activity limitation 
indicator, GALI) 
Chapter 18.5 
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Some of the methods have also been used in previous national surveys in 1978–80, 
2000 and 2011 (see Aromaa et al. 1989, Sievers et al. 1985, Heistaro 2008, 
Lundqvist & Mäki-Opas 2016). 
 
18.1 Physical functioning 
 
Päivi Sainio, Sari Stenholm, Heli Valkeinen, Mariitta Vaara, Markku Heliövaara 
and Seppo Koskinen 
 
The assessment of physical functioning was based on self-reports and performance 
tests (Table 18.1.1). The methods are well-established and have been widely used in 
population surveys and clinical studies (McWhinnie 1981, Sievers et al. 1985, 
Guralnik et al. 1994, Guralnik et al. 1995, Curb et al. 2006).  
 
Table 18.1.1. Methods for assessing mobility and physical functioning for adults 
aged 30 years or older in the Finnish national health examination surveys. 
 Mini-Finland 
1978–801) 
Health 20002) Health 20112) FinHealth 
20173) 
Self-reported 
items 
    
Walking 500 m interview (400m), 
questionnaire  
interview interview questionnaire 
Walking 2 km - interview interview  
Walking about in the 
apartment 
interview interview interview questionnaire5) 
Going out of home - -  questionnaire5) 
Climbing stairs for 
one flight 
interview, 
questionnaire 
interview interview questionnaire 
Climbing stairs for 
several flights 
interview, 
questionnaire 
interview interview - 
Running a short 
distance (100 m) 
questionnaire interview interview questionnaire 
Running a long 
distance (500 m) 
questionnaire interview interview - 
Walking difficulties 
due to knee pain 
interview interview questionnaire questionnaire 
Walking difficulties 
due to hip pain 
interview interview questionnaire questionnaire 
Mobility status  questionnaire interview, 
questionnaire 
interview, 
questionnaire 
- 
Preclinical 
questions on 
- - interview - 
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mobility 
Using public 
transport 
questionnaire interview interview - 
Driving a bicycle - interview - - 
Driving a car - interview interview - 
Performance tests     
Chair stand - 1 and 5 times4) 1, 5, 10 times 1, 5, 10 times 
Walking test - 6,1 m4) 6,1 m/4 m - 
Joint function test 10 tests for legs 
and arms  
10 tests4) only shoulder 
(abduction, 
internal and 
external rotation) 
and squatting4) 
only shoulder 
(abduction, 
external 
rotation) and 
squatting4) 
Grip strength both hands 
(dynamometer: 
self-constructed) 
4) 
dominating hand 
(dynamometer: 
Good Strength, 
Metitur)  
dominating hand 
(dynamometer: 
Jamar/Saehan)  
dominating 
hand 
(dynamometer: 
Jamar/Saehan)  
Standing balance - performance test: 
Guralnik’s 
protocol; postural 
sway: Good 
Balance, Metitur 
performance test: 
Guralnik’s 
protocol5) 
- 
1) Mini-Finland 
2) Health 2000 and Health 2011 Surveys   
3) FinHealth 2017 Study 
4) Only age group 55+  
5) Only age group 70+ 
 
 
Self-reported physical functioning 
 
Assessment of self-reported physical functioning focused on mobility 
(Questionnaire 1). The questions gathered information about ability to run a short 
distance (about 100 meters), ability to climb up one flight of stairs and ability to 
walk 0.5 km (Rosow & Breslau 1966, McWhinnie 1981, Aromaa et al. 1989, see 
Table 18.1.1). Questions on ability to move about from one room to another and 
ability to go out from the apartment were asked from participants aged 70 years or 
older (Questionnaire for persons aged 70 years or older). The core question in all 
items was phrased “Are you able to …?” The response options were: without 
difficulties, with minor difficulties, with major difficulties, not at all. In addition, 
two questions about difficulties in walking or limping due to hip or knee problems 
were also asked (with response options yes/no). 
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Performance tests for physical functioning 
 
Performance tests measuring mobility, strength, and joint functions were conducted 
by the study nurse and performed in a standard order, following written instructions. 
Before each test the study nurse ensured that the test could be safely administered. If 
the test was not conducted (e.g. due to severe disability), the reason for this was 
recorded in the data collection sheet. The study nurse explained and showed the test 
movements to the subject prior to each test. 
 
Hand grip strength   
 
The hand grip strength was measured with a Jamar/Saehan dynamometer (Sammong 
Preston Rolyan 2003) from the dominating hand, which was defined as the writing 
hand. If the subject could not use the dominating hand due to severe injury or 
disorder (e.g. cast due to fracture, hemiplegia), the measurement was conducted with 
the non-dominating hand. The size of the grip handle was adjusted according to the 
size of the subject’s hand. The width of the grip was appropriate, when the middle 
joint of the index finger was in a 90 degree angle. The subjects were asked whether 
they felt comfortable with the width of the grip. The subjects sat straight in a chair, 
feet slightly apart on the floor. They held the dynamometer with wrist in a neutral 
position (i.e. in slight dorsal flexion) and elbow in 90 degrees. The opposite upper 
limb was resting on the lap. The subjects were asked to grip the handle as hard as 
they could for 3–5 seconds; throughout this time the study nurse urged the subjects 
to do their best. The second measurement was conducted 30 seconds later. More 
information on the test can be found in the TOIMIA-database (in Finnish).  
 
The chair stand test 
 
The chair stand test (Csuka & McCarty 1985, Guralnik et al. 1994) was conducted 
with a standard chair with no arm rests, seat height 43–45 cm from the floor and seat 
depth 39–43 cm. The back of the chair was placed against a firm table or wall. The 
subjects were asked to sit on the chair, with arms crossed in front of the chest and 
feet on the floor and slightly apart. From this position, they were asked to stand up 
once. If this did not succeed or the subjects had to use their hands to support the 
rising, the test was ended and the performance recorded. If the subjects managed to 
get up without using hands, they were asked to get up and sit down 10 times as 
quickly as possible. A split time was taken at five stands and timekeeping was ended 
after 10 stands. The test was discontinued if it was not completed in 120 seconds, or 
if it posed any risk to the subject’s safety.  Contraindications for the 10 times 
repetitive test were myocardial or cerebral infarction within 3 months, or blood 
pressure higher than 200/120 (or 180/110 if accompanied with coronary heart 
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disease, other cardiac disease or transient ischemic attack). More information on the 
test can be found in the TOIMIA-database (in Finnish).  
 
The joint functions tests  
 
From the original joint function test protocol (Sievers et al. 1985) only two tests 
were used, squatting and abduction of the upper arms. In addition, internal rotation 
of the shoulder joints was added. The tests were conducted for persons aged 55 
years or older. 
Squatting. The subjects were asked to squat and stand up. Light support for balance 
from a table edge was allowed. Performance was rated as 1) normal, if squatting 
down (thighs at horizontal level, or thighs and calfs touching) and getting up without 
support was successful; 2) restricted, if some support was needed or if the squat was 
not full (thighs not reaching horizontal level); 3) failed, if the subject could not stand 
up without using notable support or knees were flexed less than 45 degrees (Sievers 
et al. 1985). 
Abduction of the upper arms. The subjects were asked to abduct both arms 
towards the ceiling. Each arm was rated separately: 1) normal, if the arm was raised 
up (near the head, 30 degrees short of vertical line was accepted); 2) restricted, if the 
abduction was above horizontal level but not all the way up; 3) failed, if the 
abduction remained below horizontal level (Sievers et al. 1985). 
Internal rotation of the shoulder joints. The subjects were asked to rotate one arm 
at a time behind the back to reach with fingers the lower corner of the opposite 
scapula. The performance was rated as 1) normal, if scapula was reached; 2) 
restricted, if the fingers reached only the waist level; 3) failed, if the movement was 
less (Hoppenfeld 1976). 
  
18.2 Vision and hearing 
 
Hannu Uusitalo, Alexandra Mikhailova, Päivi Sainio and Seppo Koskinen 
 
Vision was assessed on the basis of self-report and with vision charts and hearing on 
the basis of self-report only. 
 
Self-reported vision and hearing 
 
Vision and hearing were assessed in Questionnaire 1 by the question: “How do you 
manage the following activities nowadays? ...”, with four response categories 
(without difficulties, with minor difficulties, with major difficulties, not at all). For 
vision the question continues as ”… to read an ordinary newspaper print (with or 
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without glasses)”, and for hearing as “… to hear what is said in a conversation 
between several people (with or without a hearing aid)”. 
 
Visual acuity tests 
 
Binocular visual acuity was measured using well illuminated distant and near vision 
charts (Oriola). Eye glasses or contact lenses were allowed if normally worn by the 
subject. Illumination was adjusted using the lights at each examination site and an 
additional spotlight. If the test was not performed the reason was recorded in the 
data collection form, e.g. refusal. The same tests were conducted in the Health 2000 
Survey (Rudanko and Koskinen 2008) and in the Health 2011 Survey (Sainio 2016). 
Before the tests, all subjects were asked the following questions (yes/no): Have 
you had refractive surgery (to improve eyesight)? Have you had cataract surgery? 
Do you usually use spectacles or contact lenses when reading? In addition, 
information on whether the subjects were wearing their own spectacles during the 
near and/or distant vision examination was recorded. 
For the examination of near vision, the subjects held the chart at the distance 
where they could see it best. The subjects were asked to indicate the last line that 
they could still easily read. Testing was started on the line above by asking the 
subjects to read the letters on that line. If the subjects correctly identified all those 
letters or at least four letters of five, they were asked to move one line down towards 
smaller letters. The result was the lowest line on which the subject correctly 
identified at least four letters. If the subject was unable to see even the biggest letters, 
the result was entered in the data collection form as “did not see any of the lines”.  
For the examination of distant vision, the subject sat in a chair at four meters’ 
distance from the chart, with eyes at the level of the chart. As in the near vision test, 
the result was entered as the lowest line on which the subject correctly identified at 
least four letters. If the subject was unable to see even the biggest letters, the result 
was entered in the data collection form as “did not see any of the lines”. 
If the result (visus value) in the distant vision examination was <0.50, the test 
was carried out again using a pin hole test for both eyes separately. In the pin hole 
test the subjects were first asked to look through a pinhole and identify the letters on 
the line with the smallest letters that they could recognize in the previous phase. If 
they identified at least four letters on that line they were asked to move one line 
down towards smaller letters. If the vision improved in either eye compared to the 
distant vision test, the result of the pin hole test was entered as the lowest line on 
which the subject correctly identified at least four letters. Furthermore, the subjects 
were asked whether they had had their eyesight examined within the last year. 
Subjects with visual acuity values of 0.40 or less for near vision or 0.80 or less for 
distant vision were urged to contact an optician or eye specialist. If distant vision 
acuity was 0.25 or lower, the subjects were asked about rehabilitation services for 
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the visually impaired and recommended to visit an ophthalmologist or contact the 
Federation of the Visually Impaired.   
 
18.3 Cognitive functioning  
 
Annamari Tuulio-Henriksson and Päivi Sainio 
 
In the health examination, cognitive functioning was assessed with selected tasks 
from the CERAD neuropsychological test battery, originally developed for 
screening early phases of dementia and memory disturbances (Morris et al. 1989, 
Hänninen et al. 1999, Pulliainen et al. 1999, Hänninen et al. 2010). The cognitive 
functions assessed were verbal fluency, and encoding and retaining verbal material. 
Furthermore, the subjects were asked to self-evaluate their memory, ability to 
concentrate and ability to learn new things.  
 
Cognitive tests 
 
The tests were not performed if the subject’s native language was other than Finnish 
or Swedish, or if the subject had severe cognitive dysfunction that hindered the 
testing. The reason for not performing the test or refusing from it was recorded in 
the data collection form. The same tests were conducted in the Health 2000 
(Suutama et al. 2008) and Health 2011 (Tuulio-Henriksson & Sainio 2016) surveys 
as well. 
 
Verbal fluency 
 
In the test of verbal fluency, the subject was asked to say aloud as many animals as 
possible in one minute. The study nurse measured the time with a stopwatch and 
kept a tally to count the number of correctly and incorrectly cited animals, as well as 
any repetitions of the same animal, which all were recorded separately in the data 
collection form.  
 
Word list memory and word list recall 
 
The subjects were shown 10 words one after another that they were to read aloud 
and memorize. After this, the subjects were given 90 seconds to say aloud the words 
they were able to recall. Then, they read the words again, in a different order, and 
this was repeated also a third time. After each round the subjects said aloud the 
words they recalled in 90 seconds. The number of words correctly and incorrectly 
recalled after each showing was recorded in the data collection form. If the subject 
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was unable to read aloud the words, the study nurse read them out loud. The delayed 
recall of the words was assessed by asking the subjects to repeat the same words 
about five minutes later, after the grip strength test and chair stand test had been 
conducted.  
 
Self-evaluation of memory, concentration and learning new things 
 
Self-evaluation of memory, concentration and learning new things was enquired in 
Questionnaire 1. The respondents were asked to evaluate their ability in these 
functions using a 5-point response scale (very well, well, adequately, poorly, very 
poorly). The same questions were used previously in the Regional Health and 
Wellbeing Study (ATH, Murto et al. 2017). It was also used in the interview of the 
Health 2011 Survey in a slightly different form (Tuulio-Henriksson & Sainio 2016). 
 
18.4 Social functioning  
 
Tuija Martelin, Tarja Nieminen, Päivi Sainio, Seppo Koskinen and Pirjo Tiikkainen 
 
Social functioning can be defined as ability to act in close relationships and in 
different communities. For example, a person is able to interact with social 
networks, to participate and to experience social inclusion. The concept of social 
functioning has not been fully established. Due to this, it has been assessed using 
proxy indicators which have been used in measuring other related concepts, such as 
social capital and social inclusion. In general, measures are classified into two 
categories: those describing interpersonal relationships and those indicating social 
participation. (Tiikkainen & Pynnönen 2018).  
The FinHealth 2017 Study includes several questions that can be used to map 
both dimensions of social functioning. The first mentioned dimension is measured 
by questions of communication with relatives and friends, the existence of a close 
friend and feelings of loneliness as well as the availability of social support.  In 
addition, interpersonal trust and trust in reciprocity are connected with the 
functioning of social networks. Moreover, they are usually considered to be the key 
elements of social capital, along with social participation. Living alone, helping 
others (see Chapter 18.9) and satisfaction with one’s personal relationships (part of 
the EUROHIS-Qol 8-item index measuring quality of life, see Chapter 10) are also 
related to interpersonal relationships. Activity in hobbies and recreation describe 
social participation. Most of the questions measuring social functioning were also 
included in the Health 2011 Survey. 
Communication with friends and relatives was asked with a question “How often 
are you in contact with your friends and relatives who do not live in the same 
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household with you?”. Both face-to-face contacts and contacts by phone or internet 
were asked. The five options were ‘Daily or almost daily’, ‘1–3 times a week’, ‘1–3 
times a month’, ‘less than once a month’ or ‘never’ (Questionnaire 2). In addition, 
the existence of close friends was asked “Do you currently have a close friend with 
whom you can talk confidentially about almost any issues concerning yourself?” 
with answer options ‘I don’t have any close friends’, ‘I have one close friend’, ‘I 
have two close friends’ and ‘I have several close friends’ (Questionnaire 2). 
Loneliness was examined with a question “Do you ever feel lonely?” The response 
options were ‘Never’, ‘Very rarely’, ‘Sometimes’, ‘Fairly often’ or ‘All the time’ 
(Questionnaire 1).  
Social support was measured in Questionnaire 2 by means of two questions, 
based on the more extensive Social Support Questionnaire developed by Sarason et 
al. (1983). The respondents were asked to estimate their possibilities to get help 
from people close to them when in need of help or support. Several sources of help 
were listed (husband, wife or partner; other relative; friend etc.), and the respondent 
could choose several options or tick “no one”. The two items were: 1) “Who do you 
think really cares about you no matter what happened to you?”, and 2) “From whom 
do you get practical help when needed?”. 
Trust is an essential part of social communication and connectedness. It was 
measured with indicators of interpersonal trust and trust in reciprocity. Trust in other 
people was examined with a statement “It is better not to trust anyone”, which could 
be answered either ‘Absolutely agree’, ‘Somewhat agree’, ‘Somewhat disagree’ or 
‘Absolutely disagree’. Trust in reciprocity was examined with a statement “Most 
people would not want to go through the trouble to help other people” with the same 
answer options. Both statements were included in Questionnaire 2, and they were 
selected to the FinHealth 2017 form among the eight items of the short version of 
the Cook–Medley hostility scale (Cook & Medley 1954, Greenglass & Julkunen 
1989).   
Social participation was inquired in Questionnaire 1 by asking “Do you 
participate in the activities of any club, association, hobby group or religious or 
spiritual community (e.g. sports club, residents’ association, political party, choir, 
parish)?” The options were ‘No’, ‘Yes, occasionally’ or ‘Yes, actively’. Moreover, 
Questionnaire 2 included a question concerning leisure time activities: “How often 
do you practice the following activities on an average?” with the response options 
‘Every day or during most days’, ‘Once or twice a week’, ‘Once or twice a month’, 
‘Once or a few times a year’, ‘Less frequently or never’. This battery of questions 
included six items, all more or less relevant from the point of view of social 
participation: club or society activities (including posts of trust in society); theatre, 
movies, concerts, art exhibitions, sport competitions etc.; studying; church or other 
religious activities; exercise, hunting, fishing, gardening or other outdoor activity; 
and handicrafts, playing music, singing, photo-graphing, painting, collecting (e.g. 
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stamps). A corresponding set of questions has been included in several earlier 
Finnish health surveys (e.g. Aromaa et al. 1989).     
18.5 Global Activity Limitation Indicator 
 
Päivi Sainio 
 
Global Activity Limitation Indicator (GALI) is a comprehensive survey instrument 
which is used by EU and its member states as a measure of participation restrictions 
(Robine & Jagger 2003, Bogaert et al. 2018). It is also the measure underlying the 
European indicator Healthy Life Years (HLY). Originally GALI was a single 
question, but due to its complexity a routed version (comprising two questions) is 
currently recommended. A recent review has shown the concurrent and predictive 
validity as well as reliability of GALI to be good (van Oyen et al. 2018). However, 
its comparability between countries and translation validity have been questioned 
(Sihvonen et al. 2017), and it has not yet been validated in the Finnish population. 
GALI is included as a measure of disability in many European surveys, such as 
the European Health Interview Survey (EHIS), Survey on Income and Living 
Conditions (SILC) and the Survey of Health, Ageing and Retirement in Europe 
(SHARE). In Finland, it has been added to the National FinSote Survey and the 
FinHealth 2017 Study.    
The two-part GALI question was included in Questionnaire 1, after the questions 
on self-perceived health and longstanding illness or health problem. The first part of 
the question was “Are you limited because of a health problem in activities people 
usually do? Would you say you are…” with three response alternatives (severely 
limited, limited but not severely or, not limited at all). If the respondent indicated 
being limited, the question continued as “Have you been limited for at least the past 
6 months?” (yes/no). Those having any limitations (first question’s options 1 and 2) 
that had lasted at least 6 months (second question, option 1) are classified as having 
longstanding activity limitation. This is also the basis for counting Healthy Life 
Years.  
 
18.6 Work ability 
 
Päivi Sainio and Seppo Koskinen  
 
The questions concerning work ability were presented in the Questionnaire 1 and 
Questionnaire 2. Some of the instruments are described in more detail by Gould et 
al. (2008) in the report “Dimensions of Work Ability”, and in the TOIMIA-database 
(in Finnish, Gould et al. 2015). The questions were presented to all respondents 
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regardless of age or employment status (with instructions to answer according to the 
most recent job if not employed at present). Most of the questions were included 
also in the Health 2000 and Health 2011 surveys (Aromaa 2008; Gould et al. 2016). 
 
Work ability estimate 
 
In the three-level assessment of work ability, the participants were asked to assess 
their current work ability regardless of whether they worked or not (Questionnaire 
1). The options were 1=completely fit for work, 2=partially unable to work, and 
3=completely unable to work. The question originates from the Mini-Finland Survey 
(Aromaa et al. 1989) and it has thereafter been included in many health surveys, e.g. 
Health 2000 and Health 2011.  
 
Work ability score 
 
In Questionnaire 1, the respondents were asked to compare their current work ability 
to their best lifetime work ability on a scale from 0 to 10, where a score of 0 
represented full work disability and a score of 10 indicated work ability at its best. 
This question was also included in the Heath 2000 and Health 2011 Surveys, and it 
is part of the Work Ability Index (WAI, Tuomi et al. 2006); however, not all 
questions in the WAI were included in the FinHealth 2017 Study. 
 
Other questions on work ability and working conditions 
 
Questionnaire 2 included four questions on work ability. Sickness absence was 
inquired with a question “Over the past 12 months, how many whole days have you 
been absent from work or unable to do your chores due to illness?”. Furthermore, 
the respondents were asked to assess their current work ability in relation of the 
physical as well as psychological demands of their job with a 5-point response scale 
ranging from “very good” to “very poor”. These three questions are also part of the 
Work ability index. The fourth question in this section was “In terms of your health, 
do you feel that you will be able to work in your current profession until retirement 
age? If you are not employed at present, please answer as for your most recent job”, 
with five response alternatives (I am already retired, no, probably no, probably yes, 
and yes). The three first questions were also included in the Health 2000 and Health 
2011 Surveys. 
Working conditions were inquired with the following propositions, "I can make 
many independent decisions in my job" and "I don’t have enough time to get my 
work done", with a 5-point response scale ranging from “completely agree” to 
“completely disagree” (Karasek 1985). Modified versions of these two questions 
were also included in the Health 2000 and Health 2011 Surveys.  
18 Functioning 
 
THL – Report 17/2019 94 The FinHealth 2017 Study – Methods 
 
18.7 Basic and usual activities of daily living  
 
Päivi Sainio 
 
The questions on basic and usual activities were presented to persons aged 70 years 
and older (Questionnaire for persons aged 70 years or older). Some changes and 
reductions of the items were made compared to the Health 2011 Survey. The items 
were modified from the Katz index of ADL and the Lawton IADL scale (Katz et al. 
1963, Katz et al. 1970, Lawton and Brody 1969), and some of them were already 
used in Mini-Finland Survey in 1978–80 (Aromaa et al. 1989).  The ADL (activities 
of daily living) items were dressing and undressing, cleaning teeth and mouth, and 
moving in the apartment from one room to another. The IADL (instrumental 
activities of daily living) items were: cooking or heating meals; heavy cleaning, e.g. 
carrying and beating carpets or washing windows; getting out of one’s apartment (to 
run errands, to get some fresh air); and shopping. The response categories were: 
without difficulties, with minor difficulties, with major difficulties, not able. 
Furthermore, the respondents were asked about the use of internet by themselves or 
with assistance by others. 
 
18.8 Living environment and housing 
 
Päivi Sainio 
 
Information on living environment and housing was obtained through the 
Questionnaire for persons aged 70 years or older. There were questions on the place 
of residence (a regular private residence; a sheltered housing unit, etc.), and on 
various features of the living environment and apartment of the respondent, and 
whether these features were experienced as hindering.  Questions on facilitating 
factors and safety equipment at home were also asked from persons aged 70 years or 
older. Two questions concerned the respondent’s future plans on living 
arrangements and factors affecting the decisions regarding the living arrangements. 
 
18.9 Need and use of assistance and helping others, use of 
assistive devices 
 
Päivi Sainio 
 
In Questionnaire 2, the need of help was inquired with a single question “Do you 
need and do you get help for your everyday activities due to your impaired 
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functional capacity?” with five response alternatives (I do not need help and do not 
get it; I would need help but do not get it; I get help, but not enough; I get enough 
help; I get more help than I need). Corresponding information was collected in the 
Health 2000 and Health 2011 Surveys, using more detailed questions.  
More specific questions on need and use of assistance or help in everyday 
activities (for example household work, bathing, shopping etc.) were placed in the 
Questionnaire for persons aged 70 years or older. For each activity it was inquired if 
the respondent received help, and from whom they received it. Also unmet needs for 
help were inquired. The last question inquired how often the respondents received 
help.  
Information on helping others was obtained through Questionnaire 2. First the 
respondents were inquired if they provided regular help for people not living in their 
household. Those helping such persons were then asked in what activities they 
provided assistance, and to whom (parents, grandparents, children, etc.), and how 
often. In addition, they were asked if they were a formally appointed caregiver of a 
person who is not a member of their own household. 
Secondly, questions about helping a person living in the same household were 
presented. These questions gathered information on who was helped, how much, and 
whether the respondent was a formally appointed caregiver for this person, or if 
she/he in general had ever been an informal caregiver. 
The use of assistive devices was assessed in the Questionnaire for persons aged 
70 years or older. The questions concerned assistive devices for vision, hearing, and 
mobility. 
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19 Use of health and social 
services and experiences from 
primary care 
Päivikki Koponen and Anna-Mari Aalto 
 
Most questions on health services in the FinHealth 2017 questionnaires were 
modified versions of questions included in previous Finnish surveys (Health 2000, 
Health 2011, FINRISK). Many of these questions were modified to meet the needs 
of evaluating the social and health care reform in Finland and also to simplify the 
original Health 2000/2011 interview questions for the self-administered 
Questionnaire 1 and Questionnaire 2. A few questions were in the same format as in 
the previous FINRISK Studies. Questions on social services were limited to one 
question on services related to alcohol use and questions for those aged 70 and over 
(Questionnaire for persons aged 70 years or older). 
In Questionnaire 2 the respondents were first asked about the number of 
ambulatory visits to a doctor due to illness during the past 12 months. A 
corresponding question was presented on clinic or home visits by a nurse (a public 
health nurse or other). Questions on health service utilization concerned also the 
organization where the respondent primarily seeks medical services: health centre, 
occupational or student health care, hospital outpatient clinic or other. The 
respondents were also asked about their experiences on this primary care facility 
(e.g. access, communication, participation in decision making regarding own care). 
There was one question on having been to physiotherapy on a doctor’s referral 
during the past 12 months with options “no” or “yes”. 
A series of questions on the use of dental care during the past 12 months was also 
included in Questionnaire 2 (see Chapter 15).  The questions on health service use 
because of mental health problems as well as the questions on health or social 
services related to alcohol use were cut down compared to the previous Health 
2000/2011 Surveys due to less focus on mental health in the FinHealth 2017 Study 
compared to the previous surveys. The respondents were only asked if they had used 
any such services in the past 12 months or not. The question on services related to 
alcohol use specified the use of services because of own problems or somebody 
else’s problems. 
Questions on preventive services were also modified to integrate the Health 
2000/2011 and FINRISK questions. The respondents were asked about their 
participation in any health examinations (for example in occupational health care, to 
get a driving license, or at maternity clinic): the five answer options ranged from 
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during the last 6 months to never. There were also questions if the respondent’s risk 
for diabetes or risk for heart disease had been assessed during the past 12 months 
with risk tests or risk calculators.   
The questions on screening examinations were included in Questionnaire 1 in the 
context of the questions on chronic diseases, as in the previous FINRISK Studies 
and the comparability of these questions to the previous questions in the Health 
2000/2011 Surveys is very limited. The respondents were asked if they had ever had 
their blood sugar level measured and when was the last time, with six answer 
options ranging from during the last 6 months to never or “I do not know”. Similar 
questions were presented about having cholesterol levels checked and having blood 
pressure measured.  
Questions on infectious disease screening (HIV and chlamydia tests) and on 
cancer screening were presented at the end of Questionnaire 2 after questions on 
sexual and reproductive health. The slight changes in wording and the fact that the 
questions were asked in a different context, limit the comparability with the Heath 
2000/2011 questions on screening. Questions targeted to women covered 
mammography (X-ray of the breasts), ultrasonic examinations of the breasts and 
cervix cancer screening (PAP smear). A question on PSA blood test to screen 
prostate cancer or enlargement of the prostate was targeted to men. These questions 
on screening participation were not specified to organized screening, i.e. they 
include sporadic tests. The answer options for the questions on screening ranged 
from “yes, in the past 12 months” to “never”.  
The Questionnaire for persons aged 70 years or older also included questions on 
receiving help from a municipal or private service provider, non-governmental 
organization, etc. over the past 12 months in eight different activities of living, and 
the frequency of receiving such help. This questionnaire also included questions 
inquiring if the respondent had been adequately provided with services such as home 
care, rehabilitation, support for informal care and support in getting and using 
assistive devices, services for the disabled, transport services, and evaluation of 
needs for services. The answer options included no need, would have needed but did 
not receive, has received but the service was not adequate and has received and it 
was adequate. 
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20 Contents of sub-studies in the 
FinHealth 2017 Study 
20.1 The National FinDiet 2017 Study  
 
Niina Kaartinen, Heli Tapanainen, Heli Reinivuo, Heikki Pakkala, Sanni Aalto, 
Susanna Raulio, Satu Männistö, Tommi Korhonen, Suvi Virtanen and Liisa Valsta  
 
The National FinDiet Studies conducted by the Finnish Institute for Health and 
Welfare have monitored the dietary habits and nutrient intake of the adult population 
in Finland since 1982. In the year 2017, the FinDiet Study was also part of the pan-
European EU Menu food consumption data collection effort of the European Food 
Safety Authority (EFSA) among adults, EFSA contract OC/EFSA/DATA/2015/03 
CT 1_EU Menu Finland_Adults (Valsta et al. 2018, European Food Safety 
Authority 2014). 
The methodology of the FinDiet 2017 Study is described in detail by Valsta et al. 
(2018). The methodology followed the recommendations and protocols of the EFSA 
Guidance Document on the EU Menu Methodology (European Food Safety 
Authority, 2014). The data collection was carried out at individual level on two non-
consecutive days using an open-ended, 24-hour computer-assisted dietary recall 
interview method. The first interview was administered as a computer assisted 
personal interview (CAPI) at the study site, and the second interview as a telephone 
administered 24-hour dietary recall (CATI) from the central office. The entire 
survey methodology, including the newly developed CATI protocol was piloted in 
August-September 2016. The pilot sample comprised 200 subjects living in the city 
of Helsinki.   
The sampling of the survey subjects is described in Chapter 2.3. The FinDiet 
Study sample (n= 3099) was a 30% sub-sample of the FinHealth 2017 Study sample. 
The age range of the participants in the FinDiet Study was 18–74 years. Of the 
eligible sample, 59% attended the field survey, and 57% provided an acceptable first 
24-hour recall interview. Eventually, 53% of the invited subjects (n=1655) provided 
both interviews acceptably (Valsta et al. 2018).   
A group of 10 trained dietary interviewers with a minimum of B.Sc. degree in 
Human Nutrition served as interviewers in the data collection. Of the interviewers, 6 
carried out the CAPI interviews during the field survey and 4 carried out the CATI 
interviews. In addition, 3 trained replacements were available as needed. The 
interviewers were recruited during autumn 2016 and underwent uniform two-week 
training on the interview methodology in January 2017. Eventually, the data 
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collection for the CAPI interview took place from January 30 until May 19, 2017 
and for the second, the CATI interview from February 8 until October 9, 2017, so 
they covered all the four different seasons. 
The two 24-hour dietary recall interviews took place at a minimum of 8 days 
apart. The survey calendar was organized to be representative for weekdays 
(proportion of 5/7) and weekend days (2/7 proportion).  In addition to dietary 
interviews, questionnaire data about food habits were collected, through a food 
propensity questionnaire (FPQ). The FPQ questionnaire was compiled to include 
consumption information of less commonly eaten foods to differentiate consumers 
from non-consumers of selected foods. The list of less commonly eaten foods was 
part of the EU Menu Methodology (EFSA 2014) requested by EFSA and relevant 
for risk assessment. It was compiled in collaboration with the Finnish Food 
Authority (Ruokavirasto). The FPQ also included a question on food supplement use 
based on the EU Menu Methodology. Also additional questions on selected dietary 
indicators for domestic monitoring purposes and information on food allergies, 
based on the request of EFSA, were included in the FPQ questionnaire. All 
questionnaires were available in three languages (Finnish, Swedish and English).  
During the CAPI interviews, portion size assessment was based on a validated 
country-specific and age-appropriate picture book with 170 portion size picture 
series (Paturi et al. 2006, Ovaskainen et al. 2008). During the CATI interviews, a 
shortened picture book with 23 picture series was used. Other portion size 
assessment aids included household measures, standard portions and commonly 
used utensils. During the interviews, food identification was facilitated with pictures 
shown from product catalogues or product web sites.  
The dietary software used for processing the 24-hour dietary recall interviews 
was an updated version of the in-house dietary software FINESSI (Reinivuo et al 
2010) utilizing the Release 19 of the National Food Composition Database FINELI®. 
During the data collection, codes of 1721 basic foods, 3222 recipe-based foods and 
1025 dietary supplements were available in the database. The dietary interviewer 
performed the coding of the food entries immediately during the interview.  
The quality assurance of the survey was based on detailed study protocols, 
regular meetings of the survey management group and the survey planning group, 
provision and action plan for exceptional occurrences, high quality training of the 
dietary interviewers, quality checks of the questionnaire data, automatic quality 
checks and alerts included in the dietary software procedures, monitoring of 
performed interviews throughout the study (including standardization of interviews), 
as well as on a careful cross-checking of the data collected.  
The reporting of the food consumption was based on 13 main food groups and 81 
sub-groups of foods as consumed and 14 main ingredient groups and 28 sub-groups 
of ingredients (Valsta et al. 2018). Nutrient intakes were reported for 39 nutrient 
variables. The food consumption data collection method applied, i.e. two non-
consecutive 24-hour dietary recalls, enabled modelling of usual food and nutrient 
20 Contents of sub-studies in the FinHealth 2017 Study 
 
THL – Report 17/2019 100 The FinHealth 2017 Study – Methods 
 
intakes. Usual food and nutrient intake distributions are necessary for reliable 
comparison of intakes with the dietary recommendations. 
 
20.2 Physical activity and sleep  
 
Heini Wennman, Arto Pietilä, Harri Rissanen, Tomi Mäki-Opas and Katja 
Borodulin 
 
The current development in measuring physical activity and sedentary behaviours 
emphasizes the role of objective measurements of movement over 24 hours, 
obtained by accelerometers, for example. By 24-hour assessment important aspects 
of the circadian variation in movement behaviours, including sleep can be obtained. 
The use of objective devices in large-scale population studies has become easier and 
especially wrist-worn devices have shown great potential in increasing the 
compliance to measurements. Regardless of technological development, there is still 
a need for supplementing the information collected by objective measurements using 
questionnaires. 
Global recommendations of physical activity for health date to 2010 and 
encourage to at least moderate intensity physical activity in 10 minute-bouts for at 
least 150 minutes a week (WHO 2010). The guidelines are to be updated in the near 
future as device-based measurements enable more detailed information about 
physical activity intensity, volume and bout length, as well as sedentary behaviours 
and sleep. 
As part of the FinHealth 2017 Study, a sub-sample of individuals was invited to 
the Physical Activity and Sleep sub-study. At the end of the health examination 
participants were offered a wrist-worn accelerometer to be used for 24 hours during 
seven consecutive days beginning from the health examination. There were a limited 
number of accelerometers available for the study, and thus the participants were 
only offered a device if there was one available at site. Those participants who 
belonged to the sub-sample but for whom there was no wrist-accelerometer 
available at the time of their health examination were contacted after their study visit 
and offered a device (see section Postal invitations). 
 
Objectively measured physical activity 
 
Participants were instructed to use a tri-axial, wrist-worn accelerometer (Actigraph 
GT9X Link, Actigraphcorp, Pensacola, USA) during 24 hours on seven consecutive 
days beginning from the health examination. The accelerometer was attached to a 
wrist-band and placed on the non-dominant wrist by the study personnel at the 
health examination site. The accelerometer had a display showing the time and 
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battery life of the device. The study personnel also gave oral and written information 
on the use of the accelerometer, and marked the starting time for the measurement in 
the diary. The participants were advised not to remove the device except for 
swimming, having a sauna or taking a bath. After seven days of use, the 
accelerometer and diary (see below) were mailed to the Finnish Institute for Health 
and Welfare (THL) where the accelerometer was downloaded.  
 
Non-wear and sleep diary 
 
Together with the accelerometer the participants received a diary, where they were 
asked to report the times when they had removed the accelerometer during the 
measurement days, and the bedtimes and wake-up times for their longest sleep 
period each day. Participants were instructed to check the times from the 
accelerometer display. Participants were also asked to rate the quality of their sleep 
and report the number of awakenings for their sleep period. Those who received an 
accelerometer by post (see section Postal invitations) were to write down the starting 
date and time when they took the device in use. 
 
Postal invitations 
 
Participants who belonged to the sub-study, but for whom there were no 
accelerometers available at the health examination site, were contacted afterwards 
by phone and offered an accelerometer. The protocol for the measurements was 
explained to the participant on the phone, and instructions on the use of the device 
were briefly given. Those who agreed to participate were sent an accelerometer 
attached in a wrist-band by post, together with a non-wear and sleep diary, written 
instructions and a prepaid envelope for returning the device. The participant was 
instructed to take on the device as soon as it arrived, and to wear it on the non-
dominant wrist for 24 hours during 7 consecutive days. On the 7th morning the 
device and the diary were instructed to be sent back to THL where the accelerometer 
data was analysed.  
 
Accelerometer initialization 
 
The accelerometers were initialized by trained personnel at THL. Accelerometers 
were initialized by the ActiLife software version 6.3.3. and set to measure at 100Hz 
without any restrictions (sleep mode disabled). The accelerometers were set to start 
recording 06:00 in the morning, without any stop time for the measurements. The 
starting date was chosen to be 2 to 4 days after the initialization day, to account for 
the time it took to deliver the device to the health examination sites or to the 
participants mailing address. 
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Accelerometer downloading 
 
Accelerometers were returned to THL by post. Upon arrival, the accelerometers 
were downloaded using ActiLife software 6.3.3. The downloading included a gt3x 
file and an agd file as explained below. Downloaded data files were named by 
subject ID that was verified on the diary. In cases when a diary was not returned 
with the accelerometer, the subject ID was checked from the health examination 
participation list, by comparing the device’s serial number to the serial number for 
the device given to the participant.  
The accelerometer data are primarily stored in gt3x data files that are a 
compressed data format including the raw acceleration data in binary format and the 
metadata for the device. The Gt3x files can be read by the ActiLife software or by a 
package for the statistical software R (read.gt3x). The agd files are count-based data 
representing 60 second intervals (epochs). The agd files can only be used in the 
ActiLife software for analysis. For each participant the information about the 
starting and ending times for their measurement period was linked from the diary to 
the agd-file in ActiLife. 
 
Non-wear and sleep diary 
 
The information in the diaries was manually entered into an electronic data portal 
designed for data collection at THL. The subject ID, accelerometer serial number 
and the bar code were entered to secure the coupling of the diary information to the 
right participant. Diary data entering was done continuously during the data 
collection phase and data were regularly stored as SAS data files and checked for 
abnormalities and storing errors. 
 
20.3 Urine samples 
 
Laura Råman, Liisa Valsta, Katja Borodulin, Iris Erlund, Petra Arohonka and 
Jouko Sundvall 
 
Spot urine collection 
 
A random spot urine sample was collected from subjects aged 25–74 years who 
belonged to the FinDiet sub-study (n=1546, participation rate 55.2% of the eligible 
sample, 90.9% of those who participated in the health examination). No specific 
collection instructions were given to the participants and the previous urination time 
was not recorded. Samples were carefully mixed and transferred into 1 ml aliquots 
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in cryo-tubes at the study site. Sample tubes were frozen to -20 °C immediately after 
handling. 
 
24-hour urine collection 
 
In preselected study sites (Table 20.3.1), a 24-hour urine sample collection was 
carried out in a sub-set of the FinDiet participants aged 25–74 years (n=380, 
participation rate 24.6% of the eligible sample, 40.6% of those who participated in 
the health examination, 85.6% for those who agreed to take the urine collection 
canister home for later collection at home). Subjects were asked to perform the urine 
sample collection on Sundays and the sample was returned to the study site on 
Monday morning. Subjects received two urine sample collection canisters as part of 
laboratory routine and were instructed on how the sample should be collected. 
Subjects were also given written instructions and a form where the details and 
possible deviations of the sample collection protocol were recorded (i.e. time and 
volume of sample collection, as well as information on abundant perspiration, sick 
days, menstruation and medication use during the sample collection day and in long-
term). Subjects were asked to keep the urine collection canisters in a cold place, e.g. 
in the fridge, but to avoid freezing of the sample. 
When the subjects returned the urine samples to the study site, the amount of 
urine was measured and the sample was carefully mixed before the storage samples 
were collected. A total of four sample aliquots were divided each containing 
approximately 1.5 ml of urine. All the samples were stored in -20° C immediately 
after the handling.  
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Table 20.3.1. Study sites (cities and towns) for the urine sample collection. 
 
Locations Dates for 24-h urine sub-sampling* 
Team 1 Helsinki 
 
 
Helsinki 31.1.-22.3., 23.3. 
 
Espoo  24.3.-13.4. 
 
Vantaa 18.4.-5.5. 
   
Team 2 Lahti 
 
 
Lahti 31.1. - 8.2.  
 
Riihimäki 16.2.-27.2. 
 
Heinola 28.2.-9.3. 
 
Luumäki 5.4.-12.4. 
 
Hamina 13.4., 18.4.-25.4. 
Team 3 Tampere 
 
 
Tampere 31.1-17.2. 
 
Seinäjoki 17.3.-29.3. 
Team 4 Turku 
 
 
Turku 31.1-16.2. 
 
Kaarina 2.5.-8.5. 
Team 5 Oulu 
 
 
Oulu 31.1. -10.2. 
 
Raahe 13.2.-20.2.  
 
Haukipudas 21.3.-27.3. 
 
Utsjoki 5.4.-13.4. 
Team 6 Kuopio 
 
 
Joensuu 31.1-6.2. 
 
Kuopio 23.2.-2.3. 
 
Siilinjärvi 3.3.-13.3. 
 
Iisalmi 14.3.-21.3. 
  Polvijärvi 27.3.-3.4. 
* Participants who belonged to the sub-sample and had their health examination on these dates 
were given instructions. Return of the collected urine was made on the next two subsequent Monday 
mornings at the study site 
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Spot and 24-hour urine collection validation 
 
Together with the 24-hour urine sample collection, a small validation sub-study was 
conducted (n=167, participation rate 24.3% of the eligible sample, 41.8% of those 
who participated in the health examination, 78.4% for those who agreed to take the 
urine collection canister home for later collection at home). Subjects in preselected 
study sites (Table 20.3.1), were asked to collect a random spot sample, as part of 
their 24-hour collection, to a separate collection container and return this sample 
with the rest of the collected urine in another container. The subjects were asked to 
record the time of the random spot sample collection. The volume of these random 
spot samples was measured in the laboratory and handled separately. Separated 
aliquots were pipetted and frozen immediately (in -20°C) after the handling. 
 
Storage, shipment and quality assurance of urine samples 
 
The storage and shipment of the urine samples followed the same protocol and 
principles as for the blood samples (see Chapter 6.3). Further, similar quality 
assurance protocol was applied with urine samples as described in Chapter 6.4 for 
blood samples. 
 
Laboratory measurements 
 
The laboratory measurements were performed at the biochemistry laboratory of the 
Genomics and Biomarker Unit at THL, Helsinki. The laboratory measurements 
carried out for urine samples were iodine, sodium, potassium, chloride, 
microalbumin and creatinine concentrations. Sodium, potassium, chloride, 
microalbumin and creatinine measurements were performed on a clinical chemistry 
analyser Architect ci8200 (Abbott Laboratories, Abbott Park, IL, USA). Urinary 
iodine concentration measurements were determined by inductively coupled plasma 
- mass spectrometry (ICP-MS) using an Agilent 7800 ICP-MS system (Agilent 
Technologies Inc., Santa Clara, CA, USA).The biochemistry laboratory (T077) is 
accredited by the Finnish Accreditation Service, FINAS and it fulfils the 
requirements of the standard SFS-EN ISO/IEC 17025:2005. Urinary iodine 
concentration method has been added to the scope of accreditation on 12/2017. The 
determinations for urine samples were carried out from frozen samples at the end of 
2017. Table 20.3.2 provides more detailed information concerning the methods used. 
For standardizing the measurements, the laboratory has taken part in the 
Ensuring the Quality of Urinary Iodine Procedures Program (EQUIP) organized by 
the Centers for Disease Control and Prevention CDC, Atlanta, USA and External 
Quality Assessment Schemes organized by Labquality, Helsinki, Finland. The 
quality of the results of the series of analysis was ascertained by using controls, 
which were used to determine inter assay coefficients of variation (CVs). During the 
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course of the measurements in 2017, the precision between series expressed as 
coefficients of variation (CV%), the accuracy of the methods (mean bias% ± SD) 
and the traceability of the methods are demonstrated in the Table 20.3.2. The bias 
indicates the difference between the laboratory’s own result and the target value of 
the quality assessment sample and describes the laboratory’s systematic error. 
 
Table 20.3.2. The precision between series, the accuracy of the methods and the 
traceability of the urine methods. 
Assay Method CV% ± SD, 
(N)1 
Bias% ±  SD, 
(N)2 
Traceability 
Microalbumin Immunoturbidimetric, 
Abbott 
2.7 % ± 1.4 (2) + 3.4%  ±2.5 (2) ERM-DA470/IFCC 
Chloride Ion-selective electrode 
diluted, Indirect, Abbott 
0.6 % ± 0.1 (2) - 1.0 (1) NIST SRM 918 
NIST SRM 919 
Creatinine Enzymatic, Abbott 1.1 % ± 0.1 (2) + 2.5%  ±0.3 (2) NIST SRM 914 
Iodine ICP-MS 3,6 % ± 0.1 (3) - 7,6%  ±2,2 (4) NIST SRM 2670a 
NIST SRM 3668 
Level 1 and Level 2 
Potassium Ion-selective electrode 
diluted, Indirect, Abbott 
1.2 % ± 0.4 (6) - 0.4 (1) NIST SRM 918 
NIST SRM 919 
Sodium Ion-selective electrode 
diluted, Indirect, Abbott 
0.6 %  ± 0.0 
(2) 
- 1.7 (1) NIST SRM 918 
NIST SRM 919 
CV = interassay coefficient of variation; SD = standard deviation; (N)1 = number of different controls; 
(N)2 = number of quality assessment samples 
 
20.4 Eastern Finland Study  
 
Katja Borodulin, Laura Råman and Tiina Laatikainen 
 
The Eastern Finland Study was carried out as an additional sample to increase the 
sample size in the regions of North Karelia and North Savo. Larger sample size 
enabled better local representation. The history of risk factor surveys in North 
Karelia and North Savo goes as far back as to year 1972 and the increased sample 
size enables us to analyse the longer trends utilizing also the National FINRISK 
1972–2012 Studies (Borodulin et al. 2018). The original FinHealth sample 
comprised 618 subjects in North Karelia and 515 in North Savo and the additional 
sample 1400 subjects in North Karelia and 332 in North Savo (Table 20.4.1). The 
additional sample covered men and women aged 25 to 74 years of age in the same 
locations as in the FinHealth 2017 Study. One additional town of Kitee was included 
to improve regional representation. The Chapter 2.3 for sampling provides more 
detailed information on this sample.  
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Table 20.4.1. Sample sizes by study locations in the Eastern Finland Study that was 
part of the FinHealth 2017 Study.  
Study locations Health examination 
dates 
FinHealth 2017 
sample size (n) 
Additional Eastern 
Finland sample size (n) 
Combined FinHealth 
and Eastern Finland 
sample size (n) 
North Karelia  618 1400 2018 
Joensuu 21.4.-9.5. 102 534 636 
Juuka 18.5.-24.5. 172 228 400 
Kitee 7.6.-13.6 0 182 182 
Lieksa 30.5.-6.6. 172 228 400 
Polvijärvi 10.5.-17.5. 172 228 400 
     
North Savo  515 332 847 
Iisalmi 14.6.-16.6. 172 107 279 
Kuopio  11.4.-20.4. 171 118 289 
Siilinjärvi 11.4.-20.4. 172 107 279 
 
The study design followed closely the FinHealth 2017 Study design (Figure 20.4.1), 
including also the recruitment procedure and data collection. Core measurements 
were anthropometric measurements (height, weight, body composition), blood 
pressure measurements, and blood draws. The blood draw tubes (Figure 20.4.2.) and 
aliquote tubes (Figure 20.4.3.) were slightly different from the main FinHealth 2017 
Study. Self-reported information was collected through Questionnaire 1 and 
Questionnaire 2 and the FFQ. The contents of these questionnaires were identical to 
those collected in the FinHealth 2017 Study. There were no sub-studies included in 
this additional data collection. The two study nurses (Examination Room 1 and 2) 
were the same persons as in the FinHealth 2017 Study and the bioanalyst 
(Examination Room 3) was recruited and trained separately. Training for the Eastern 
Finland Study was organized on April 10, 2017 by the study coordinators from the 
central office. There were also trained substitution personnel available for acute sick 
leaves, similarly as organized in the FinHealth Study.  
The participants were reminded if they had not confirmed their examination time 
beforehand. Health examination took on average 40 to 45 minutes for the participant. 
There were examination times available starting from 7.30 a.m. until 18 p.m. The 
participant could switch the time online or by phone. The participants arrived in a 
fasting state (minimum 4 h) and visited all examination rooms during the visit. The 
Participants were instructed to fill in Questionnaire 1 before arriving at the 
examination and Questionnaire 2 and FFQ were taken back home to be filled in later 
and mailed back to the central office. The central office sent reminding letters for 
those participants who had not filled in the questionnaires in time. Participation rates 
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were similar to those in the FinHealth participants. See Chapter 4 (Table 4.7) on 
participation for detailed information. 
 
 
  
Figure 20.4.1. Study protocol of the Eastern Finland Study.  
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Figure 20.4.2. Blood tube chart in the Eastern Finland Study in the FinHealth 2017 
Study 
 
 
 
 
 
Figure 20.4.3. Aliquote tube chart in the Eastern Finland Study in the FinHealth 
2017 Study
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21 Feedback and experiences 
21.1 Feedback to the participants on their personal results 
 
Katri Sääksjärvi, Katja Borodulin, Liisa Valsta, Niina Kaartinen and Päivikki 
Koponen 
 
At the health examination site, study personnel gave feedback to participants orally 
and using a feedback form where they recorded the participant’s own results 
regarding their blood pressure, visual acuity, waist circumference, height, weight, 
BMI, body fat percentage, hand grip strength, and the chair stand  test. The feedback 
form included reference values and recommendations. Advice for health promotion 
and follow-up was also given. This feedback form was available in three languages 
(Finnish, Swedish and English).  
Laboratory results were mailed on average six weeks after the health 
examination (available in three languages). The letter included reference and target 
values, and it was clearly marked if the participant’s personal results differed from 
these. Participants with laboratory results considered as requiring rapid feedback 
were contacted by phone by a study nurse or phycisian from THL as soon as the 
results were available, before the mailed letters. The letter included results on 
cholesterol values (total, HDL and LDL), triglyserides, lipoproteins (apoA-1 and 
apoB), blood glucose values (fP-Gluc), liver function tests (S-GT, -ALAT, -ASAT), 
inflammation levels (CRP), calcium, uric acid (S-Uraat) and kidney function (S-
Krea) tests. Following the personal results, the laboratory feedback letter included a 
short explanation about each test/value as well as advice for healthy lifestyle, 
follow-up and contacting the local health centre or occupational health service, if 
needed. 
A comprehensive personalized Health Profile was mailed to all participants 
between January and February 2018. In the Health Profile, the participants received 
a summary of the results they had already received at the examination or in the letter 
with their laboratory results, as well as some additional feedback about their own 
results based on the health examination as well as the information they had given in 
the questionnaires. The Health Profile focused on factors that can be controlled with 
health behaviour and personal choices.  
The profile leaflets included average results at the population level for persons of 
the same sex and 10-year age-group as the participants themselves, as well as 
reference or target values. The participants were adviced to compare their results 
with their own age and gender group as well as with the reference and target values. 
The Health Profile also included general advice on health promotion and advice to 
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contact the local health centre or occupational health service to seek follow-up or 
advice or care, if needed. The participants were encouraged to evaluate how the 
general advice could apply to their personal situation and to discuss these with a 
health professional when needed.  
The Health Profile included information about the most common chronic 
diseases and different dimensions of functioning as well as the most significant 
factors impacting these. Results of risk tests such as the FINRISK calculator, and the 
test for type 2 diabetes (or https://www.stopdia.fi/) and test for memory disorders 
were also included. The Health Profile focused on factors that can be controlled with 
personal choices. The Health Profile also included new feedback on body 
composition (fat mass, muscle mass and fat-free mass), information processing 
(memory tests) and mental health. Furthermore, core results on the use of 
accelerometry in the sub-sample on physical activity and sleep was given as part of 
the Health Profile.  
All the feedback forms, letters and the Health Profile included contact details for 
the study nurses and researchers at THL, who gave more information or personal 
advice if needed. The number of participants who contacted the study nurse 
regarding their personal results or for additional information was rather low. If 
needed, the participants were adviced to contact their own physician or a local nurse.  
A personalized letter about the results from the FinDiet was sent in July-August 
2018. The dietary feedback was based on the two non-consecutive 24-hour dietary 
recalls, and included results of selected nutrients such as intake of energy nutrients, 
sugar, dietary fiber, vitamin C, calcium and salt. Regarding food consumption, the 
intake of vegetables, fruit and berries was reported. The feedback letter also 
included advice for health promoting dietary choices. 
The effort to give feedback to participants was important as giving feedback was 
used as an incentive when participants were recruited. The possibility to get personal 
laboratory test results and a Health Profile was mentioned already in the invitation 
letter, as well as on the internet pages of the FinHealth 2017 Study. In addition, the 
central office personnel were trained to motivate participation to the health 
examination when interacting with invitees. The information, that each participant 
would receive a personal Health Profile and other personal feedback on test results 
after the survey, was an important motivator in the recruitment of participants. 
 
21.2 Feedback on the Health Profile from the participants  
 
Päivikki Koponen, Katri Sääksjärvi, Katja Borodulin and Minttu Marttila 
 
We were able to receive feedback on the Health Profile from the FinHealth 2017 
Study participants. All health examination participants who gave the biobank 
21 Feedback and experiences 
 
THL – Report 17/2019 112 The FinHealth 2017 Study – Methods 
 
consent were invited to a subsequent, new study (the P5 study) that aims to find out 
whether the study participants benefit from getting access to information related to 
their genome and metabolism. The P5 study evaluates how the participants perceive 
the individual information they are provided with and how the received information 
affects their lifestyles and health behaviour. The P5 study questionnaire included a 
few feedback questions concerning the Health Profile. Feedback from the P5 study 
participants can be somewhat positively biased as these persons may be those who 
are most interested in getting information about their own health. A little more than 
half of the FinHealth 2017 Study health examination participants returned the P5 
questionnaire (n=3437).  
The response options for the questions on opinions and experiences (Likert scale 
statements) concerning the Health Profile ranged from “fully agree” to “fully 
disagree”.  The majority of the respondents fully agreed that the Health Profile was 
interesting and useful, and gave new information about their health. A minority 
agreed (fully or partly) that the profile was difficult to understand. About a fifth of 
the respondents agreed that the Health Profile had caused some worries or concern. 
More than a third of the respondents agreed that the profile had changed their own 
conceptions or opinions about their health, and/or that the profile encouraged 
making changes in their lifestyle. In the responses to an open ended question about 
the most useful and important results, the results of blood tests, measurements of 
functional capacity and body composition, and the risk tests were frequently 
mentioned. Many respondents also mentioned the comprehensive description of 
their health as the most important and useful aspect of the profile.  
In another open ended question the respondents were asked to list topics on 
which they would have preferred to receive more information. Among these, the 
diabetes and cardiovascular risk tests, memory function and dementia risks, body 
composition, sleep, vitamins (e.g. vitamin D-levels) or other blood test results (e.g. 
liver function, blood lipids), were frequently mentioned. Many respondents also told 
that they had nothing to add, as the profile was so comprehensive and included good 
explanations of the results.  Some participants also told that comparing their own 
results with those from their age group in general was very interesting. While most 
of the respondents gave only positive feedback, very few respondents considered 
that the Health Profile was quite inaccurate, too brief or too limited.       
 
21.3 Feedback from the fieldwork personnel 
 
Päivikki Koponen, Katri Sääksjärvi and Katja Borodulin 
 
An anonymous web-based feedback questionnaire was addressed at the end of the 
fieldwork period to all staff members at the central office who were in contact with 
21 Feedback and experiences 
 
THL – Report 17/2019 113 The FinHealth 2017 Study – Methods 
 
the invitees and participants, as well as to all personnel and nutritionists in the field 
teams. Nearly everybody responded and gave feedback (central office staff n=14, 
fieldwork team staff n=35). A feedback seminar for the fiedwork staff was also 
organized.   
Most telephone service staff members at the central office considered that they 
had received sufficient feedback, support and guidance on their tasks during the 
fieldwork. A few considered that it was challenging to balace their other tasks with 
the telephone service tasks. All staff members at the central office considered that 
interaction with the invitees and participants was mainly easy when confirming or 
changing survey appointments. However, contacting those who had not confirmed 
their appointment was more challenging, as it was sometimes hard to motivate the 
subjects to participate. A few persons were even unfriendly and rude as they didn’t 
want to be bothered by any surveys. Nearly everyone had experienced some 
difficulties with the IT programmes, as some of them were only half-finished when 
the fieldwork was started. All respondents had positive experiences on collaboration 
in the central office team even though the work load was sometimes very heavy. 
Some would have expected more active leadership and coordination at the central 
office and more staff for the telephone service. Some respondents suggested that 
home visits to those invitees with major problems in health and functional capacity 
would have been needed and some suggested more incentives for the participants in 
the future surveys. 
At the end of the fieldwork phase, some of the study personnel told that more 
practical training would have been needed with volunteer participants. Most field 
team members told that they had received sufficient feedback, support and guidance 
on their tasks during the fieldwork. Problems were mainly faced due to unexpected 
absences of field team members, or in arrangements for travel and accomodation. In 
a few locations the rooms reserved for the examinations were far from ideal, e.g. 
difficult access for participants or problems in indoor quality or ergonomics. 
Everyone considered the interaction with participants and giving feebcak to them as 
easy. A few had experiences on challenging situations, e.g. when elderly participants 
would have needed more time for the measurements and feedback, or when a few 
participants were very critical about the aims and purposes of the survey. Nearly all 
had faced some difficulties with the IT programmes and Internet connections. In all 
teams there had been days when the work load was considered too heavy, but they 
had also easier days, when many invitees did not attend as expected. There had also 
been some difficulties in the collaboration between the field work team and the 
central office as the coordinators at the central office were also very busy. 
For the future surveys the fieldwrk staff suggested more resources for 
coordination and better preparation so that all materials and IT programmes would 
be fully finalized and tested before the training. They also suggested that all study 
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locations and rooms would need to be checked before the teams arrived at new 
locations, and that the timetables should be more flexible. 
To motivate participation, the fieldwork staff members suggested e.g. longer 
study periods at each location, more incentives to the participants, better travel 
arrangements and subsidised travel for participants with a long distance between 
their home and the examination site, opportunities for home visits when needed and 
more publicity in media, especially social media and local newspapers, as well as 
better support from the local health service staff.  
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22 Discussion and conclusions 
Katja Borodulin, Seppo Koskinen and Päivikki Koponen 
 
This report describes in detail the planning, implementation and methods of the 
FinHealth 2017 Study. The study covered a large variety of topics related to health 
and wellbeing, measured by both clinical measurements in the health examination 
and by self-administered questionnaires. The data collection was implemented 
between January and June 2017.  
 
Strengths of the FinHealth 2017 Study are many, such as: 
• Relatively good participation rate that enables reasonable generalizability of 
the findings to the entire adult population. 
• Use of individual-level register-based data to correct for non-participation, 
improving the generalizability of the findings. 
• Continued and systematic use of standardized measurements that allow 
monitoring of changes in health and wellbeing.  
• Broad network of acknowledged experts who participated in planning the 
survey as well as in quality assessment, analyzing and reporting of the data. 
• THL organization (previously KTL) with nearly 50 years of expertise in 
management of population-based health examination surveys. 
 
The FinHealth 2017 Study was implemented the first time as a merger of the 
preceding health examination study traditions, the National FINRISK Studies and 
the Health 2000/2011 and the Mini-Finland Surveys. Both of the preceding series of 
health examination studies comprised elements that were also included in the 
FinHealth 2017 Study, with the aim of maximizing comparability with the earlier 
results. Due to the limited resources available and the tight schedule, some essential 
elements of the previous surveys were discarded, such as home visits for those who 
were unable to attend the health examination otherwise. This may have caused some 
bias, as persons with severely restricted functioning had poorer possibilities to 
participate.   
The number of study locations was narrowed down to 50 locations, whereas the 
earlier Health 2011 Survey was carried out in 60 locations, leading to potentially 
slightly poorer national representativeness of the data. The selection of the 50 
locations led also to somewhat poorer regional representativeness for the FINRISK 
Study regions, which was why these were complemented with an additional sample.  
It is clear that narrowing down the study topics, instruments and measurements 
as well as the limited resources available for recruitment of participants affect the 
quality and comparability of the data and the findings. In some topics the data is 
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mainly comparable only with the previous FINRISK Studies, in others with the 
Health 2000/2011 Surveys. In addition some new topics and items were introduced.  
Comparability with European EHIS questionnaires and EHES measurements as well 
as with other international standards was ensured, where feasible. In some topics 
ensuring national trends was considered more important than international 
comparability.  When making any international comparisons or analyzing time 
trends, all researchers utilizing the FinHealth 2017 Study data need to check in detail 
the possible limitations in comparability. The trend of declining response rates was 
halted through several actions, but some limitations in comparability arise also from 
the lower response rates, especially among the youngest and eldest age groups. 
The study protocol was developed during a careful planning phase with much 
emphasis on being able to collect up-to-date, high quality information on the total 
adult population in Finland. All decisions in the field phase were made based on the 
aim to secure the quality of the data. Thus, we believe that the FinHealth 2017 Study 
stands again as another rich and policy-relevant data set to be used by a large group 
of researchers and other stakeholders in Finland and internationally. 
As earlier (Kilpeläinen et al. 2019), the FinHealth 2017 Study results can be 
widely utilized for developing evidence based health strategies, care guidelines 
prevention interventions, and legislation needed to support promoting health and 
wellbeing. Projections for key health problems as well as for functional capacity are 
needed to support evidence based development of health and social services. The 
FinHealth 2017 Study data needs to be utilized to provide information on the social 
and health care needs of the growing aging population, and how their demanding 
service needs can be postponed and reduced. Information is also needed on changes 
in the working capacity among the working aged population, how longer and 
healthier working careers can be promoted, and which conditions promote 
employment opportunities among younger age cohorts. It is also imperative to 
evaluate how social inequalities in health and health behaviours as well as health 
and social welfare costs can be diminished. The FinHealth 2017 Study provides 
abundant, valuable and valid data for health monitoring and multidisciplinary public 
health and epidemiologic research. Register based follow-up also enhances the 
possibilities for scientific research. 
In addition, the results can be used in food industry and other fields to develop 
new heath promoting product concepts. To support clinical practice, the previously 
developed risk scores/calculators could be updated and verified with new data, and 
new risk scores can be developed, as well as reference values for clinical 
measurements can be developed based on the survey data. Examples of the further 
use of the FinHealth 2017 Study data include also e.g. estimates for the global 
burden of diseases (GBD), and evaluation of how the WHO targets for NCD 
prevention have been met in Finland.  
There is need for further development to make sure that the study results are utilized 
in their full potential. New data portals and dissemination strategies need to be 
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developed to promote open access to the fully pseudonymized data. While the 
coverage and quality of national registers is improving and new opportunities for 
health monitoring and scientific research may arise with big data from patient record 
systems, we need to evaluate the comparability of data from different sources. 
However, it is clear that registers and patient record systems will unlikely, at least in 
the near future, cover representative population level data on risk factors and many 
other key topics (e.g. functional capacity). To obtain more comprehensive health 
information and to enable full research potentials, possibilities for register linkages 
should be secured and the continuity of the long series of nationally representative 
health interview and health examination surveys needs to be secured. Regional level 
data are also needed to inform regional decisions on health promotion and 
development of the regional level health and social services. Thus, future health 
surveys need to be developed in collaboration with the regional authorities. 
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Appendix 2. Field coordination team of the FinHealth 2017 
Study 
 
Responsibility Member of the team 
Principal investigator Seppo Koskinen 
Research coordinator Katja Borodulin 
Field coordinator Hanna Valtonen 
Laboratory coordinator Laura Råman 
Central office coordinator Katri Sääksjärvi 
Person in charge of equipment and samples Elina Järvensivu 
Preparations for field work and training Päivikki Koponen 
Preparations for field work and pilot study Liisa Saarikoski 
Data manager Anne Juolevi 
Data manager Harri Rissanen 
Person in charge of IT-devices Eija Purkamo 
The logistics service (Research and Scheduling 
Service, TAP) 
Pekka Simola 
Functional capacity coordinator Päivi Sainio 
Research coordinator (FinDiet) Liisa Valsta 
Field coordinator (FinDiet) Niina Kaartinen 
Data manager (FinDiet) Heli Tapanainen 
Data manager (FinDiet) Heikki Pakkala 
Accelometer coordinator (Physical activity and 
Sleep) 
Heini Wennman 
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Appendix 3. The schedule for each team (study locations and 
dates) 
 
Team number Central location of team Study locations and dates 
Team 1 Helsinki Helsinki 31.1.-23.3. and 16.5.-19.5. 
  Espoo 24.3.-13.4. 
  Vantaa 18.4.-5.5. 
  Karkkila 8.5.-15.5. 
Team 2 Lahti Lahti 31.1.-8.2. and 12.5.-17.5. 
  Hämeenlinna 9.2.-15.2. 
  Riihimäki 16.2.-27.2. 
  Heinola 28.2.-9.3. 
  Lappeenranta 10.3.-16.3. 
  Ruokolahti 17.3.-24.3. 
  Imatra 27.3.-4.4. 
  Luumäki 5.4.-13.4. 
  Hamina 18.4.-25.4. 
  Kotka 26.4.-3.5. 
  Loviisa 4.5.-11.5.  
Team 3 Tampere Tampere 31.1.-17.2. and 24.4.-27.4. 
  Keuruu 20.2.-28.2. 
  Jyväskylä 1.3.-8.3. 
  Muurame 9.3.-16.3. 
  Seinäjoki 20.3.-29.3. 
  Ilmajoki 30.3.-7.4. 
  Valkeakoski 11.4.-21.4. 
Team 4 Turku Turku 31.1.-16.2. and 9.5.-12.5. 
  Vehmaa 17.2.-22.2.  
  Rauma 23.2.-1.3.  
  Pori 2.3.-9.3. 
  Harjavalta 10.3.-16.3. 
  Loimaa 17.3.-23.3. 
  Masku 24.3.-30.3. 
  Naantali 31.3.-6.4. 
  Forssa 7.4.-19.4. 
  Lohja 20.4.-28.4. 
  Kaarina 2.5.-8.5. 
Team 5 Oulu Oulu 31.1.-10.2. and 5.5.-9.5. 
  Raahe 13.2.-20.2. 
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  Kokkola 21.2.-28.2.  
  Vaasa 1.3.-7.3. 
  Uusikaarlepyy 8.3.-17.3. 
  Haukipudas 20.3.-27.3. 
  Rovaniemi 28.3.-4.4.  
  Utsjoki 6.4.-12.4. 
  Taivalkoski 18.4.-25.4 . 
  Kiiminki 26.4.-4.5. 
Team 6 Kuopio Joensuu 31.1.-6.2., 4.4.-6.4 and 24.4.-9.5. 
  Lieksa 7.2.-14.2. and 30.5-6.6. 
  Juuka 15.2.-22.2. and 18.5.-29.5. 
  Kuopio 23.2.-3.3., 22.3.-24.3 and 11.4.-20.4. 
  Siilinjärvi 6.3.-13.3. and 11.4.-20.4. 
  Iisalmi 14.3.-21.3. and 14.6.-16.6. 
  Polvijärvi 27.3.-3.4 and 10.5.-17.5. 
  Kitee * 7.6.-13.6. 
* Town of Kitee was additionally included in the Eastern Finland sub-study to improve regional 
representation. 
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Appendix 4. Example of morning and evening shifts in the 
daily appointment plans 
 
Coding of the type of slot: 1=normal; 2=diet; 3=normal reserve time; 4=diet reserve.  
 
Normal morning shift  Normal evening shift 
Time Rank Type of slot  Time Rank Type of slot 
7:30 1 2  11:00 1 2 
7:40 2 1  11:10 2 1 
7:50 3 1  11:20 3 1 
8:00 4 3  11:30 4 1 
8:10 5 2  11:40 5 2 
8:20 6 1  11:50 6 3 
8:30 7 1  12:00 7 1 
8:40 8 2  12:10 8 2 
8:50 9 1  12:20 9 1 
9:00 BREAK BREAK  12:30 10 1 
9:10 10 2  12:40 11 2 
9:20 11 3  12:50 12 3 
9:30 12 1  13:00 13 1 
9:40 13 2  13:10 14 2 
9:50 14 1  13:20 15 1 
10:00 15 1  13:30 16 1 
10:10 16 1  13:40 17 1 
10:20 17 4  13:50 18 4 
10:30   LUNCH  14:00   LUNCH 
10:40   LUNCH  14:10   LUNCH 
10:50   LUNCH  14:20   LUNCH 
11:00   LUNCH  14:30   LUNCH 
11:10 18 1  14:40 19 1 
11:20 19 2  14:50 20 2 
11:30 20 1  15:00 21 1 
11:40 21 1  15:10 22 3 
11:50 22 2  15:20 23 2 
12:00 23 3  15:30 24 1 
12:10 24 1  15:40 25 1 
12:20 25 2  15:50 26 2 
12:30 26 1  16:00 27 1 
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12:40 27 1  16:10 BREAK BREAK 
12:50 28 4  16:20 28 4 
13:00 29 1  16:30 29 1 
13:10 30 1  16:40 30 1 
13:20 31 2  16:50 31 2 
13:30 32 1  17:00 32 1 
13:40 33 3  17:10 33 3 
13:50 34 2  17:20 34 2 
14:00 35 1  17:30 35 1 
14:10 36 1  17:40 36 1 
14:20 37 1  17:50 37 1 
14:30 38 1  18:00 38 1 
 
